Copper(II) Coordination Chemistry of Cyclic Pseudo Hexa- and Octapeptides by Dovalil, Nina
  
 
INAUGURAL-DISSERTATION 
 
 
 
 
zur 
Erlangung der Doktorwürde 
der 
Naturwissenschaftlich-Mathematischen Gesamtfakultät 
der 
Ruprecht-Karls-Universität Heidelberg 
 
 
 
 
 
 
 
vorgelegt von 
Diplom-Chemikerin Nina Dovalil 
aus Waibstadt 
 
 
Tag der mündlichen Prüfung 19.11.2010  
  
  
 
Copper(II) Coordination Chemistry 
of 
Cyclic Pseudo Hexa- and Octapeptides 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gutachter:     
Prof. Dr. Peter Comba 
Prof. Dr. Roland Krämer
This thesis was accomplished performed in at the Inorganic Chemistry Department of the 
Ruprecht-Karls-University in Heidelberg from July 2007 until September 2010 and was 
supervised by Prof. Dr. Peter Comba.  
Experimental work was also accomplished at the Centre for Advanced Imaging (former 
CMR) at the University of Queensland, Brisbane, Australia under supervision of Prof. Dr. 
Graeme Hanson. 
 
Publications: 
Comba, Peter; Dovalil, Nina; Haberhauer, Gebhard; Hanson, Graeme R.; Kato, Yuki; Taura, 
Toshiaki “Complex formation and stability of westiellamide derivatives with copper(II)” 
2010, Journal of Biological Inorganic Chemistry. 
 
Talks: 
„Kupfer(II)-Koordinationschemie zyklischer Peptide“ 
At the annual“Weihnachtskolloqium“ of the Graduate College 850, December 2008.  
„Kupfer(II)-Koordinationschemie zyklischer Peptide“ 
At the „Koordinationschemikertreffen 2010“ in Mainz, February 2010 
 
Posters: 
“Copper(II) Chemistry of Cyclic Peptides: Towards Understanding the Metabolic Role of 
Patellamides”  
At Lecturetour Korea, Japan 2009 
“Copper(II) Chemistry of Cyclic Peptides: Towards Understanding the Metabolic Role of 
Patellamides”  
Presented at the International Conference of Bio Inorganic Chemistry, Nagoya, Japan, 2009 
“Copper(II) coordination Chemistry of Cyclic Peptides: Understanding the Metabolic Role of 
Patellamides?” 
Presented at the European Conference of Bio-Inorganic Chemistry, Thessaloniki, Greece, 
2010  
  
 
 
 
 
Für Mama und Oma 
  
 
 Acknowledgements/Danksagungen 
I 
Acknowledgements/Danksagungen 
Als erstem möchte ich Prof. Dr. Peter Comba danken, für das interessante Thema, die 
Möglichkeit nach Brisbane zu gehen, die Konferenzen zu denen ich durfte und vor allem für 
die mir gewährten Freiräume bei der Erforschung der zyklischen Peptide. Es hat mir sehr viel 
Spaß gemacht. Danke auch, für die vielen Gespräche und Diskussionen und dafür, dass deine 
Tür immer offen steht. 
Dr. Marion Kerscher sei gedankt dafür, dass sie sich durch die ganzen Seiten durchgelesen 
hat, trotz fehlender oder zu vieler Kommata und für das rote Knäul. Danke dass du dich 
durchgekämpft hast. 
Dass der DFT Teil nicht nur eine halbe Seite lang ist, verdanke ich Dr. Bodo Martin und 
Sascha Hausberg, die meine Rechenfragen mit Geduld beantworten haben. Dr. Prabha 
Vadivelu, sei dank für die MM Berechnungen in Kapitel 4. 
Ein riesen Dankeschön an Marlies von Schönebeck-Schilli und Karin Stelzer, die mich durch 
den ganzen Verwaltungsdschungel geführt haben und ohne die mir bestimmt heute noch 
Unterschriften oder Verwaltungskrams für die Annahme als Doktorand fehlen würden. 
Prof. Dr. Haberhauer, möchte ich herzlich für die Bereitstellung der Makrozyklen (H3L2, 
H3L3, H4Lox) danken, sowie Yuri Kato für die Messung der ITC Daten und Michael Westphal 
für die Messung einiger ESR und CD Daten.  
Miau und Danke Marta! Ohne dich wär’s im Mopslabor maximal halb so schön gewesen. In 
den letzten drei Jahren bist du mir echt ans Herz gewachsen – Liebe Frau Zett, die Frau D 
wird dich ganz schön vermissen. 
Prof. Graeme Hanson was a big help with all the EPR stuff, he corrected my English, 
accommodated me in Brisbane, and has become a friend. It was a great time at the CMR and 
in Brisbane! Of course I’d also like to thank all people at the CMR (or now CAI) for making 
me feel at home, during my stay there. A special thank goes to Dr. Christopher Noble, for all 
the help with the EPR, especially helium EPR, for giving me a ride, for throwing snowballs at 
me and for taking me to the stuff club for lunch. It was really fun! Ross Barnard, Luke 
Guddat, Tony Miscamble, Gary Schenk, and Chris I’d like to thank you guys for those 
productive (lunch) times, all the jokes, the high quality conversations and of course all the 
muffins (Would you please say hi to Kim from me?). 
Acknowledgements/Danksagungen  
II 
Außerdem ein herzliches Dankeschön an den kompletten AK Comba, der mein Chaos 
ertragen hat, mit dem ich viel Spaß hatte und den ich vermissen werde. Natürlich auch danke 
an die „Nachbarn/Mitbewohner“ den AK Linti (für Steine Kocher, seid ihr echt lustig ;)). Vor 
allem geht mein Dank an Philipp der meinen ganzen Schleim gemessen hat, immer und 
immer wieder… Euch allen danke ich für die schöne Zeit, die ich in 503 verbracht habe. 
Hierzu gehört natürlich auch Björn Seibold: auch wenn du schon ne ganze Weile nimmer da 
bist, war ‘ne echt schöne Zeit mit dir im Labor und das Thema ist auch ein schönes. 
Allen Mitarbeitern der chemischen Institute, die in der Analytik beschäftigt sind, möchte ich 
vielmals danken, vor allem der OC-Massenabteilung, ohne euch würde meine Analytik nicht 
existieren. Desweiteren ein Dankeschön an den AK Klein, dessen CD Spektrometer ich 
verwenden durfte und natürlich an meine Forschungspraktikanten Max Hanke, Marta 
Wolczyk, Laura Waigel und Franziska Schenk. Danke für Eure Hilfe bei Laborarbeiten. 
Ein Dank dem kleinen Gecko dafür, dass er mir nen neuen Faden geschickt hat, nachdem ich 
schon keinen hatte. Und außerdem Nervennahrung und dass du weißt, wie man oinkt. 
Thanks George for correcting my English and proofreading my thesis. 
Pubsch. Hierfür gibt’s keine richtigen Worte. Danke, dass du auch da bist, wenn alles aus ist. 
Wenn’s nur noch KO und Maulen im Doppelpack gibt und überhaupt: Ohne Dich wär doof. 
Ich bin froh, dass ich dich hab. 
Der illustren Reihe der kochenden Chemiker, aka Kochzirkel, möchte ich für die ganzen 
Pfunde danken, die ich in der Zeit zugelegt habe, ihr seid nicht ganz unschuldig. Aber lecker 
war es immer wieder. 
Danke der DFG, der HGS und dem GK850 für die finanzielle Unterstützung. 
Last but not least, gilt der wohl größte Dank meiner Familie: Tantili und Erich, den „Elfen“ 
(Cousinen), der „Schwabenfraktion“ und den „Sinsheimern“. Es ist schön, dass es euch gibt. 
Allen voran jedoch meiner Mutter und Oma, ohne euch wäre es mir nicht möglich gewesen zu 
studieren. Ihr habt immer zu mir gehalten und überhaupt: Ihr seid die Besten, ich liebe Euch! 
 Cyclic Pseudo Peptide Structures and Abbreviations 
III 
Cyclic Pseudo Peptide Structures and Abbreviations  
 
The following cyclic pseudo peptides are relevant for the present thesis. 
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Abstract 
 
Cyclic pseudo peptides that can be isolated from the marine genus lissoclinum (ascidians) 
exhibit an interesting and versatile copper(II) coordination chemistry. They are highly 
preorganized, well suited for the complexation of copper(II) and are found to preferably form 
dinuclear copper(II) complexes. The accumulation of copper(II) in the ascidians and its 
complexation in the ascidians by cyclic pseudo peptides suggests a metabolic role of the 
copper(II) complexes of these interesting molecules. Recent findings imply the involvement 
of dinuclear copper(II) complexes in capture and/or hydrolysis of atmospheric CO2. This 
thesis deals with the synthesis of the cyclic pseudo peptides H3L1, H4L4, H4L4-bn, H4Lrs, and 
H4LascA and with the investigation of the mono- and dinuclear copper(II) complexes of the 
cyclic pseudo hexa- and octapeptides H3L1-3, H3Lwa, H4L4, H4Lrs, H4Lox, and H4LascA and 
their potential as model systems for the natural macrocycles. The main focus is on the 
investigation of the dinuclear copper(II) complexes of cyclic pseudo octapeptides, their 
reaction with atmospheric CO2 to the corresponding carbonato bridged species, and the 
differences in coordination chemistry that arise from their different molecular structures 
(Chapter 4).  
An overview over the origin of the natural cyclic pseudo peptides, their preferred 
conformations, and their so far studied metal coordination chemistry together with the 
perspective of this thesis is given in Chapter 1. The syntheses of the artificial pseudo peptides 
(H3L1, H4L4, H4L4-bn, H4Lrs, and H4LascA) are described in Chapter 2.  
Chapter 3 deals with the mono- and dinuclear copper(II) complexes of the cyclic pseudo 
hexapeptides H3L1-3 and H3Lwa. The stability constants of the copper(II) complexes of H3L1-3 
have been measured by ITC (Chapter 3.2.2) and, most interestingly, it was found that at low 
base concentrations H3L2 coordinates copper(II) in an unusual way at the outside of the 
macrocycle. This coordination mode has not been reported before and was further 
investigated by EPR and NMR studies. The EPR spin Hamiltonian parameters of the 
mononuclear copper(II) complexes of H3L1-3 and H3Lwa were also calculated by DFT 
methods (see Chapter 3.2.4) and it was found that the accurate prediction of g and A tensors is 
complicated and in order to get reasonable results the consideration of the spin orbit coupling 
of copper is mandatory. However, no combination of functional and basis set was found that 
provides reliable results when used with a variety of cyclic pseudo peptides.  
Abstract  
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The coordination chemistry of the cyclic pseudo octapeptides H4L4, H4Lrs, H4Lox, and 
H4LascA is described in Chapter 4. Although all cyclic pseudo octapeptides studied show a 
high cooperativity, the addition of base was found to be mandatory in order to achieve a 
complete complexation, as per coordinated copper(II) one amide of the macrocycles is 
deprotonated. Despite their similarity, there are significant differences in the copper(II) 
coordination chemistry and in the adopted conformations of the macrocycles. The 
configuration at C was found to substantially influence the adopted conformation of the 
macrocycles. This can be nicely seen, when the X-ray structures of the tetra-imidazole macro-
cycles H4L4, H4L4-bn, and H4Lrs are compared (see Chapter 4.1). The combination of 
alternating R*- and S*-configured stereocenters in the linkers with imidazole rings seems to 
rigidify the macrocycle and leads to interesting EPR features of the dinuclear complexes. As a 
result of a so called magic angle setup, the copper(II) centers do not interact and thus exhibit 
an EPR spectrum that would usually be assigned to a mononuclear species (see 
Chapter 4.3.3). The assumed rigidity seems to influence the reaction with atmospheric CO2, as 
H4Lrs is the only cyclic pseudo octapeptide studied, where no formation of a carbonato 
bridged complex could be observed.  
H4Lox, the larger analogue of H3L2, was also found to coordinate copper(II) from the 
outside of the macrocycle, thereby building H4Lox/copper(II) 2:1 complexes (Chapter 4.4), 
comparable to the observed coordination chemistry of H3L2. This coordination mode could 
not be observed for any of the other pseudo octapeptides studied and it is likely that the 
outside coordination is only present in cyclic pseudo peptides whose heterocycles are merely 
oxazoles, e.g. H3L2 and H4Lox. The dinuclear hydroxo complexes of the cyclic pseudo 
octapeptides H4L4, H4Lox and H4LascA, [H2LnCu2II(OH)]+ (n = 4, ox, ascA) were found to 
reversibly react with atmospheric CO2 to the corresponding carbonato bridged species. This 
reaction had previously been observed for the natural pseudo peptide ascidiacyclamide and 
thus was studied in detail by experimental and computational methods (DFT and MM) by 
means of the copper(II) complexes of H4L4, to probe whether the catalytic hydration of CO2 
was a metabolic function of natural cyclic pseudo peptides. However, the reaction of H4L4 
with CO2 was found not to be catalytic. The fact that, besides H4Lrs, all studied cyclic pseudo 
octapeptides readily react with CO2 suggests that copper(II) complexes of the natural cyclic 
pseudo peptides are related to a function that includes their reaction with CO2, such as CO2 
transport or carbonate formation.  
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Die vorliegende Arbeit beschäftigt sich mit der Kupfer(II)-Koordinationschemie von 
zyklischen Pseudopeptiden, die aus Meeresorganismen, den Ascidien, isoliert werden können. 
Diese Pseudopeptide sind präorganisiert für die Koordination von Kupfer(II)ionen und weisen 
bei der Koordination einen ausgeprägten kooperativen Effekt auf, der sich in der bevorzugten 
Bildung zweikerniger Komplexe wiederspiegelt. Die hohe Konzentration an Kupfer(II) in den 
Organismen und dessen Komplexierung durch zyklische Pseudopeptide lassen vermuten, dass 
die Kupfer(II)komplexe eine Rolle im Metabolismus der Ascidien haben. Die genaue metabo-
lische Aufgabe dieser Moleküle ist noch ungeklärt, jedoch weisen neuere Ergebnisse auf eine 
mögliche Beteiligung an der Hydrolyse oder Fixierung von atmosphärischem CO2 hin. Im 
Rahmen dieser Arbeit wurden die synthetischen zyklischen Pseudopeptide H3L1, H4L4, 
H4L4-bn, H4Lrs und H4LascA synthetisiert und die ein- und zweikernigen Kupfer(II)komplexe 
der zyklischen Pseudohexa- und -oktapeptide H3L1-3, H3Lwa, H4L4, H4Lrs, H4Lox und H4LascA 
untersucht. Das Hauptaugenmerk galt der Reaktion der zweikernigen Kupfer(II)komplexe von 
zyklischen Pseudooktapeptiden mit atmosphärischem CO2 zu den entsprechenden Karbonato-
verbrückten Komplexen und den Besonderheiten in der Koordinationschemie der Makro-
zyklen, die sich aus deren unterschiedlicher Struktur ergibt (siehe Kapitel 4).  
Der Kenntnisstand ist in Kapitel 1 zusammengefasst. Dort wird auf die Herkunft der 
natürlichen zyklischen Pseudopeptide eingegangen und ein Überblick über bereits untersuchte 
Pseudopeptide, sowie deren Metallkomplexe gegeben. Die Synthese der künstlichen 
Makrozyklen (H3L1, H4L4, H4L4-bn, H4Lrs und H4LascA) ist in Kapitel 2 beschrieben. 
Die untersuchten ein und zweikernigen Komplexe der zyklischen Pseudohexapeptide 
H3L1-3 und H3Lwa werden in Kapitel 3 behandelt. Mittels ITC wurden die Komplexbildungs-
konstanten der ein und zweikernigen Kupfer(II)komplexe von H3L1-3 gemessen 
(Kapitel 3.2.2). Unerwarteterweise wurde beobachtet, dass die Koordinationschemie von 
H3L2 deutlich von der der anderen untersuchten Makrozyklen abweicht. Bei niedrigen 
Basenkonzentrationen koordiniert H3L2 Kupfer(II) an der Außenseite des Makrozyklus mit 
den Sauerstoffen der Amidbindung und bildet dabei H3L2/Kupfer(II) 2:1 Komplexe. Diese 
ungewöhnliche Koordinationsart wurde mittels ESR und NMR Studien eingehend untersucht. 
Die experimentell ermittelten ESR Parameter der einkernigen Kupfer(II)komplexe von H3L1-3 
und H3Lwa wurden mit DFT Methoden berechnet (Kapitel 3.2.4). Die präzise Vorhersage der 
Kurzfassung  
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Parameter erwies sich als schwierig, denn genaue Werte können nur erhalten werden, wenn 
die Spin-Bahn-Kopplung des Kupfers berücksichtig wird. Eine generell gültige Kombination 
aus Funktional und Basissatz, welche auf die Kupfer(II)komplexe aller zyklischen Peptide 
angewandt werden kann, konnte nicht gefunden werden. 
Kapitel 4 befasst sich mit der Koordinationschemie der zyklischen Pseudooktapeptide 
H4L4, H4Lrs, H4Lox und H4LascA. Alle Makrozyklen weisen eine ausgeprägte Kooperativität 
für die Koordination von Kupfer(II) auf, und bilden bevorzugt zweikernige Kupfer(II)-
komplexe. Um eine vollständige Komplexierung zu erreichen, ist jedoch die Zugabe von Base 
zu den Komplexlösungen zwingend erforderlich, da pro koordiniertem Kupfer(II)ion ein 
Amid Stickstoff deprotoniert wird. Obwohl sich die Pseudooktapeptide sehr ähnlich sind, gibt 
es große Unterschiede in ihrer bevorzugten Konformation und darum in ihrer 
Koordinationschemie. Die Veränderung der Konfiguration an C führt zu einer beträchtlichen 
Änderung der Konformation des Makrozyklus. Dies wird besonders deutlich, wenn man die 
Kristallstrukturen der Makrozyklen H4L4, H4L4-bn und H4Lrs vergleicht (siehe Kapitel 4.1). 
Interessanterweise sind die zweikernigen Kupfer(II)komplexe von H4Lrs die einzigen, für die 
keine Hinweise auf eine Reaktion mit atmosphärischem CO2 oder Karbonationen gefunden 
werden konnte (siehe Kapitel 4.3). Es wird vermutet, dass der Makrozyklus aufgrund der 
Kombination von R*- und S*-konfigurierten C-Kohlenstoff Atomen und eingebauten 
Imidazolringen sehr rigide wird und die Kupfer(II)zentren deshalb nicht mehr mit Karbonat 
verbrückt werden können. Bemerkenswert sind die zweikernigen verbrückten Kupfer(II)-
komplexe von H4Lrs, die Aufgrund einer „Magic Angle“ Ausrichtung der beiden Kupfer 
Zentren ein ESR Spektrum aufweisen, das dem eines einkernigen Komplexes gleicht. 
H4Lox, ein größeres Analogon des zyklischen Hexapeptids H3L2, zeigt ebenfalls die 
ungewöhnliche Koordination von Kupfer(II) über die Außenseite des Ringsystems, die bereits 
für H3L2 beobachtet wurde (Kapitel 4.4). Diese Koordinationsart konnte bei keinem der 
anderen zyklischen Oktapeptide beobachtet werden und wird von den eingebauten 
Oxazolringen verursacht. Die zweikernigen Hydroxokomplexe der Pseudopeptide H4L4, 
H4Lox und H4LascA, [H2LnCu2II(OH)]+ (n = 4, ox, ascA) reagieren mit atmosphärischem CO2 
zu den entsprechenden Karbonat-verbrückten Komplexen. Diese Reaktion wurde bereits bei 
den zweikernigen Komplexen des natürlichen Pseudooktapeptids Ascidiacyclamid beobachtet 
und wurde anhand der zweikernigen Kupfer(II)komplexe von H4L4 im Detail untersucht, um 
herauszufinden, ob es sich hierbei um die metabolische Rolle der Pseudopeptide handelt. Die 
Reaktion ist reversibel, jedoch nicht katalytisch. Die Tatsache, dass abgesehen von H4Lrs alle 
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untersuchten Makrozyklen bereitwillig mit CO2 zu den entsprechenden karbonatverbrückten 
Komplexen reagieren, lässt vermuten, dass die metabolische Aufgabe der zweikernigen 
Kupferkomplexe der natürlichen zyklischen Peptide mit CO2 zusammenhängt. Hierbei könnte 
es sich um den Transport von CO2 oder um die Bildung von Karbonat handeln. 
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1. State of the Art 
1.1. Introduction 
 
The oceans have been a source of fascination for humanity over many years. They cover more 
than 70% of the Earth’s surface and, when their depth is considered, they encompass about 
300 times the habitable volume of the terrestrial habitats on Earth. Nevertheless we are still 
far away from understanding marine life and ecosystems – the majority of marine life is not 
discovered yet, particularly that of the deep sea, and of the discovered life forms few are 
studied in detail.  
In the 1970s, secondary metabolites from marine organisms were found to have excellent 
antiviral and cytotoxic properties.[1-11] These findings and the fact that some of the drugs 
derived from them are able to overcome multidrug resistance or to act as antineoplastic agents 
has boosted the interest in molecules derived from marine organisms.[12] Prior to the discovery 
of the drug potential of marine derived molecules the pharmaceutical researches had almost 
exclusively focused on the investigation of terrestrial metabolites.[13-17] However, the 
molecular design of molecules of terrestrial origin is fairly well studied and new isolated 
substances often only repeat known themes.[18] Marine metabolites on the other hand seem to 
cleverly manipulate the molecular structure that we know, including unusual functional 
groups or stereochemical quirks.[19] With the discovery of their potential as anti cancer drugs 
the number of isolated marine substances increased significantly. In just ten years (between 
1977 and 1987) approximately 2500 molecules were isolated from marine sources.[20] Since 
then their number has continuously increased up to 3700 in 2007.[13, 21] The sensitivity of the 
marine ecosystem and the low availability of most metabolites has created an increasing 
demand for viable synthetic routes to the natural products or their model systems.[22] 
Synthesized mimics help study the function of the metabolites in the marine organisms as 
their exact metabolic purpose is still under investigation – some of the molecules, that showed 
a high anti tumor activity, are thought to be initially responsible for metal ion 
complexation.[19] They have structural features that are predestinated for metal ion 
complexation, such as functional groups, for example amides, heterocycles or ethers and 
preorganized chelate or ring structures. This is unsurprising as the oceans are a rich source for 
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a variety of metal ions. However, the number of metal complexes directly isolated from 
marine organisms is quite small.[23-25] 
In some organisms, e.g. ascidians (sea squirts), the metal ion concentration, compared to 
the surrounding seawater, was found to be increased to a large extent, especially the concen-
tration of copper(II) up to a factor of 104.[26-28] This is amazing, particularly considering the 
fact that the toxic effect of copper(II) on organisms is already observable at concentration in 
the range of 10-7 to 10-6 M.[29] In the ascidians the copper(II) chelation occurs in vivo by 
cyclic pseudo peptides that are produced by a symbiotic prochloron organism.[26, 30] Besides 
the fact that copper(II) ions are accumulated, little is known so far about the actual 
complexation chemistry of the cyclic pseudo peptides and of the chemistry of the copper(II) 
complexes of cyclic pseudo peptides. The high enrichment of copper(II) is suggestive for a 
metabolic role of the copper(II) complexes in the ascidians.[5, 31-38] A major hindrance to 
examining the chemistry of the natural metabolites is their low availability from the organism, 
only available with expensive extraction from natural sources or complex synthesis of 
artificial compounds.  
The work presented in this thesis focuses on the interaction of copper(II) ions with cyclic 
pseudo hexa- and octapeptides and the possible CO2 fixation of the dinuclear copper(II) 
complexes of the cyclic pseudo octapeptides. The studied cyclic pseudo peptides are models 
of natural compounds that can be isolated from ascidians, invertebrate marine organisms. 
 
 
1.2. Cyclic Pseudopeptides from Lissoclinum Patella and Lissoclinum 
Bistratum 
 
Sea squirts are sessile, marine animals, thus they remain firmly attached to substratum such as 
rocks and shells. Their name is derived from the Greek word , which means leather 
bottle and describes their physical appearance. They have a sac-like body structure, with a 
tough outer "tunic" made of the polysaccharide tunicin, which compared other to tunicates 
leads to a more rigid “exoskeleton”. Ascidians can be found all over the world, usually in 
shallow water with salinities over 2.5%, and are among those marine organisms whose 
copper(II) accumulation is high. The fact that copper(II) is found in the non-polar fractions 
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suggests its complexation by organic molecules, such as natural cyclic pseudo peptides, e.g. 
patellamides (see Figure 1.2). Indeed, the marine genus lissoclinum is a rich source of 
cyclopeptide alkaloids featuring multiple oxazoline, thiazoline, oxazole or thiazole rings that 
have interesting properties.[39]  
In 1980, Ireland and Scheuer reported the structure of ulicyclamide, that was isolated 
from a lissoclinum patella tunicate found near the Palau Islands in the Pacific Ocean 
(Figure 1.1).[40] In the following years, the patellamides A-E were isolated from various 
species of the genus lisoclinum patella (Figure 1.2).[41-46] 
 
               
Figure 1.1. Chemical structure of the cyclic pseudopeptides ascidiacyclamide (left) and ulicyclamide. 
The different amino acids that build up a cyclic pseudo octapeptide are color coded in the structure of 
ascidiacyclamide (left): D-valine (red), L-cysteine (blue), L-isoleucine (green) and D-threonine 
(orange).[40, 45] 
 
Five-membered heterocyclic rings are incorporated in the natural metabolites and alter-
nate in the ring sequence with amino acid residues. The five-membered heterocyclic rings 
result from the condensation of serine, threonine and cysteine side chains with the preceding 
carbonyl groups in the peptide sequence. Due to these “disguised” peptide functionalities, the 
macrocycles are also referred to as pseudo peptides, e.g. patellamides are so called pseudo 
octapeptides as each of their heterocycles is derived from the condensation reaction of two 
amino acid residues (see Figure 1.1). Cyclic pseudo peptides that contain imidazole units in 
their scaffold have not yet been isolated from nature, most likely as a result of the low natural 
abundance of diaminopropionic acid (Dap), formally the amine analogue of serine.[47-48] The 
natural cyclic pseudo peptides are produced by symbiotic cyanobacteria up to several percent-
age of the dry weight of the ascidians, and due to this rather high production it is assumed that 
the macrocycles complexes are involved in the ascidian’s metabolism.[30, 49] Furthermore, as 
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they are most likely produced in order to coordinate copper(II) it seems reasonable that the 
copper(II) complexes of the cyclic peptides are also involved in the ascidian’s metabolism. 
 
Patellamides R1 R2 R3 R4 R5 
A D-val H L-ile D-val L-ile 
B D-ala Me L-leu D-phe L-ile 
C D-ala Me L-val D-phe L-ile 
D D-phe Me L-ile D-ala L-ile 
E D-val Me L-val D-phe L-ile 
F D-phe H L-val D-val L-val 
G D-phe Me L-ile D-ala L-leu 
Ascidiacyclamide D-val Me L-ile D-val L-ile 
Figure 1.2. Scaffold of the natural cyclic pseudo octapeptides (left); substituents of the patellamides 
A-G and ascidiacyclamide (right).[41-46] 
 
Besides the described cyclic pseudo octapeptides, ascidians were also found to contain 
smaller macrocycles. Various cyclic pseudo hexapeptides could be isolated from the marine 
genus lissoclinum bistratum, found on the Great Barrier Reef (Northeast Australia). The 
structures of bistratamide A and B have been reported by Watters et al. in 1989 (see 
Figure 1.3).[42]  
 
 
Figure 1.3. Natural cyclic pseudo hexapeptides isolated from lissoclinum bistratum (bistratamide A 
and B; left) and westiellopsis prolifica (westiellamide, H3Lwa, right).[42, 50-51] 
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Three years later, in 1992, the same group reported the isolation and structure of a C3-
symmetric cyclo tris-oxazoline from a marine organism, while at the same time, Prinsep et al. 
isolated an identical substance from the terrestrial cyano bacterium westiellopsis prolifica and 
named it westiellamide (see Figure 1.3).[50-51] As most of the previous work focused on the 
pharmaceutical application of the maritime metabolites, their actual coordination chemistry is 
hardly known.[1-11] 
The synthesis of a variety of natural as well as modified cyclic pseudo peptides can be 
found in the literature.[22, 39, 52-55] Besides the naturally occurring heterocycles, imidazoles and 
oxazoles are incorporated into the macrocycle. Depending on the complexity of the desired 
macrocycle, they are either synthesized via cyclo oligomerization or cyclo dimerisation of the 
respective building blocks (see Chapter 2).  
 
 
1.3. Structural Features of Cyclic Pseudo Peptides 
 
In order to understand and investigate the copper(II) coordination chemistry of cyclic pseudo 
peptides, one has to be aware of their structural features. Studies of the conformations of 
azole-based marine cyclic peptides, both in solution and in the solid state, have provided 
valuable insights into the factors which may affect the reactivities and the biology of these 
unique secondary metabolites.[9, 43, 56-63] 
 
 
Figure 1.4. Nomenclature of the heterocyclic building blocks of the macrocycles. 
 
The structure of cyclic pseudo peptides and their analogues is dependent on the amino 
acid residues that connect the heterocycles, on the absolute configuration (R* vs. S*) of the 
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amino acids, and on the incorporated heterocycles. The macrocycles adopt a relatively rigid 
structure, as the macrocyclic ring closure fixes the position of five ring atoms (C-Cazole-Nhet-
Chet-Camide; see Figure 1.4 for nomenclature) and the incorporation of unsaturated heterocycles 
reduces the flexibility of the macrocycle as the planarity of the heterocycle is enhanced to the 
vicinal peptide group.[64-65]  
Usually, all protons of the peptide NH groups point towards the center of the ring and the 
peptide carbonyl functions towards the outside of the macrocycle. In the case of an identical 
configuration (e.g. H3Lwa, all-S*) of the amino acid that connect the heterocycles in the 
macrocycle, all amino acid residues face the same side of the molecule and adopt axial 
positions. The incorporation of oxazole or oxazoline units results in azole moieties of the 
macrocycle that are almost coplanar, whereas in the case of the thiazole or imidazole 
containing peptides, the heterocyclic moieties of the macrocycle have a cone-like structure 
(see Chapter 4.1.1).[65] The dihedral angle  [Namide-C-Cazole-X] can be taken to express the 
extent of deviation from planarity ( = 180° in case of planarity). Haberhauer et al. showed 
that the adopted angle  is dependent on the azole system and on the size of the amino acid 
side chains.[64] They calculated the change in energy of a reference system induced by a 
change of . A plot of the calculated energies is given in Figure 1.5.  
 
 
Figure 1.5. DFT-calculated (G03, B3LYP/6-31g**) energy profiles of the oxazole- , thiazole- and 
imidazole- reference systems, respectively, in relation to the dihedral angle [64-65] 
 
The energy profile reflects the flexibility of the distinct reference systems and also 
reveals the reason for the different conformations of the macrocycles. The imidazole and 
oxazole reference systems with a small side chain (Figure 1.5, left) show two minima in the 
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region of 0-200°; the minima of the imidazole system are at 90° and 150° and those of the 
oxazole system at 60° and 170°. The small thiazole reference system, on the other hand, has 
three energetically similar minima at 30°, 80° and 160° respectively, suggesting that thiazole 
containing macrocycles are slightly more flexible. The energy profiles change remarkably 
upon replacement of the methyl groups by the sterically more demanding tert-butyl groups 
(Figure 1.5, right). As a consequence of the large side groups, the rotation around the dihedral 
angle  has a higher activation barrier, and in combination with electronic effects the energy 
profile changes remarkably, especially in the region of 120°–200°. Each profile has a single 
minimum now in the range of 100°-150°. The distinctive minima are 149° for the oxazole-, 
129° for the thiazole- and 104° for the imidazole tert-butyl reference system. The computed 
preference of the azole systems for different dihedral angles corresponds to what was found in 
the X-ray structures of the respective cyclic pseudo hexapeptides (see Chapter 3). The reason 
for this difference is mainly of electronic origin: the (Cazole-Nhet)-orbital of an imidazole ring 
is high in energy and, accordingly, preferably interacts with the *(C-Namide)-orbital. The 
optimum interaction between these two orbitals is at an angle of 90°, where the *(C-Namide)- 
orbital is oriented parallel to the (Cazole-Nhet)-orbital. In contrast, the *(Cazole-Nhet)-orbital of 
an oxazole ring is of low energy and therefore preferably interacts with the energetically high 
(CC)- and (CH)-orbitals. This interaction has its optimum at an angle  of 180°.[64] 
 
 
Figure 1.6. Adopted conformations (square and figure of eight) of ascidiacyclamide and the patell-
amides in solution and the solid state.[26, 59, 66]  
 
The majority of the cyclic pseudo hexapeptides reported to date are built up from 
standard L-amino acids, resulting in all-S* configured amino acid linkers. In contrast, the 
patellamides A-G and ascidiacyclamide are built up from D- and L-amino acids and exhibit an 
A
square conformation
B (solution) C  (solid state)
figure of eight
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alternating stereochemistry in the linkers. The cyclic pseudo hexapeptides adopt a C3-sym-
metrical conformation in solution and solid state.[64, 67] The lower symmetry caused by the 
configurational difference in the linker of cyclic pseudo octapeptides enables them to adopt 
different conformations in solution and the solid state (see Figure 1.6).[26, 59, 66] In the solid 
state the formation of a intramolecular hydrogen bond network can be observed that 
presumably is no longer present in solution.[26] 
An early X-ray crystal structure determination of the C2-symmetric ascidiacyclamide, 
reported by Ishida et al., in 1988, showed that it adopts a “square” (also sometimes referred to 
as “saddle-shaped”) conformation, i.e. A in Figure 1.6, in the solid state with its thiazole and 
oxazoline rings occupying the corners of a rectangle.[58, 61, 66, 68-69] Patellamide A has a similar 
rectangular shape in the solid state, but, by contrast, the X-ray analysis of patellamide D (see 
Figure 1.7) shows that it adopts a “twisted figure of eight” conformation (see Figure 1.6, C), 
stabilized by intramolecular hydrogen-bonds and by -stacking of its thiazole rings.[59-60, 69-70] 
Ishida et al. have suggested that the different solid state conformations found in patellamides 
A and D are related to the degree of asymmetry in patellamide D.[59] 
  
 
 
Figure 1.7. X-ray (left) and chemical structure of patellamide D (right).[43] (nitrogen = blue, oxy-
gen = red, carbon = grey, sulfur = yellow, hydrogen atoms and solvent molecules are omitted for 
clarity).  
 
They conclude that the square conformation in patellamide A (and ascidiacyclamide), is 
able to resist, to a degree, the transition to the twisted figure-of-eight conformation, since this 
would lead to deformation of its preferred C2-symmetric structure. In agreement with this 
assumption, the solution conformations (measured in chloroform) of the related non-
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C2-symmetric patellamides B and C have similar twisted figure-of-eight-like backbone 
conformations, albeit without intramolecular hydrogen-bonding (see Figure 1.6, B). 
 
 
1.4. Metal Coordination to Cyclic Pseudo Peptides 
 
The previously mentioned high copper(II) concentration in ascidians together with the 
structural similarity of the cyclic pseudo peptides to aza-crown ethers and porphyrins suggests 
that the peptides are tailor made for association and binding to metal ions.[26] The interaction 
of patellamides and ascidiacyclamide with metal ions, was first studied by Hawkins et al.[71-73] 
In 1988, they reported the circular dichroism of the mono- and dinuclear copper(II) 
complexes of patellamide D.[74-75] Later on, in 1994, they reported the carbonato-bridged di-
nuclear copper(II) complex of ascidiacyclamide (Figure 1.8), where two copper(II) ions are 
bridged by a carbonate anion and embedded in the saddle-shaped ascidiacyclamide macro-
cycle.[73-74] The copper(II) ions are coordinated to three nitrogen donors, two of heterocyclic 
origin and the third originates from a deprotonated amide. The coordination sphere of 
copper(II) is completed by two water molecules. The reported affinity of the ascidia-
cyclamide–copper(II) complex for carbonate is of special interest as it suggests that these 
metal peptide conjugates could be involved in the activation and transport of CO2 in vivo for 
specific biochemical processes.[71] In this perspective the cyclic pseudo peptides are also of 
environmental interest.  
 
 
 
Figure 1.8. X-ray structure of the carbonato-bridged dinuclear copper(II) complex of ascidia-
cyclamide. Top view (left), side view (middle) and chemical structure (right).[71] (Color code: car-
bon = grey, sulfur = yellow, nitrogen = blue, oxygen = red). 
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The ongoing climate change debate demands the discovery and investigation of new 
methods and technologies that are capable to fixate and hydrolyze atmospheric CO2.[76-77] CO2 
fixation and hydrolysis usually occur at neutral to slightly basic conditions, although some 
metal complexes have been reported to hydrolyze atmospheric CO2 under acidic condi-
tions.[78-79] The hydrolysis of CO2 in general takes place in an intramolecular reaction and, 
therefore, the formation of intermolecular carbonato-bridged complexes is rare.[80-81] 
Dinuclear zinc(II) complexes that catalytically hydrolyze CO2 via a nucleophilic attack of 
coordinated water or hydroxide have been studied in detail.[82-88] However, although 
copper(II) complexes are known that react with CO2 to respective carbonato-bridged com-
plexes and also some that are able to catalyze the hydration of CO2, they have not been 
investigated in detail.[79, 89-92] 
At the same time that Hawkins et al. studied the interaction of copper(II) with ascidia-
cyclamide and patellamides, Wipf et al. described the synthesis and X-ray structure of a silver 
complex of the C3-symmetric cyclic peptide westiellamide (see Chapter 3).[53, 93] These 
studies provided the first clear evidence for the binding of lissoclinum peptides to metal ions 
and provided the impetus for further investigations in this area. 
These investigations revealed that although patellamides A, B and E easily bind to 
zinc(II) and copper(II), they show no affinity for binding to other metals, such as 
magnesium(II) and calcium(II).[62, 94-95] All studied cyclic pseudo octapeptides bind up to two 
metal ions, copper(II) and zinc(II), respectively, having binding constants in the range of 
2 x 104 to 2 x 105 for the first binding domain and 20 to 230 for the second binding site.[95] 
The CD spectra of the patellamide–metal conjugates are consistent with a square conforma-
tion of the cyclic pseudopeptide’s backbone. Jaspars et al. found that patellamide C showed a 
higher affinity for copper(II) ions than patellamide A and assigned this feature to the ability of 
patellamide C to readily change its conformation from figure-of-eight to square.[26] Complex-
ation of the second copper(II) ion then occurs without further change in conformation, 
suggesting a cooperative effect of the macrocycles, i.e. the coordination of the first metal ion 
preorganizes the macrocycle for the coordination of the second. These findings provide strong 
evidence for copper(II) as the biological relevant metal. 
In order to probe the importance of oxazoline rings in patellamides for metal chelation in 
more detail, Comba et al. synthesized analogues of patellamide A, where the oxazoline rings 
have been hydrolyzed, resulting in cyclic pseudo octapeptides that only contain two hetero-
cycles in their macrocycles. Their studies showed, that these macrocycles are also preorgan-
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ized for the complexation of copper(II) ions.[96-97] Further studies by van den Brenk et al. 
showed that hydrolyzed patellamide A coordinates potassium, see Figure 1.9.[97] As a 
consequence of the presence of hydrolyzed oxazolines, the macrocycle is larger now and 
more flexible. In the X-ray structure, the potassium(I) ion is coordinated to two thiazole-
nitrogen atoms and two amide oxygen atoms in a octahedral coordination environment, where 
the coordination sphere is completed by the oxygen atoms of two perchlorate ions.  
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Figure 1.9. X-ray (left) and chemical structure (right) of the potassium(I) complex of hydrolyzed 
ascidiacyclamide.[97] 
 
 
1.5. Synthetic Routes to Cyclic Pseudo Peptides 
 
The general synthesis used to construct macrocyclic pseudo peptides consists of two parts. 
Firstly, the heterocyclic building blocks (see Figure 1.4, for an example of a building block), 
consisting of an amino acid linker and a heterocycle, are synthesized and are secondly cyclo-
oligomerized to form the desired macrocyclic pseudo peptide. When oxazolines, which are 
very sensitive towards hydrolysis, are present in the pseudo peptides, the oxazoline forming 
ring closure is performed as one of the last synthetic steps, either after the macrocycle is 
already formed or in the preceding step.[98-100] Symmetrical pseudo peptides can also be built 
from mono- or dimeric building blocks in a one pot reaction, while asymmetric macrocycles 
require the synthesis of a linear peptide sequence with a subsequent intramolecular ring 
closure.[101] The syntheses of ascidiacyclamide and the patellamides A-C were already 
reported in the mid 1980’s by Hamada et al.[56-57, 98] As an alternative to reactions in solution, 
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solid phase reactions were developed, which are well suited to the synthesis of asymmetric 
macrocycles.[62, 96-97]  
 
 
Figure 1.10. Molecular structures of the cyclic pseudo hexapeptides H3L1-3 and octapeptides H4L4 and 
H4Lrs and their retrosynthetic disassembling into monomeric or dimeric building blocks.  
 
Recently the one-pot syntheses of macrocyclic pseudo peptides have been intensively 
studied and improved by Haberhauer et al.[52-53, 65, 102] The C3-symmetric westiellamide and its 
analogues are usually synthesized in a cyclo-oligomerisation reaction from the enantio-
merically pure azole building blocks. C4-symmetric pseudo octapeptides are either derived via 
cyclo-oligomerization of the respective monomeric azole unit (analogous to the synthesis of 
westiellamide and its analogues) or by cyclodimerisation of two coupled azole units. 
Although cyclo-dimerisation enhances the yields, it also elongates the synthesis by four time 
consuming steps. The retrosynthetic disassembling into mono- and diazole units, respectively, 
is depicted in Figure 1.10. A detailed description of the syntheses can be found in the 
experimental section (Chapter 5). 
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1.6. Aim 
 
Important questions that are related to the marine organisms and their metabolites are: why do 
ascidians and other marine organisms produce these complicated molecules? Are they rele-
vant for the ascidian’s metabolism? And if so – what is their actual function? Is it “just” metal 
ion complexation and transport in the organisms or do the metal complexes themselves have a 
metabolic role? A point of interest is the mode of interaction of copper(II) with the macro-
cycles and from where the differences between the synthetic and natural cyclic pseudo 
peptides arise. The role of the heterocyclic moieties as well as the influences of the stereo-
chemistry of the amino acid linkers and their correlation to the coordinating properties of a 
pseudo peptide are of special interest.  
 
 
Figure 1.11. Chemical structure of the studied cyclo pseudo octapeptides H4L4, H4Lrs, H4Lox, and 
H4LascA. 
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Recent experiments showed that the dinuclear copper(II) complexes of patellamide 
analogues are able to react with atmospheric CO2 and hydrolyze it to form bridged carbonato 
complexes, similar to the natural pseudo peptide ascidiacyclamide.[103] Initial experiments 
indicated that this process might be catalytic. 
The main focus of this work is the investigation of the copper(II) coordination chemistry 
of the cyclic pseudo octapeptides H4L4, H4Lrs, H4Lox, and H4LascA (see Figure 1.11). The 
stereocenters of the connecting amino acids in the natural cyclic pseudo octapeptides have an 
alternating R*- and S*- configuration and the incorporated macrocycles are oxazolines and 
thiazoles. By variation of the incorporated heterocycles, e.g. H4L4 vs H4Lox, and of the 
stereochemistry in the linkers (H4L4 vs H4Lrs), the studied macrocycles gradually approach 
the molecular design of the natural macrocycles patellamide A-G and ascidiacyclamide. This 
enables the investigation of the influence of the heterocycle and of the stereochemistry of the 
amino acids on the formation of the copper(II) complexes and on the reaction of dinuclear 
copper(II) complexes with atmospheric CO2. Thus, it is expected to gain a more sophisticated 
knowledge and new insight into a possible metabolic role of the copper(II) complexes of these 
interesting molecules.  
 
 
Figure 1.12. Chemical structure of the studied cyclic pseudo hexapeptides H3L1-3 and the natural 
cyclic pseudo hexapeptide westiellamide H3Lwa. 
 
Besides the investigation of the copper(II) coordination chemistry of cyclic pseudo 
octapeptides also cyclic pseudo hexapeptides have been studied. The smaller macrocycles 
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give rise to a different coordination chemistry. The cyclic pseudo hexapeptides H3L1-3, syn-
thetic analogues of the natural pseudo peptide westiellamide H3Lwa (see Figure 1.12) have 
been studied previously.[103] For a better understanding of their coordination chemistry, the 
complexation constants of the mono- and dinuclear will be measured by isothermal titration 
calorimetry (ITC). The emphasis in this work will be put on the calculation of the EPR 
parameters of the mononuclear copper(II) complexes of H3L1-3 and H3Lwa. The performed 
benchmark calculations will be used to find a combination of functional and basis set that 
reproduces the EPR parameters correctly. The thus identified combination can then be applied 
to dinuclear complexes and new complexes, helping to gain structural informations. 
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2. Syntheses of Cyclic Pseudo Peptides 
2.1. Synthesis of H3L1 and H4L4 
 
A detailed description of all syntheses is given in the experimental section (Chapter 5). The 
cyclic pseudo octapeptides H4L4 and H3L1, have precedence in the literature and were 
synthesized according to the published procedures. They are synthesized in a cyclo-oligomeri-
zation reaction from the monomeric imidazole building block 6 (Scheme 2.1), and the tri- and 
tetrameric products can be separated by column chromatography.[39] 
 
 
Scheme 2.1. Synthesis of H3L1 and H4L4. 
 
Variation of the dilution of the reaction mixture allowed the ratio of H3L1/H4L4 to be 
altered, at low dilution the percentage of H4L4 increases. The synthesis of the monomeric 
imidazole building block 6 is known from the literature and was prepared from methyl aceto 
acetate in six steps (see Scheme 2.2).[39] The first step was the reaction of methyl aceto acetate 
with sodium nitrate in glacial acetic acid to give the oxime 1, that was obtained in 88% yield. 
It was important to repeatedly wash the diethyl ether solution of the product with a saturated 
bicarbonate solution, in order to obtain the oxime 1 in high purity and enable its 
crystallization. In the second step, the oxime 1 was reduced with a 3 M solution of HCl in 
ethanol under a hydrogen atmosphere, using 5 % palladium on charcoal as catalyst. The 
temperature sensitive, white ammonium chloride salt 2 was obtained in high yields (85%) and 
was purified by repeated washing with cold dichloromethane. In the third step the ammonium 
chloride salt 2 was coupled to Boc-protected L-valine, using isobutyl chloroformate and 
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NMM as coupling agents, giving the Boc-protected dipeptide 3 in 75% yield. The imidazole 
ring was then formed by reaction of the Boc-protected L-valine-dipeptide 3 with acetic acid 
and an 8 M methanol solution of methylamine in xylene. The doubly protected monomeric 
methyl-imidazole building block 4 was thus obtained in moderate yields of 53%. Subsequent 
saponification with NaOH and deprotection of the amine with TFA, respectively, gave the 
desired monomer, 6, in two quantitative steps. 
 
 
Scheme 2.2. Synthesis of the monomeric building block 6. 
 
 
2.2. Synthesis of H4L4-bn 
 
As a result of its C2-symmetry, H4L4-bn cannot be synthesized in a one-pot reaction from 
monomeric building blocks. Instead, it was synthesized in a dimerisation reaction from the 
bis-imidazole building block 15 (see Scheme 2.3). The chosen reaction conditions, analogous 
to the known literature coupling of monomeric building blocks, gave the cyclic pseudo 
octapeptide H4L4-bn, using FDPP as a coupling agent, EDIPA as base and acetonitrile as 
solvent (Scheme 2.3).[39, 52] The reaction was monitored by TLC and found to be complete 
after six days. H4L4-bn was obtained in moderate yields of 48% after purification by flash 
chromatography. Suitable crystals for X-ray diffraction were obtained from H4L4-bn (see 
Chapter 4).  
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Scheme 2.3. Retrosynthetic disassembling of H4L4-bn. 
 
The bis-imidazole building block 15 was constructed in a reaction sequence from the 
monomeric benzyl and methyl imidazole building blocks 7 and 12, respectively. Firstly the 
building block 7 and 12 were coupled, using FDPP as coupling agent and EDIPA as base. The 
doubly protected bis-imidazole building block 13 was thus obtained in 60% yield. It was 
subsequently deprotected to quantitatively yield the bis-imidazole building block 15 (see 
Scheme 2.4). Both building blocks 7 and 12 are known compounds and can be synthesized 
from the ammonium chloride salt 2 in moderate yields.[52, 104] 
 
 
Scheme 2.4. Synthesis of the bis-imidazole building block 15. 
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The synthesis of the monomeric imidazole building block 7 is straight forward and nearly 
identical to the synthesis of the imidazole building block 6. Only the acid function was not 
saponificated.  
The synthesis of the benzyl imidazole building block 12 is more complicated and 
involves a series of deprotection and reprotection steps (see Scheme 2.5). It is available from 
the ammonium chloride salt 2 in a five step synthesis. In the first reaction step, the ammonium 
chloride salt 2 was coupled with Cbz-protected L-valine to the Cbz-protected dipeptide 8 in 
moderate yields of (46%). The reaction conditions were identical to those of the synthesis of 
the Boc-protected dipeptide 3. In the second reaction step, the Boc-protected dipeptide 8 was 
reacted with 8 M ammonia in ethanol and trifluoro acetic acid in xylene to give the doubly 
protected monomeric imidazole building block 9, that can be obtained in moderate yields 
(50%). Subsequently the Cbz group was changed to the Boc group by the reaction with 
di-tert-butyl dicarbonate giving the Boc-protected imidazole building block 10 in 88% yield. 
In the following reaction step building block 10 was reacted with benzylbromide and sodium 
hydride in DMF to give the Boc-protected benzyl-imidazole building block 11 in high yield 
(95%), which was then quantitatively converted to the monomeric benzyl-imidazole building 
block 12 by saponification. 
 
 
Scheme 2.5. Synthesis of the monomeric benzyl-imidazole building block 12. 
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2.3. Synthesis of H4Lrs 
 
H4Lrs was prepared from the bis-imidazole building block 21 in an analogous manner to the 
literature procedures for the dimerization of bis-heterocyclic building blocks to cyclic pseudo 
octapeptides (see Scheme 2.6). [39, 52] 
 
 
Scheme 2.6. Synthesis of H4Lrs. 
 
The reaction was performed at room temperature, and a complete conversion of the 
starting material was achieved after three days. The crude cyclic pseudo octapeptide H4Lrs 
was then purfied by flash column chromatography and obtained in moderate yields of 51%. 
The bis-imidazole building block 21 was synthesized by analogy to the synthesis of the bis-
imidazole building block 15. 
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Scheme 2.7. Synthesis of the bis-imidazole building block 21. 
 
The ammonium chloride salt 2 was converted to the D-valine dipeptide 16 via reaction 
with Boc-protected D-valine in THF, using NMM and isobutyl chloroformate as coupling 
agents. The dipeptide 16 was obtained in yields of 87%. In the next reaction step the 
imidazole ring was formed by reaction of the dipeptide 16 with methylamine and acetic acid 
in xylene. The doubly protected monomeric methyl-imidazole building block 17 was obtained 
in moderate yields of 51%. After the quantitative saponification, the acid 18 was coupled to 
the monomeric methyl-imidazole building block 7 to yield the doubly protected bis-imidazole 
building block 19 in 68% yield. This was then quantitatively converted to the bis-imidazole 
building block 21 by a reaction sequence of saponification and deprotection with TFA (see 
Scheme 2.7). 
 
 
2.4. Synthesis of H4LascA 
 
H4LascA was synthesized from the thiazole-oxazoline building block 31, according to a known 
procedure (see Scheme 2.8).[103] As a consequence of the easy hydrolysis of the oxazoline 
rings, acidic conditions have to be avoided throughout the synthesis. In a one-pot reaction, the 
thiazole-oxazoline building block 31 was first deprotected by stirring for one hour in 
methanol under a hydrogen atmosphere, using 10% palladium on charcoal as catalyst. After 
the removal of the catalyst and evaporation of the solvent, the crude product was dissolved in 
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acetonitrile and used without further purification in the next step. Reaction with FDPP and 
EDIPA gave the cyclic pseudo octapeptide H4LascA in poor yields of 30%.  
 
 
Scheme 2.8. Synthesis of H4LascA. 
 
The thiazole-oxazoline building block 31 was obtained in 56% yield from the monomeric 
oxazoline and thiazole building blocks 26 and 30 (see Scheme 2.11) by a coupling reaction 
using FDPP and EDIPA in acetonitrile (Scheme 2.9). 
 
 
Scheme 2.9. Synthesis of the thiazole-oxazoline building block 31. 
 
The monomeric oxazoline building block 26 was synthesized in a five-step synthesis, 
starting from L-threonine methyl ester, that in the first step was coupled with Boc-protected 
L-valine to the dipeptide 22, using isobutyl chloroformate and NMM as coupling agents. In 
the next step, the oxazoline ring was formed, using Burgess’ Reagent in dry THF, giving the 
monomeric building block 23 in 68% yield. However, the stereochemistry at the oxazoline 
does not match the desired one. Therefore, the oxazoline ring was opened using methanolic 
hydrochloric acid (80% yield) and subsequently closed again, with the desired stereo-
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chemistry under equivalent reaction conditions as for the formation of 23. The doubly 
protected monomeric building block 25 was obtained in 80% yield. Saponification of the acid 
function, using sodium hydroxide in a methanol dioxane mixture quantitatively yielded the 
oxazoline building block 26. 
 
 
Scheme 2.10. Synthesis of the monomeric oxazoline building block 26. 
 
The thiazole building block 30 was derived from the Boc-protected D-valine dipeptide 16 
in a four step synthesis. Initially the thiazole ring was formed in 72% yield, using Lawesson’s 
Reagent in THF. Subsequently, the ester functionality was quantitatively hydrolyzed to the 
thiazole acid 28, which was then converted to the benzyl protected thiazole building block 29 
in 60% yield. In the last reaction step the amine function was deprotected to quantitatively 
yield the thiazole building block 30 (Scheme 2.11). 
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Scheme 2.11. Synthesis of the thiazole building block 30. 
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3. Copper(II) Complexes of the Cyclic Pseudo Hexapeptides 
H3L1-3 
3.1. Introduction 
 
Westiellamide, a cyclic pseudo hexapeptide, that can be isolated from the marine genus 
lissoclinum bistratum and from the terrestrial genus westiellopsis prolifica, is known to 
accumulate in leukemia cells and found to inhibit cytokinesis.[105] Initial studies on the metal 
complexation of westiellamide were performed by Wipf et al., who reported an unusual Ag4 
cluster complex formed with westiellamide.[93] In this cluster three of the silver(I) ions are 
disposed in a pseudo trigonal arrangement about Ag1 and are sandwiched between two 
westiellamide, H3Lwa, macrocycles (see Figure 3.1). The central silver ion Ag1 is coordinated 
in a distorted octahedral arrangement by the carbonyl oxygen atoms of the two westiellamide 
molecules. 
 
 
 
Figure 3.1. X-ray structure of the Ag4 cluster of westiellamide.[93] 
 
In solution and the solid state, the metal free macrocycle H3Lwa adopts a highly sym-
metric configuration (see Figure 3.3), where the heterocyclic nitrogens and the amide hydro-
gen atoms point towards the inside of the macrocycle, while the isopropyl residues face to the 
same side of the macrocycle. This conformation, however, is strongly distorted in the silver 
cluster. In order to coordinate to the central silver(I) ion Ag1, the carbonyl groups of westiell-
amide are rotated towards the inside of the ring and simultaneously rotate the amide nitrogens. 
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As a result the amide nitrogen and hydrogen atoms now point towards the outside of the 
macrocycle. Apart from the interaction with silver(I), Wipf et al. only observed weak 
interactions between westiellamide and other metal ions such as sodium (I), copper(I), 
iron(II), iron(III), mercury(II), gold(II), and zinc(II).[93] 
Van den Brenk found evidence for a strong interaction of copper(II) with H3Lwa.[106] 
Further studies on the copper(II) interaction of H3Lwa and a series of its synthetic analogues 
H3L1-3 (see Figure 3.2) by Comba et al., revealed that after addition of base all cyclic pseudo 
hexapeptides readily form stable mono- and dinuclear copper(II) complexes.[107] In these 
complexes each copper(II) is coordinated by three nitrogen atoms of the macrocycle and its 
coordination sphere is completed by one or two solvent molecule. In the mononuclear 
complexes two of the coordinating nitrogen atoms originate from incorporated azole rings and 
one from the connecting amide bond, forming the Nhet-Namide-Nhet binding motif. A coordi-
nation in a Namide-Nhet-Namide motif is also possible, yet in the mononuclear complexes a strong 
preference for the coordination in the Nhet-Namide-Nhet binding motif can be observed, while in 
the dinuclear copper(II) complexes the copper(II) centers have to be bound to both binding 
sites. In order to complex copper(II), the amide nitrogen of the binding site needs to be 
deprotonated. This deprotonation is metal ion assisted and takes place at relatively low pH 
values. The protons that are released upon coordination of copper(II) acidify the solution, and 
thus addition of base is mandatory in order to achieve complete complexation. The fact that 
seawater is slightly basic (pH ~8) supports the notion that cyclic peptides are likely involved 
in metal ion coordination and transport and potentially have a metabolic role.  
 
 
Figure 3.2. Binding sites in H3L1-3 and H3Lwa. Het = heterocyclic-, A = amide-, O = oxazoline nitro-
gen. 
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Due to the similarities in shape and size of the macrocycles, H3L1-3 are possible model 
systems for westiellamide. Their differences in electronics, e.g. basicity of the heterocycles 
(pKa values: pKa (5-methyl-imidazole) = 7, pKa (5-methyl-oxazole) = 1.29, pKa (5-methyl-
thiazole) = 2.8, pKa (oxazoline) = 4.8) allows a detailed investigation of the heterocycles influ-
ence on the copper(II) complex stabilities.[108] This might reveal new ideas about the meta-
bolic role of westiellamide and cyclic peptides in general.  
H3L1-3 and H3Lwa have a common backbone, derived from L-valine amino acid residues, 
and differ solely in their heterocyclic donor groups. Plots of their X-ray structures are shown 
in Figure 3.3.[64] Importantly, the difference in the heterocycles results in a subtle difference 
of the shape of the four macrocycles as the single bonds of the oxazoline rings of westiell-
amide H3Lwa enlarge the flexibility of the macrocycle.  
 
 
 
Figure 3.3. Top (top) and side view (bottom) of the X-ray structures of H3L1-3 and H3Lwa. From left to 
right: H3L1, H3L2, H3L3, and H3Lwa. 
 
In the mononuclear complexes copper(II) is exclusively bound in the Nhet-Namide-Nhet 
binding motif. In the dinuclear copper(II) complexes, however, the second copper(II) has to 
be bound to the less favored Namide-Nhet-Namide motif. The dinuclear copper(II) complexes are 
methoxide or methanol bridged and it is assumed that methoxide or methanol is needed as an 
anchor to coordinate the second copper(II).[107]  
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3.2. Results and Discussion 
3.2.1 General Remarks 
 
The copper(II) coordination chemistry of H3L1-3 was studied by means of ESI-MS 
spectrometry, isothermal titration microcalorimetry (ITC), EPR, NMR, MCD, and UV-vis 
spectroscopy. Due to the low solubility of the macrocycles in aqueous solution, methanol was 
used as a solvent. All experiments were performed under aerobic conditions. Upon 
coordination of each copper(II) at least one amide nitrogen is deprotonated, therefore the 
number of amide protons present in the macrocycles is added to the ligand abbreviations 
(H3L3, H2L3, etc). The complexation equilibria were further studied by computational 
methods. So far no suitable crystals for X-Ray single crystal structure determination could be 
obtained from the copper(II) complexes.  
 
 
3.2.2 Determination of the Stability Constants of the Copper(II) Complexes 
of H3L1-3 
 
Isothermal titration calorimetry (ITC) is a sensitive and versatile technique, widely used to 
obtain thermodynamic data of biochemical processes at constant temperature. In an ITC 
experiment the heat released or absorbed upon binding of a host to a guest is measured and it 
is thereby possible to obtain all binding parameters of a host-guest interaction in a single 
experiment, i.e. the enthalpy ∆H°, entropy ∆S°, reaction stoichiometry N, and the binding 
constant K.[109-113] In a typical isothermal titration microcalorimetry experiment, one reactant, 
A, is titrated into a sample solution containing the other reactant B. After each addition of a 
known amount of A, the heat released or absorbed is monitored by the calorimeter. The 
thermodynamic analysis allows the quantitative characterization of the energetics of the 
processes associated with the binding reaction. The analysis of the calorimetric data is based 
on standard fitting procedures with known computational approaches.[109, 114-115] 
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The ITC experiments were performed under conditions, where the formation of either 
exclusively mono- or dinuclear copper(II) species was expected.[107] The mononuclear 
copper(II) complexes of H3L1-3 were investigated in methanolic solutions containing the 
macrocycle and triethylamine in a 1:1 ratio, and the dinuclear copper(II) complexes were 
investigated at a macrocycle to base ratio of 1:3. For the formation of the mononuclear 
copper(II) complexes [H2L1-3CuII(solvent)n]+ (n = 1,2) the equilibria described in Eq. 3.1 and 
Eq. 3.2 were considered. Eq. 3.3 - Eq. 3.6 have been considered, for the formation of the 
dinuclear copper(II) complexes [L1-3Cu2II]+.  
 
CuII+ [ H2L1-3 ሿ-  ֕  ሾH2L1-3CuII ሿశ Eq. 3.1 
K ൌ ሾH2L1-3CuII ሿ൅
[CuII] ሾH2L1-3ሿ൅
   Eq. 3.2  
 CuII+ ሾL1-3 ሿ3ି ֕  ሾL1-3CuII ሿ– Eq. 3.3 
 CuII+ ሾL1-3CuII ሿି  ֕   ሾL1-3Cu2II ሿା Eq. 3.4 
K1 ൌ ሾL1-3 CuIIሿ൅
[CuII] ሾL1-3 ሿ3-
 Eq. 3.5 
K2 ൌ ሾL
1-3Cu2
II ሿశ
[CuII] ሾL1-3CuII ሿష Eq. 3.6 
 
The parameters derived from the analysis are listed in Table 3.1 (see Appendix B for 
original data). The values are in the expected range for copper(II) binding constants to 
peptides and heterocyclic nitrogens, which generally are in a range of logK = 5-8.[116-118] The 
calculated stoichiometric parameter N indicates a diverse coordination chemistry of the cyclic 
peptides at low base concentrations. The stability constants and coordination chemistry at low 
base concentrations of the imidazole and thiazole macrocycles H3L1 and H3L3 are identical 
within experimental accuracy (logK = 5.77 (13) for [H2L1CuII]+ and 5.74 (6) for [H2L3CuII]+), 
however, the values derived for the oxazole-based ligand H3L2 differ remarkably.  
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Table 3.1. Best Fit Parameter of the ITC data obtained for the mono- and dinuclear copper(II) 
complexes (e.s.d.’s given in parentheses). Reaction conditions: methanol (µ = 0.1 M (n-Bu4N)(ClO4)), 
T = 25°C, c(H3L1-3) = 0.1 mM, base (A: c(NEt3) = 0.1 mM, B: c(NEt3) = 0.3 mM). 
The stoichiometric factor N indicates that, for H3L2 there is an unexpected formation of a 
H3L2/copper(II) 2:1 complex, while the other two cyclic pseudo peptides form the expected 
H3L1,3/copper(II) 1:1 complexes. This complex not only has a different stoichiometry but also 
differs from the other macrocycles in terms of formation entropy and enthalpy. The formation 
of the mononuclear copper(II) complexes of H3L1 and H3L3 is endotherm and thus entropy 
driven (∆S° ~ 180 J/mol, ∆H° ~ 22kJ/mol), while the formation of the H3L2/copper(II) 2 :1 
complex is exotherm (∆H° = -40kJ/mol), thus enthalpy driven. It is expected that the different 
stoichiometry of the complexes is reflected in the formation entropy and most likely also a 
different coordination mode is present in the complexes. In NMR experiments it could be 
shown that in the 2:1 complex copper(II) is coordinated by the amide oxygen atoms of the 
macrocycle instead of the nitrogen atoms of the binding site (see Section 3.2.3). In the 
mononuclear copper(II) complexes of H3L1 and H3L3 copper(II) is bound to the Nhet-Namide-
Nhet binding motif and the positive formation enthalpies indicate that copper(II) is stronger 
coordinated to the solvent (methanol) than to the binding site of the cyclic pseudo peptide. 
A [H2L1CuII(MeOH)]+ [(H3L2)2CuII(MeOH)n]+ [H2L3CuII(MeOH)]+ 
N a) 0.962 (21) 0.439 (27) 0.725 (11) 
K b) 5.85 x 105 (170) 2.41 x 105 (80) 5.60 x 105 (81) 
LogK 5.77 (0.13) 5.38 (0.14) 5.74 (6) 
∆H° [kJ/mol] 22.0 (12) -40.1 (38)  21.0 (7) 
∆S° [J/(mol K)] 184 -40 181 
B.  [L1Cu2II(µ-MeOH)]+ [L2Cu2II(µ-MeOH)]+ [L3Cu2II(µ-MeOH)]+ 
K1(b) 2.03 x 105 (22) 3.31 x 105 (83) 1.97 x 105 (19) 
LogK1 5.31 (5) 5.51 (0.11) 5.29 (4) 
∆H°1 [kJ/mol] 9.0 (7)  -113.4 (101)  -4.4(13) 
∆S°1 [J/(mol K)] 132  -274  86 
K2(b) 0.67 x 105 (0.07) 4.14 x 105 (0.99) 0.50x 105 (6) 
LogK2 4.83 (5) 5.61 (0.1) 4.69 (5) 
∆H°2 [kJ/mol] 42.6 (5) 72.1 (99) 51.2 (9) 
∆S°2 [J/mol K] 236 350 262 
a) computed CuII/(HLn)- ratio of the complex formed in solution, b) complex formation constant. 
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However, upon coordination of copper(II) to the cyclic peptide, coordinated solvent 
molecules are dissociated and the entropy of the system significantly enlarges. The deviation 
from the expected stoichiometry in the coordination of copper(II) to H3L3, N = 0.75 instead 
of 1, is presumably a result of the lower nucleophilicity of the thiazole heterocycles in 
combination with a less favorable ligand conformation (see Table 3.2), that leads to an 
incomplete complex formation under the conditions of the performed experiments.  
As expected from previous experiments, at high base concentrations all three macro-
cycles form dinuclear H3L1-3/copper(II) 1:2 complexes.[107] While at low base concentrations 
no H3L2/copper(II) 1:1 complex is observed (see stoichiometry N above), with higher base 
concentrations (starting from 1.3 equivalents of base), the formation of a H3L2/copper(II) 1:1 
complex could be detected (ITC, ESI and EPR experiments). Higher base concentrations lead 
to a higher degree of deprotonation in the cyclic pseudo hexapeptide H3L2 and the 
deprotonated (preorganized) Nhet-Namide-Nhet binding motif enables the formation of the 
mononuclear complex. From the ITC experiments it can be concluded that at three 
equivalents of base the deprotonated cyclic pseudo peptides first form the mononuclear 
copper(II) complexes and subsequently the dinuclear copper(II) complexes. H3L2 is the only 
cyclic pseudo peptide that exhibits a cooperative effect, i.e. K2 > K1 (see Table 3.1). The 
parameters of the first complexation step, at high base concentrations, in solutions of [L1]3- 
and [L3]3- (K1, ∆H°1, ∆S°1) are very similar to those obtained with lower base concentrations. 
Small differences in the values are expected due to the different degree of protonation of the 
ligands. For the second complexation step, the thermodynamics of the three ligands are very 
similar to each other. Remarkably H3L2 forms the most stable dinuclear complexes (logK2 
(H3L2) = 5.61 vs logK2 (H3L1) = 4.83 vs logK2 (H3L3) = 4.69), although it is the macrocycle 
with the least basic heterocycles. 
The issues described above must have their origin in subtle structural and electronic 
effects. DFT (density functional theory) calculations with Gaussian 03[119] were performed to 
investigate the energetic changes in the macrocyclic backbone upon coordination to one and 
two copper(II) ions. Overlay plots of the X-ray structures (see Figure 3.3) of the metal-free 
ligands H3L1-3 with the corresponding DFT-optimized structures (G03, B3LYP/6-31g*) of the 
mononuclear copper(II) complexes [H2L1-3CuII(MeOH)]+ (see Figure 3.5) reveal that upon 
copper(II) coordination, all macrocycles maintain a conformation close to that of the metal-
free ligand. However, the calculation of the relative energies of the particular macrocyclic 
conformations shows that there are remarkable differences in terms of the energy change.  
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Table 3.2. Relative single point energies [kJ/mol] of the macrocyclic ligand backbone of the mono- 
and dinuclear copper(II) complexes of H3L1-3, compared to the energy of the metal-free ligand (X-ray 
coordinates, calculated at the B3LYP/6-31g* level). 
energy [kJ/mol] H3L1  H3L2 H3L3 
X-ray structure 0 0 0 
mononuclear copper(II) complexes 
[H2LCuII(MeOH)]+ 
63.3 68.7 77.8 
dinuclear copper(II) complexes 
[LCu2II(MeOH)]2+ 
82.5 75.8 93.4 
 
The energies of the ligand conformations were calculated by taking a fully optimized 
DFT structure of the mono- or dinuclear copper(II) complexes (see Figure 3.4 for the 
calculated structures of H3L1 and Appendix C for those of H3L2,3 and H3Lwa), removing the 
copper(II) ion(s) and coligands, resaturating the ligand with hydrogen atoms, where required, 
and reoptimizing the position of the added hydrogen atoms. A single point calculation was 
then performed on the macrocyclic conformation.  
 
 
Figure 3.4. DFT calculated (G03, B3LYP/6-31g*) structures of the mono- and dinuclear copper(II) 
complexes of H3L1. 
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The relative energies listed in Table 3.2 indicate that coordination of the first copper(II) 
ion and formation of the mononuclear copper(II) complex (for H3L2 only observable at high 
base concentrations), considerably distorts the macrocyclic backbone and that the steric strain 
is similar for all three ligands. Conversely, the energy needed for the conformational change 
in the macrocycle going from a mono- to a dinuclear complex is much smaller. While H3L2 
requires a relatively small energy of 7.1 kJ/mol for the reorganization of the macrocyclic 
backbone conformation, the reorganization energy that is needed for the change of the 
macrocyclic backbones of H3L1 and H3L3 is two to three times as large (15.6 kJ/mol for H3L3 
and 19.5 kJ/mol for H3L1). The differences in energies are most the reason for the high 
stability of the dinuclear copper(II) complexes of H3L2, at high base concentrations, in spite 
of the inherently less basicity of the oxazoles, which is responsible for the formation of the 
unusual H3L2/copper(II) 2:1 complex at low base concentrations. This 2:1 complex is the 
reason for the observed negative formation entropy of [(H3L2)2CuII]2+, observed at low base 
concentrations, in contrast to the positive formation entropies of the [H2L1CuII(solvent)2]+ and 
[H2L3CuII(solvent)2]+. 
 
 
 
Figure 3.5. Overlay plots (top view) of the X-ray structures of H3L1-3 with the DFT geometry 
optimized structures (G03, B3LYP/6-31g*) of the corresponding mononuclear copper(II) complexes 
[H2L1-3CuII(MeOH)2]+ (hydrogen atoms and co-ligands omitted for clarity, carbon = grey, nitrogen = 
blue, oxygen = red). Left to right: H3L1, H3L2 and H3L3.  
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3.2.3 UV-vis and NMR spectroscopy of H3L2/copper(II)/base equilibria 
 
The unusual copper(II) coordination chemistry of H3L2 compared to H3L1, H3L3, and H3Lwa 
was investigated in more detail by UV-vis and NMR experiments. A detailed UV-vis investi-
gation of H3L1 has been performed previously.[107] UV-vis titrations were performed at 20°C 
in quartz cuvettes with a path length of 1 cm. After each titration step the well mixed solution 
was allowed to equilibrate for 5 minutes before the spectrum was measured. 1 mL of a H3L2 
solution (c(H3L2) = 2mM) was titrated with a copper(II) triflate solution (c(Cu(Otf)2) = 
40mM) in 5 µL (0.1eq) steps.  
 
 
Figure 3.6. UV-vis spectra of the titration of H3L2 (c = 2mM, methanol) with 0-2 eq copper(II) in 
0.1 eq (0-1 eq) and 1 eq (1-2 eq) steps. 
 
UV-vis spectra of the titration of copper(II) to a solution of H3L2 are shown in Figure 3.6. 
Addition of up to two equivalents of copper(II)triflate to a solution of H3L2 leads to the 
formation of an absorption band at 840 nm that approximately linearly increases with the 
copper(II) concentration. Upon binding of copper(II) to the Nhet-Namide-Nhet binding motif a 
hypsochrome shift is expected as nitrogen ligands cause a higher ligand field than oxygen 
ligands. The fact that the absorption band does not shift supports the assumption that in the 
absence of base no coordination in the Nhet-Namide-Nhet binding mode occurs, but rather 
copper(II) remains coordinated by a set of oxygen atoms. In combination with the ITC data, 
that in presence of one equivalent of base predict a H3L2/copper(II) 2:1 complex, this suggests 
  3. Copper(II) Complexes of the Cyclic Pseudo Hexapeptides H3L1-3 
37 
that copper(II) is not coordinated in the Nhet-Namide-Nhet binding side, but rather coordinated to 
the carbonyl oxygens of H3L2 in a probably similar fashion to the central silver in the Ag4 
cluster of westiellamide, reported by Wipf et al. (see Figure 3.1). The absence of copper(II) 
coordinated to the Nhet-Namide-Nhet motif could also be supported by the ESI-MS and EPR 
experiments. 
In contrast to H3L2 the time-dependant spectra of a H3L1/copper(II) 1:2 solution in 
absence of base shows a shift of the absorption maximum from 840 to 771 nm consistent with 
the coordination of copper(II) in the Nhet-Namide-Nhet binding motif of the macrocycle (see 
Figure 3.7).  
 
 
Figure 3.7. UV-vis spectra of solvated copper(II) (dotted line) and time-dependent spectra (15 min) of 
H3L1/copper(II) 1:1. 
 
13C-NMR proved to be a useful tool to probe the coordination of copper(II) by the 
carbonyl oxygens of H3L2. Paramagnetic ions, such as copper(II), coordinated to an organic 
ligand shorten the relaxation time of nearby nuclei and therefore broaden the corresponding 
NMR signals. Consecutive addition of Cu(CF3SO3)2 to a solution of H3L2 (MeOH-d4, 10 mM) 
gradually broadens the 13C-resonance of the amide carbon atom, assigned to the resonance 
observed at 162 ppm (see Figure 3.8).  
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Figure 3.8. Section of interest of the 13C-NMR spectra of H3L2 in MeOH-d4 (50 MHz, 10 mM) with 
varying amounts of CuII. 0 eq copper(II) (blue, back); 0.2 eq copper(II) (red, middle); 0.5 eq copper(II) 
(black, front); δ = 155.41 (CimCH3); 162.79 (Camide); 163.19 (NimCim) ppm (see Figure 1.4 for used 
abbreviations). 
 
After addition of 0.5 equivalents of copper(II) to the solution, the resonance of the amide 
carbon atom is broadened to an extent where it is hardly detectable. Because all other reso-
nances of H3L2 are not affected, copper(II) must interact with the corresponding carbonyl 
oxygen atom. The NMR spectra of imidazole-containing macrocycles, which are known to 
exclusively form complexes where copper(II) is coordinated in the Nhet-Namide-Nhet cleft, do 
not show this behavior. Therefore it is concluded that in the H3L2/copper(II) 2:1 complex, 
identified from the ITC experiments, the copper(II) is coordinated by at least one carbonyl 
group of each H3L2 macrocycle.[103, 107]  
 
 
3.2.4 EPR Experiments and DFT Calculation of EPR Parameters 
 
EPR experiments are commonly used to gain insight into the coordination geometry of 
complexes that contain a paramagnetic metal center. In the case of dinuclear complexes they 
also provide information about the exchange coupling constant J and the zero field splitting. 
In order to extract the structural and electronic informations the spectra need to be simulated. 
While the simulation of mononuclear complexes is generally straight forward, that of di-
nuclear complexes is often complicated. The DFT calculation of the EPR tensors of a given 
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complex can help simulate the experimentally obtained spectra, however, it is known that the 
accurate prediction of the EPR tensors of metal complexes is challenging.[120-121]  
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Table 3.3. Anisotropic spin Hamiltonian parameters of the mononuclear copper(II) complexes 
[H2L1CuII(MeOH)2]+, [H2L2CuII(MeOH)2]+, [H2L3CuII(MeOH)2]+, and [H2LwaCuII(MeOH)]+.[107], a), b) 
 [H2L1CuII]+ [H2L2CuII]+ [H2L3CuII]+ [H2LwaCuII]+ 
gx 2.088 2.083 2.082 2.083 
gy 2.051 2.034 2.037 2.051 
gz 2.278 2.279 2.263 2.267 
Ax (Cu) 17.0 17.3 15.7 14.0 
Ay (Cu) 15.4 17.2 19.9 16.2 
Az (Cu) 153.4 153.0 150.0 175 
Ax (Nhet) 14.5 15.7 14.3 12.4 
Ay (Nhet) 7.1 7.1 7.0 6.2 
Az (Nhet) 9.0 9.0 9.0 10.4 
Ax (N) – Namide (+ Nhet) c) 13.2 13.4 11.5 16.5 
Ay (N) – Namide (+ Nhet) c) 15.2 14.1 15.7 12.7 
Az (N) – Namide (+ Nhet) c) 9.5 9.5 9.5 13.4 
a) A in 10-4 cm-1; b) the simulated spectra included two magnetically equivalent heterocyclic nitrogen nuclei; 
c) for [H2LwaCuII]+. 
 
The experimental EPR parameters (see Table 3.3)[107] of the mononuclear copper(II) 
complexes of H3L1-3 and H3Lwa are known and have been simulated previously with the 
program packages XSophe-Sophe-XeprView[122] (version 1.1.4) and Molecular Sophe[123] 
(version 2.0.91), using Eq. 3.7.[124-126] So far, the EPR spectra of the dinuclear copper(II) 
complexes of H3L1-3 and H3Lwa could not be simulated in good agreement with the experi-
ment. Given that the EPR tensors of the dinuclear copper(II) complexes of a cyclic pseudo 
peptide could be reproduced by a DFT calculation, a correct simulation might be obtained and 
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provide structural informations. To ensure that the derived EPR tensors from the DFT 
calculation are accurate, benchmark calculations, using the program packages ORCA 2.6[120] 
and MAG-ReSpect 1.2[127] were performed on the mononuclear copper(II) complexes of 
H3L1-3 and H3Lwa. The benchmark calculations were performed on fully DFT optimized 
structures (G03, B3LYP/6-31g*) of the respective complexes. 
The computed g tensors of the mononuclear copper(II) complex of H3L1, derived from 
DFT calculations with various combinations of functionals and basis sets are shown in 
Table 3.4 (see Appendix D for the calculated values of the mononuclear copper(II) complex 
of H3L2, H3L3 and H3Lwa). 
 
Table 3.4. Calculated and experimental g tensors of the mononuclear copper(II) complex of H3L1. 
Calculated with program packages MAG-ReSpect and ORCA. The dependence of the g factors on the 
functional is reflected in the large deviation of the calculated values. The most accurate predicted 
parameters are denoted in bold. A visualization is given in Figure 3.9 
 Experimental g values 
Functional / Basis set#) gx = 2.088 gy = 2.051 gz = 2.278 
PBE / SVP 2.027 2.039 2.105 
PBE / 6-311g* 2.026 2.036 2.101 
TPSS / 6-311g* 2.026 2.035 2.097 
TPSS / 6-311g* a) TZVP b, c)  2.029 2.040 2.104 
B3PW / 6-311g* 2.041 2.052 2.148 
B3PW / 6-311g* a) TZVP b, c)  2.046 2.059 2.163 
B3LYP / 6-311g* a) Wachters c) 2.043 2.055 2.155 
B3LYP / 6-311g*  2.040 2.051 2.146 
B1LYP / SVP  2.046 2.059 2.163 
B1LYP / SVP a) Wachters c) 2.047 2.061 2.171 
B38LYP / IGLO-II a) Wachters c) 2.071 2.084 2.248 
B40LYP / IGLO-II a) Wachters c) 2.074 2.088 2.259 
B40LYP / IGLO-III a) Wachters c) 2.072 2.085 2.254 
BHLYP / IGLO-II a) Wachters c) 2.085 2.100 2.304 
BHLYP / EPR-II a) Wachters c) 2.084 2.099 2.303 
BHLYP / IGLO-II a) TZVP b) Wachters c) 2.090 2.100 2.310 
BHLYP / IGLO-II a) Wachters c) SOC  2.100 2.080 2.306 
MAG-ReSpect (BHandHLYP / TZVP) 2.093 2.076 2.278 
a) C, H, N, O; b) first coordination sphere; c) Cu; #)see text for references. 
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The influence of the amount of exact exchange in the functional on the calculated g 
tensors was probed by using pure GGA functionals and functionals with various amounts of 
exact exchange B3LYP (25% HF) vs B1LYP (20% HF) as well as modified BXLYP 
functionals, where X corresponds to the percentage of exact exchange. The functionals: 
PBE,[128-129] B3PW,[130-133] TPSS,[134] B3LYP,[130, 135-136] B1LYP,[137] B38LYP, B40LYP, 
BHLYP, and BHandHLYP in combination with the basis sets SVP,[138] TZV,[136] TZVP,[136] 
6-31g*,[139] 6-311g*,[139] IGLO-II,[140] IGLO-III,[140] EPR-II,[141] and Wachters[142] have been 
used in the benchmark calculations (see Table 3.4). 
It was not possible to predict all g values with the same accuracy. The general under-
estimation of the g shift (especially g||) has been attributed to a combination of too covalent 
bonding and the prediction of a too large d-orbital splitting and hybrid functionals like 
B3LYP are certainly to be preferred.[120] However, elevated levels of HF exchange are prob-
lematic since they lead to strong spin contamination.[143]  
 
 
 
Figure 3.9. Calculated and experimental g tensors of H3L1, calculated with various combinations of 
functionals and basis sets with the program packages ORCA and MAG-ReSpect. The experimental 
values are depicted as horizontal lines. 
 
It was found that increasing the amount of exact exchange to at least 38% is mandatory to 
obtain g|| tensors in a reasonable range (see Figure 3.9). The best agreement of g|| and gy with 
the experimentally derived values is obtained applying the B40LYP functional. Although in 
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most of the cases the g tensors are overestimated by the BHLYP functional (50% HF 
exchange), this was used for further investigations. BHLYP is a well established functionnal, 
and its various dependencies are well understood. Manually changing the amount of exact 
exchange might have some unforeseen influence on the calculation, and thus the application 
of an established functional was considered reasonable. The MAG-ReSpect calculated g 
tensors of [H2L1CuII(µ-OMe)]+ are so far those that agree best with the experimental findings, 
especially g|| is predicted in excellent agreement with the experiment. 
 
Table 3.5. Calculated (MAG-ReSpect and ORCA) A tensors [10-4 cm-1] of the mononuclear copper(II) 
complex of H3L1 [H2L1CuII(HOMe)]+. A visualization of these data is given in Figure 3.10. Most 
accurate calculated parameters are depicted in bold. 
 Experimental A tensors [10-4 cm-1] 
Functional / Basis set *) Ax = 15 Ay = 17 Az = 153 
PBE / SVP 49 63 131 
PBE / 6-311g* 61 73 122 
TPSS / 6-311g* 61 76 129 
TPSS / 6-311g* a) TZVPb) 93 110 111 
B3PW / 6-311g* 63 79 161 
B3PW / 6-311g* a) TZVPb) 94 111 146 
B3LYP / 6311g* a) Wachtersc)  3 19 252 
B3LYP / 6311g*  65 81 153 
B1LYP / SVP  47 66 182 
B1LYP / 6311g* a) Wachtersc) 67 84 168 
B38LYP / IGLO-II a) Wachtersc) 10 30 290 
B40LYP / IGLO-II a) Wachters c) 9 30 295 
B40LYP / IGLO-III a) Wachters c) 11 29 294 
BHLYP / IGLO-II a) Wachters c) 10 33 312 
BHLYP / EPR-II a) Wachters c)  10 34 312 
BHLYP / IGLO-II a) TZVPb Wachters c)) 10 33 312 
BHLYP / IGLO-II a) Wachters c) SOC 13 31 175 
MAG-ReSpect 21 5 133 
a) C, H, N, O; b) first coordination sphere; c) Cu; *)see text for references. 
 
The g and A tensors have different dependencies on functional and basis set. While the g 
tensors strongly depend on the applied functional, the A tensors are hardly effected by the 
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functional yet strongly change with the basis set and therefore one needs to offset the accurate 
prediction of g|| values for the accurate prediction of A|| and A┴. The most reasonable results 
for A and g tensors are obtained with the BHLYP functional (50% HF exchange) and a com-
bination of the IGLO-II (C, H, N, O and S) and Wachters (Cu) basis sets. The good agreement 
with the experimental findings that was obtained with MAG-ReSpect for the g tensors could, 
unfortunately, not be reproduced for the A tensors of [H2L1CuII(HOMe)2]+ nor for any of the 
EPR tensors of the mononuclear copper(II) complexes of H3L2, H3L3, and H3Lwa 
[H2L2,3,waCuII(HOMe)2]+ (see Appendix D). Considering the higher computational costs of 
the MAG-ReSpect calculation and the comparable accuracy of MAG-ReSpect and ORCA 
calculations, it was decided to use ORCA for the benchmark tests. 
 
  
Figure 3.10. Calculated and experimental A tensors [10-4cm-1] of H3L1 (taken from Table 3.5). The 
experimental values are represented as horizontal lines. 
 
The EPR-II basis set of Barone is commonly applied in A tensor calculations.[144] 
However, for the investigated copper(II) complexes of H3L1-3 and H3Lwa, it was found that 
the basis set limit is reached at the IGLO-II level (see Figure 3.10), IGLO-III as well as 
EPR-II basically provided identical results to those of IGLO-II. Analyzing the data it emerges 
that a basis set with a flexible core region is important as otherwise the A|| values are in good 
agreement with the experiment but the A┴ values are strongly overestimated, e.g. TZVP and 
6-31g*. Applying Wachters basis set to copper significantly improves the calculation, 
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reproducing the observed trend that A┴ is significantly smaller than A||, yet A|| is overestimated 
by a factor of about two.[142] This massive overestimation is caused by the neglection of the 
spin orbit coupling (SOC) of copper(II) and the results are substantially improved when the 
spin orbit coupling is included. The calculated A tensors and their dependence on the applied 
basis sets is depicted in Figure 3.10.  
The calculation of the g and A tensors of the mononuclear copper(II) complexes of H3L1-3 
and H3Lwa was found to be challenging and to significantly differ from the experimentally 
derived values. Considering that the calculation of EPR parameters of transition metals, and 
copper(II) in particular is considered as demanding, the obtained results are acceptable. 
However, given that no combination of functional and basis set was found to reproduce the g 
and A tensors of all complexes accurately the calculation of the EPR tensors of the dinuclear 
copper(II) complexes is not expected to reveal reliable results. From the performed calcula-
tions it can be concluded the spin orbit coupling is an important contribution for the accurate 
computation of the parameters. Additionally, the incorporation of at least 40% HF exchange 
leads to g|| tensors that are in a reasonable range, though the amount of HF exchange should 
not exceed 50% in order not to overestimate g||. For the accurate prediction of the A tensors 
the Wachters basis set proved to be very useful. Considering that the g and A tensors are also 
dependent on the structure of a complex one has to be sure that the geometry of the complex 
used to calculate the EPR parameters is identical to the one measured in the experiments. The 
obtained results from the calculations have to be considered with care as a significant 
deviation from the experiment can occur. 
 
As mentioned above the DFT calculation of the g and A tensors of the dinuclear 
copper(II) complexes of H3L1-3 and H3Lwa were not expected to provide further insight into 
the electronic structure of these complexes. However, it is known, that the isotropic exchange 
coupling J, i.e. the interaction of an unpaired electron at metal center (1) with the unpaired 
electron at metal center (2), of dinuclear transition metal complexes can be calculated 
relatively accurately.[145-148] Thus, in order to gain insight into the electronics of the dinuclear 
complexes, the J coupling of the dinuclear copper(II) complexes of H3L1-3 and H3Lwa was 
calculated using the program package ORCA (version 2.6) and a combination of the B3LYP 
functional and the 6-31g* (C, H, N, O, S) and TZVP (Cu, first coordination sphere) basis sets.  
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The magnetic properties of dinuclear transition metal complexes may be described with 
the Heisenberg-Dirac-van Vleck spin Hamiltonian, given in Eq. 3.8.[145-148]  
 
ܪ  ൌ  െ2ܬଵଶ ଵܵ · ܵଶ Eq. 3.8 
 
The broken-symmetry approach, given in Eq. 3.9 (EBS = energy of the broken symmetry 
state (BS); EHS = energy of the high spin state (HS); <S>2 = spin expectation value of HS or 
BS state) is known to be well adapted for complexes with weak as well as complexes with 
strong orbital overlap and was used for the DFT based calculation of the exchange coupling 
constants.[149-151] In the broken symmetry formalism one tries to obtain a wave function that 
breaks spatial and spin symmetry. This can be done by an unrestricted calculation (for low 
spin open-shell molecular systems) in which the  and  densities are allowed to be localized 
on different atomic centers. 
 
ܬଵଶ ൌ ா
ಳೄିாಹೄ
ۃௌۄಹೄమ ିۃௌۄಳೄమ
 Eq. 3.9 
 
The J coupling constants of the dinuclear complexes could not be extracted from the 
performed experiments as J > hν. However, the fact, that it is possible to obtain EPR data at 
77 K for the dinuclear copper(II) complexes of H3L2, H3L3, and H3Lwa is a strong indication 
for their ferromagnetic coupling, while the fact that the dinuclear copper(II) complex of H3L1 
is EPR silent at 77 K suggest that the copper(II) centers are antiferromagnetically coupled. 
The calculated J couplings of the dinuclear complexes of H3L1-3 and H3Lwa are consistent 
with the EPR experiments. The copper(II) centers in H3L1 are antiferromagnetically coupled, 
while H3L2, H3L3, and H3Lwa are ferromagnetically coupled (see Table 3.6). The J coupling 
depends on the structure of the complex, especially the relative orientation of the copper(II) 
centers. From the accurate prediction of the J coupling it can be concluded, that the DFT cal-
culated geometries of the complexes are close or identical to the actual structures in solution. 
The deviation of the J coupling constants is a result of the slightly different relative 
orientation of the copper(II) centers in the respective complexes.   
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Table 3.6. DFT-calculated J values of the dinuclear copper(II) complexes of H3L1-3 and H3Lwa. 
Experimental J values could not be extracted from the performed experiments. Computational detail: 
ORCA, version 2.6; B3LYP/6-31g*(C, H, N, O, S)/TZVP(Cu, first coordination sphere). 
 H3L1 H3L2 H3L3 H3Lwa 
Calculated J coupling -147 cm-1 76 cm-1 31 cm-1 179 cm-1 
 
While for the formation of the mononuclear copper(II) complexes of cyclic pseudo 
hexapeptides, H3L2 was found to exhibit a different coordination chemistry, the calculated 
J coupling constants and recorded EPR spectra at 77 K suggest that in case of the dinuclear 
copper(II) complexes H3L1 differs from the other macrocycles. The J coupling of a dinuclear 
metal complex can either be extracted from a variable temperature EPR measurement or from 
an MCD experiment and thus, the copper(II) coordination chemistry of H3L1 was further 
investigated by MCD.  
 
 
3.2.5 MCD Spectroscopy of the Copper(II) Complexes of H3L1 
 
An MCD experiment provides simultaneous information about the ground and excited states 
of the investigated substance.[152-153] A spectrum can be observed when circularly polarized 
light is propagated through a sample positioned within a strong magnetic field parallel to the 
direction of propagation and, in order for the MCD spectrum to be detected, an absorbance 
difference of the substance between left circularly polarized and right circularly polarized 
light is required.[154]  
The general equation that describes the MCD signal is given in Eq. 3.10 (γ = constant; 
B = magnetic flux density; k = Boltzman constant; μB = Bohr magneton; f(E) = line shape 
function; T = temperature; d = path length; c = concentration; E = hν, energy of the incident 
radiation).[152-156] A, B and C are characteristic terms that depend on the electronic and geo-
metric structure of the molecule under investigation. Each molecule with degenerate excited 
states exhibits an A term with a derivative band shape. While the B term has an absorption 
like band shape and arises when the applied field causes a mixing of the ground state or an 
excited state with an intermediate state. The C term is caused by degenerate ground states, and 
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therefore only present in paramagnetic species. It is the only temperature dependent term, 
dominating the spectra at low temperatures and identifies paramagnetic species. 
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The MCD spectra of the monomeric copper(II) complex [H2L1CuII(MeOH)]+ are in good 
agreement with the experimental findings from the EPR, UV-vis, and CD experiments.[103, 107] 
These predict a monomeric copper(II) complex bound to the Nhet-Namide-Nhet binding motif, 
with a square pyramidal coordination environment of the copper(II) center. The variable 
temperature (VT) MCD spectrum of the monomeric copper(II) complex [H2L1CuII(MeOH)]+ 
is depicted in Figure 3.11. The strong temperature dependence of the signals is result of a 
large C term that arises from the paramagnetic copper(II) center. The MCD saturation curve 
of the absorption at 700 nm and its fit (red) is shown in the right corner of Figure 3.11. It was 
fitted assuming g|| = 2.283 and an xy polarized transition. This is in agreement with the simu-
lated EPR data (see Table 3.3, g|| = 2.278).  
 
 
Figure 3.11. VT MCD spectra of the mononuclear copper(II) complex of H3L1, [H2L1CuII(MeOH)]+ 
measured at 5 T in methanol/glycerol 1:1, c(H3L1) = 30 mM, and experimental (black bars) and 
simulated (red line) saturation curve (inlay) at λ = 700 nm. 
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The dinuclear copper(II) complex, used for the MCD spectra is assumed to be methoxide 
bridged, i.e. [H1L1Cu2II(µ-OMe)]2+, however, this is in contrast to the observed EPR data (see 
Figure 3.12). While the EPR measurements predict an antiferromagnetically coupled species, 
e.g. EPR silent at 77 K, the MCD data are consistent with a ferromagnetically or weakly anti-
ferromagnetically coupled species (nested VTVH curves) and it should be possible to obtain 
an EPR spectrum at 77 K. The possibility that the recorded MCD spectrum arises from an 
impurity of monomeric copper(II) complex [H2L1CuII]+ in the sample can be excluded for 
several reasons. The signal, that was recorded for the dimeric complex is strong and the 
absorption values ( are similar to those of the monomeric species, while a signal arising 
from an impurity is expected to have considerably smaller absorption values. Furthermore, the 
spectra of the mono- and the dinuclear species are significantly different. The monomeric 
copper(II) complex [H2L1CuII]+ has a negative absorption band at 700 nm and a positive 
absorption at 940 nm, whereas the dinuclear copper(II) complex of H3L1  exhibits two 
negative absorption bands at 550 and 660 nm (see Figure 3.12). Moreover, the variable 
temperature variable field (VTVH) curves of the dinuclear copper(II) complex, measured at 
660 nm are nested, which is a strong indication for a ferromagnetically coupled species (see 
Figure 3.13).  
 
 
Figure 3.12. VT MCD spectra, measured at 5T in methanol/glycerol 1:1 (c(H3L1) = 30 mM), of the 
dinuclear copper(II) complex of H3L1 [H2L1CuII(MeOH)]+. 
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The reason for the discrepancy between the MCD and EPR results was found to be due to 
slightly different experimental conditions. In the MCD experiments, glycerol was added to the 
methanol solutions, in order to get a high resolution. It was then found that in the presence of 
glycerol the bridging methanol is replaced by glycerol and the macrocycle adopts a different 
conformation, in which the copper(II) centers now are ferromagnetically coupled. 
 
 
Figure 3.13. VTVH curves (black = experimental, red = fit; λ = 660 nm; T = 1.75 K – 50 K; me-
thanol/glycerol 1:1) of the dinuclear copper(II) complex of H3L1 (c = 30 mM), i.e. [H1L1Cu2II(µ-
OHCH(CH2OH)2)]2+ measured at 7 Tesla. 
 
From the experimental splitting of the VTVH curves of the dinuclear copper(II) complex 
the g tensor as well as the J coupling and D and E values can be derived via a fitting of the 
nested VTVH curves. The VTVH data has been analyzed using the formalism developed by 
Neese and Solomon, using Eq. 3.11.[152] For a particular coupled spin system S1 and S2, the 
MCD magnetization curves are calculated as:  
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where Ni are the Boltzmann populations of the energy levels; <Sxli> is the expectation value 
of the spin operator Sx1 for spin 1 in level i; and l, m, n specifies the direction of the magnetic 
field with respect to a molecular fixed axis system, and the integration is carried out numer-
ically over all orientations. The effxyM , 
eff
xzM , effyzM  are the effective transition dipole moment 
products for transitions centered on either the S1 or S2 metal. For a transition allowed in x and 
y polarization, one expects effxyM  ب effxzM  ~ effyzM . The population factors Ni and the spin ex-
pectation values are calculated from the energies and wavefunctions, respectively, of the spin-
Hamiltonian for the coupled system, given in Eq. 3.12. 
 
 ܪௌ௣௜௡  ൌ  െ2ܬଵଶ ଵܵ · ܵଶ ൅ ܪ௦ሺ ଵܵሻ ൅ ܪ௦ሺܵଶሻ Eq. 3.12 
 
The best fit of the experimental data is shown in Figure 3.13. It assumes two ferro-
magnetically coupled copper(II) centers with a small J value (0.4 cm-1) and a small zero field 
splitting (D = 0.68). The g tensors assumed for this fit are gx = gy =2.05 and gz = 2.254. The 
data can also be fitted to an isolated S = ½ system, e.g. a monomeric impurity, or an antiferro-
magnetically coupled dinuclear copper(II) species (see Appendix E). However, in order to ob-
tain an acceptable fit g|| value had to be set to unreasonable values of 2.856 (monomer) and 
3.41 (dimer). Therefore, it can be concluded, that a ferromagnetically coupled dinuclear 
copper(II) species gives rise to the MCD spectra. 
 
 
Figure 3.14. DFT calculated structure (G03, B3LYP/6-31g*/TZVP) of the glycerol bridged dinuclear 
copper(II) complex of H3L1. 
 
Cu1
N1 N10Cu2
Cu1
N1
N10
Cu2
  3. Copper(II) Complexes of the Cyclic Pseudo Hexapeptides H3L1-3 
51 
The assumed ferromagnetically coupled dinuclear glycerol bridged complex of H3L1, 
[H1L1Cu2II(µ-OHCH(CH2OH)2]2+ was optimized with DFT methods (B3LYP/6-31g* (C, H, 
N, O)/TZVP(Cu); see Figure 3.14) and the coupling constant J was calculated for the 
structure thus obtained. The calculated value of J is -18 cm-1. The calculation does not 
reproduce the experimentally derived J value, yet can be considered as within in accuracy. 
The measured MCD spectra are those of an exchange coupled glycerol bridged complex. To 
verify its existence an EPR measurement of the dinuclear copper(II) complex [H1L1Cu2II(µ-
MeOH)]+ dissolved methanol/glycerol was recorded (see Figure 3.15).  
 
 
Figure 3.15. Experimental X-Band EPR spectra of the glycerol bridged dinuclear copper(II) complex 
[H1L1Cu2II(µ-OHCH(CH2OH)2]2+, c(H3L1) = 15 mM, methanol/glycerol 1:1, ν = 9.434401 GHz, 
T = 50 K. Formally forbidden ms = ± 2 (left)and allowed ms = ± 1 transitions (right). 
 
The EPR spectrum arises from a dipole-dipole coupled dinuclear copper(II) species, with 
allowed transitions (ms = ± 1) and formally forbidden (ms = ± 2) EPR transitions around 
300 and 160 mT, respectively (see Figure 3.15). When the temperature is decreased to 10 K, a 
saturation of the EPR transitions is observed, which is consistent with a small exchange 
coupling, predicted by the MCD measurements. The influence of glycerol on the dinuclear 
copper(II) complexes of H3L2, H3L3 and H3Lwa has not been measured yet. 
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3.3 Summary and Outlook 
 
The investigation of the cyclic pseudo hexapeptides H3L1-3, models of the natural pseudo 
peptide westiellamide H3Lwa revealed interesting differences in their coordination chemistry.  
At low base concentrations H3Lwa, H3L1, and H3L3 exclusively form mononuclear 
complexes. However, the incorporation of oxazole rings substantially alters the coordination 
chemistry of the pseudo peptides: at low base concentrations H3L2 coordinates copper(II) in 
an interesting and new coordination mode, where instead of a “normal” coordination in the 
Nhet-Namide-Nhet binding site copper(II) is coordinated from the outside of the macrocycle by 
the oxygen atoms of the peptide bonds, thus forming a H3L2/copper(II) 2:1 complex. This 
coordination mode was verified by EPR and NMR spectroscopy and is reminiscent of the un-
usual Ag4-cluster that was reported by Wipf et al. for westiellamide.[93]  
At high base concentrations all macrocycles show the formation of dinuclear methanol 
bridged copper(II) complexes. Most interestingly H3L2, the ligand with the least basic 
heterocycles (oxazoles) is the only pseudo hexapeptide that has a cooperative effect. The 
imidazole pseudo hexapeptide H3L1, on the other hand, is the only macrocycle that was found 
to form an antiferromagnetically coupled dinuclear copper(II) complex. This difference in 
coordination chemistry was reflected in the DFT calculations of the exchange coupling con-
stants of the dinuclear complexes. The divergent behavior of H3L1 was found to be the result 
of a slightly different orientation of the copper(II) planes within the complex of H3L1 
compared to the dinuclear complexes of H3L2 and H3L3. Addition of glycerol replaces the 
bridging methanol in the dinuclear complex of H3L1 and leads to a reorganization of the 
complex, resulting in a weakly coupled species that was investigated by DFT, EPR, and MCD 
experiments.  
The calculation of the EPR properties of the mononuclear copper(II) complexes of H3L1-3 
and H3Lwa was found to be challenging. It was aimed to find a generally applicable combi-
nation of functional and basis set that provides good results, both for the calculated g and A 
tensors. Acceptable results were obtained with the BHLYP functional in combination with the 
basis sets 6-31g* (C, H, N, S, O), TZVP (first coordination sphere), and Wachters (Cu). 
However, a substantial deviation of the Az (CuII) tensor from the experimental derived values 
has to be accepted. It cannot be predicted whether Az is over or underestimated by the 
calculations the prediction of EPR tensors by DFT methods and it is concluded that the 
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prediction of copper(II) EPR tensors with DFT methods is too inaccurate to provide 
meaningful results for the investigation of unknown complexes of cyclic pseudo peptides.  
The performed experiments provided new insights into the various factors that influence 
the copper(II) coordination chemistry of cyclic pseudo hexapeptides, yet the question of the 
metabolic role of westiellamide remains. The performed experiments did not provide any 
evidence for a reaction of the dinuclear copper(II) complexes with atmospheric CO2, as found 
for the cyclic pseudo octapeptides (see Chapter 4). Most likely the cyclic pseudo hexapeptides 
have a different role in the metabolism of the ascidians than the cyclic pseudo octapeptides. 
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4 Cyclic Pseudo Octapeptides 
4.1 Introduction and General Remarks 
 
Recent findings reinforce the involvement of the dinuclear copper(II) complexes of patell-
amides and ascidiacyclamide in CO2 fixation and as yet it is unclear whether this is a catalytic 
reaction or not.[103] To investigate the impact of structural features for CO2 hydrolysis and 
subsequent formation of carbonato-bridged complexes a variety of cyclic pseudo octapeptides 
(H4L4, H4L4-bn, H4Lrs, H4Lox, and H4LascA) was synthesized and studied (see Figure 4.1). 
Their molecular structure gradually approaches the configuration and composition of the 
natural pseudo octapeptides (see Figure 1.2, page 4). 
 
 
Figure 4.1. Chemical structure of the studied macrocycles H4L4, H4Lrs, H4L4-bn, H4Lox, and H4LascA. 
 
From the simple model systems with C4-symmetry and all S*-configured amino acid 
linkers, e.g. H4L4, the gradual exchange of the linkers and the heterocycles leads to 
C2-symmetric macrocycles, e.g. H4Lrs, and thus enables the investigation of the influence of 
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the linker and the incorporated heterocycle on the copper(II) coordination chemistry of a 
cyclic pseudo octapeptide. 
The copper(II) coordination chemistry of the cyclic pseudo octapeptides H4L4, H4Lrs, 
H4Lox, and H4LascA was studied by a variety of spectroscopic methods in combination with 
computational methods (ESI-MS, CD, UV-vis, and EPR spectroscopy as well as DFT and 
molecular mechanics calculations). The cyclic peptides are poorly soluble in water. Therefore 
all experiments were performed in methanol. Unless stated otherwise freshly prepared 
methanolic solutions with variable ratios of cyclic pseudo octapeptide/copper(II)triflate/base 
((n-Bu4N)(OMe)) were used for the experiments. The concentration of the pseudo octa-
peptides was 1.25 mM in case of the spectroscopic and 1.25 µM in case of the MS experi-
ments. The ESI-MS experiments in methanolic solutions were used to gain initial insight into 
the copper(II) coordination chemistry. The observed signals were assigned to the potential 
copper(II)-macrocycle complexes, and the solution equilibria were then investigated by UV-
vis and CD spectroscopy. Those deemed interesting were, further studied by EPR spectros-
copy and computational methods (DFT and MM calculations). Suitable crystals for X-ray 
crystallography could be obtained from the cyclic pseudo octapeptides H4Lrs and H4L4-bn and 
from a dinuclear copper(II) complex of H4Lrs (see Appendix F for crystallographic informa-
tion). The structural features and differences of cyclic pseudo octapeptides are discussed in 
Section 4.1.1. Their copper(II) coordination chemistry is discussed in detail in the following 
sections of this Chapter. 
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4.1.1 Structural Features of Cyclic Pseudo Octapeptides 
 
The cyclic pseudo octapeptides include four heterocycles in their macrocycle and are thus, 
unlike the cyclic pseudo hexapeptides discussed in Chapter 3, able to bind two copper(II) ions 
in the preferred Nhet-Namide-Nhet binding motif (see Section 3.1). In the complexes the 
copper(II) centers are coordinated to trans-disposed binding sites.  
While the C4-symmetric macrocycles with all S*-configured linkers, e.g. H4L4, have four 
identical Nhet-Namide-Nhet binding sites (see Figure 4.2, left), and therefore two identical di-
nuclear copper(II) complexes with identical copper(II) sites. The alteration of the stereo-
chemistry of the linkers, e.g. H4Lrs, leads to two enantiomeric binding sites in the mono- and 
dinuclear copper(II) complexes. Depending on the configuration of the linker, copper(II) can 
either be coordinated to a Nhet-NR-amide-Nhet or a Nhet-NS-amide-Nhet binding site (see Figure 4.2, 
right). In the dinuclear copper(II) complexes both copper(II) ions are either coordinated by a 
Nhet-NR-amide-Nhet or a Nhet-NS-amide-Nhet binding site forming enantiomeric complexes. The al-
ternating stereochemistry of H4Lrs is identical to the molecular design of the natural metabo-
lites patellamide A-G and ascidiacyclamide. As a consequence of the incorporated oxazoline 
rings with additional stereocenters leads the coordination of copper(II) in the Nhet-NR-amide-Nhet 
or the Nhet-NS-amide-Nhet binding site of the natural cyclic pseudo peptides not to the formation 
of enantiomers but diasteromers. 
 
 
Figure 4.2. Binding motifs of the cyclic pseudo octapeptides H4L4 and H4Lrs. I = imidazole-, 
A = amide-, AS,R = amide nitrogen at S*/R*-configured linker. 
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The conformation that is adopted by a cyclic pseudo peptide in solution and in the solid 
state is dependent on various factors: the stereochemistry of the amino acid linker, the 
incorporated azole moieties, the potential existence of sterically demanding residues, and the 
molecule’s symmetry (see Chapter 1.3).  
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Figure 4.3. Abbreviations for the heterocyclic moiety of cyclic pseudo peptides (left) and definition of 
the up- and downside of the macrocycles (right). 
 
To simplify the description of the cyclic pseudo peptides one can define an “up” and a 
“down” side of their ring system: looking at the amino acid linker (Camide-Namide-C-Cazole) 
from the inside of a pseudo peptide’s macrocycle in such a way that the amide bond is located 
on the left hand side, all atoms that are above the linker-plane are defined as up, while all 
those that are below are assigned as down (see Figure 4.3, right). 
 
  
Figure 4.4. Top (top) and side view (bottom) of the X-ray structures of H4Lrs, H4L4, and H4L4-bn. 
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The dependency of the adopted conformation on the stereochemistry of the amino acid 
linker and on sterical demanding residues can be seen by comparing the X-ray structures of 
H4L4, H4Lrs, and H4L4-bn (see Figure 4.4 for a comparison of their X-ray structures and 
Figure 4.5 for the ORTEP plots of H4L4-bn and H4Lrs). The pseudo peptides only differ 
slightly from each other with respect to their chemical structure. They all consist of four 
imidazole heterocycles connected via valine linkers, and the only differences are the configu-
ration at C and the substituents at the imidazole nitrogen atoms Nimi (see Figure 4.3, left for 
abbreviations). From NMR studies and X-ray crystallography it is known that in solution and 
the solid state, the pseudo peptides H4L4, H4Lrs, and H4L4-bn adopt the square conformation 
(see Chapter 1.3, page 7 for definition of the conformations), as expected for C2- and C4-
symmetric pseudo octapeptides. However, there are remarkable differences in the orientation 
of the imidazole units and the valine side chains. As a result of the large benzyl residues at the 
imidazole rings in H4L4-bn, these are rotated in the solid state structure and the benzyl substi-
tuted imidazole rings are nearly collinear, while the methyl substituted imidazole rings are 
turned towards the outside of the ring system. In contrast the trans-disposed imidazole rings in 
H4L4 and H4Lrs are twisted with respect to each another with angles of 78° and 54°, respec-
tively. The parallel orientation of the imidazole rings in H4L4-bn is reflected in the distance of 
the outer imidazole nitrogens Nimi. This distance is small for the parallel imidazole rings, and 
increases with the degree of rotation of the imidazole ring towards to outside of the macro-
cycle (see Table 4.1). While in H4L4 all trans-disposed imidazole nitrogens Nimi have a 
distance of ~10.4 Å the distance of the benzyl substituted Nimi atoms shrinks to 7.88 Å in 
H4L4-bn. In solution, however, the NMR data (see Chapter 5.2.2, page 160) indicate, that the 
benzyl substituted imidazole rings are no longer parallel but instead adopt a conformation 
similar to the X-ray structure of H4L4 and this is also reproduced by the DFT-calculated 
structures. This indicates that the twist of the substituted imidazole rings is mainly caused by 
crystal packing effects and, indeed a stacking between the benzyl rings of different H4L4-bn 
molecules can be observed in the crystal lattice. This induces the rotation of the substituted 
imidazole rings. These findings indicate that the influence of large substituents at Nimi is 
primarily present in the solid phase. 
  
Table 4.1. Selected angles and distances (e.s.d.’s are given in parantheses) of the X-ray and the DFT optimized structures of H4L4, H4Lrs, H4Lox, and H4L4-bn. 
 H4L
4 H4Lrs H4L4-bn H4Lox [102] 
X-ray DFT a) X-ray DFT a) X-ray DFT a) X-ray 
θ [H-Namide-C-H]b, c) 178, 160 all 160 -165*), 165 -162*), 162 -136*), 176 -153*), -156 158/168 
 [amideCCazoleimi 120, 102 all 102 -133*), 133 -126*), 126 94*), 124 -98*), 104 79/187 
[N4-N10-N16-N22] d) 4 0 20 20 8 1 3 

d 93, 49 71 -160, 160 -145, 145 79, 53
*) 69,70 133/68 
 [N26-N29-N32-N35] d)
 [O26-O29-O32-O35] d) 9 0 -18 -21 20 2 8 
angle between binding sites) 161 161 78 78 170/160 172/168 129/66 
d (Namide-Namide) consecutive  5.398(4), 5.623(4) all 5.60 all 5.3637(6) all 5.25 5.4183(6), 5.868(1) 5.58, 5.66 5.265(5)/5.891(5) 
d (Namide-Namide) trans-disposed 7.951(4), 7.560(4)  all 7.93 all 7.189(1) all 6.59 8.2250(8)*), 7.854(1) 7.81*), 8.00 6.918(5)/8.293(5) 
d (Nhet-Nhet) consecutive 5.139(3), 5.346(4) all 5.28 all 4.9633(7) all 4.71 5.1809(9), 5.4497(6) 5.34, 5.25 4.585(5)/5.446(5) 
d (Nhet-Nhet) trans-disposed 7.620(3), 7.196(3) 7.48 all 6.9027(8) 6.56 7.0801(7)*), 7.904(2) 7.41*), 7.56 7.592(5)/6.606(5) 
d (Nimi-Nimi) trans-disposed 
d(Ooxa-Ooxa) 
10.464(4), 10.306(4) 10.16 11.079(1) 10.67 
7.8848(7)*), 
11.403(2) 
9.78*), 10.24 8.859(5)/11.875(5) 
d (Nimi-Nimi) consecutive 
d(Ooxa-Ooxa) 
7.123(4), 7.607(3) all 7.18 all 7.929(1) 7.68 6.9043(7), 7.166(1) all 7.08 6.770(5)/8.026(5) 
Units: d [Å], angles [°]      a) TURBOMOLE, B3LYP/6-31g*;      b) analysis of the 1H-NMR data provided the following angles: H4L4, H4Lox = 155°<│ θ │<165°; 
H4Lrs = 140°<│ θ │<165°; H4L4-bn = 135°<│ θ │<155° and 145°<│ θ │<180°;       c) see Figure 4.3 for used abbreviations      d) see Figure 4.4, Figure 4.5, and Figure 4.7 for 
atom numbers        *) at benzyl-imidazole/R*-configured C
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Figure 4.5. ORTEP plots: Top (left) and side view (right) of the X-ray structures of H4L4-bn (top) and 
H4Lrs (bottom). Ellipsoids are drawn at 50% probability (hydrogen atoms and solvent molecules are 
omitted for clarity, carbon = grey, nitrogen = blue, oxygen = red, see Appendix F for crystallographic 
information). 
 
In comparison to H4L4 and H4L4-bn, two of the stereocenters in H4Lrs are inverted. This 
rather minor modification has a considerable influence on the shape of the macrocycle (for 
selected angles and distances see Table 4.1). H4L4 and H4L4-bn adopt a cone like structure, 
where all valine residues are oriented on the up side and the substituents at Nimi are oriented 
downwards (see Figure 4.4 bottom). Apart from the distance of trans-disposed Nimi atoms, the 
cone like shape of the macrocycles is also reflected in the dihedral angle  between the 
nitrogen atoms (Nhet-Nimi-Nimi-Nhet) of trans-disposed imidazole rings N4-N10-N16-N22 (see 
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Table 4.1, Figure 4.4). The geometry optimized structures of H4L4 and H4L4-bn have identical 
values of  (70°), while in H4Lrs a strikingly different angle of 145° is adopted. The 
configurational modification of two Ccarbon atoms in H4Lrs induces a change of the 
macrocycle’s shape from a cone to a zig-zag like structure, resulting in valine residues that 
have alternating orientations on the up and down side (see Figure 4.4, bottom and Figure 4.5, 
bottom) and this also influences the diameter of the macrocycle (see Table 4.1). While trans-
disposed Namide atoms in H4L4 and H4L4-bn are roughly 8 Å apart (e.s.d. = 0.004 Å), their 
distance shrinks to 7.189(1) Å in the X-ray and further down to 6.5 Å in the fully optimized 
DFT structure of H4Lrs thereby changing the degree of planarity of the inner heterocyclic Nhet 
and amide nitrogen atoms Namide (see Figure 4.6, bottom). Their deviation from perfect 
planarity in H4L4 is marginal, two of the heterocyclic nitrogens Nhet are 0.09 Å distant from 
the plane that is spanned by the inner nitrogens and two of the amide nitrogens, Namide, are 
0.33 Å apart and insignificantly enlarges in H4L4-bn: 0.17 Å distance for two heterocyclic 
nitrogens Nhet and 0.33 Å for two Namide atoms. Yet, within the experimental error they can be 
considered as coplanar and this could be verified by DFT calculations and is also visible in 
the dihedral angle  of the inner imidazole nitrogen atoms of 0° for H4L4 and 1° for H4L4-bn 
(see Table 4.1).  
  
Figure 4.6. Structural parameters of H4L4 (left) and H4Lrs (right). Planes spanned by the coordinating 
nitrogen atoms Nhet-Namide-Nhet of the respective binding sites, depicted in blue and red (top); folding of 
the macrocycles and the plane spanned by the inner nitrogen atoms Nhet and Namide of H4L4 (bottom). 
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H4Lrs, however, has a conformation that precludes coplanar inner nitrogen atoms. The 
zig-zag folding makes it impossible to span a plane that includes all nitrogen atoms, or all 
imidazole/amide nitrogen atoms, e.g. the dihedral angle between the nitrogen atoms is 20°. 
The zig-zag structure of H4Lrs is closer to the conformation of the natural cyclic pseudo 
octapeptide ascidiacyclamide than the cone like structures of H4L4 and H4L4-bn.  
The differences of the macrocycles can also be visualized comparing the planes of the 
binding sites in the molecules. When in each of the two trans-disposed binding sites a plane is 
constructed from the coordinating nitrogen atoms Nhet-Namide-Nhet, the folding of the 
macrocycle is reflected in the angle  between the planes (see Table 4.1 and Figure 4.6, top). 
Trans-disposed binding sites of H4L4 include an angle of 160°, this angle is remarkably 
smaller in H4Lrs (78°). It is expected that the orientations of the binding sites influence the 
copper(II) coordination chemistry, e.g. stability of complexes, preorganization for complexes, 
and magnetic properties of the dinuclear complexes. However, it is not known so far which 
characteristics influence the coordination chemistry the most. 
 
 
 
Figure 4.7. Top (left) and side view (right) of the X-ray structure of H4Lox.[102] 
 
Apart from the influence of the configuration of C and large substituents at the hetero-
cyclic rings the adopted conformation in the solid phase also strongly depends on the incorpo-
rated heterocycles. This effect can be seen when the X-ray structure of H4Lox is examined 
(see Table 4.1 for structural parameters).[102] It has all S*-configured amino acid linkers (as 
H4L4) and thus one would expect that in the solid phase it also adopts a cone like 
conformation. However, the adopted conformation remarkably differs: similar to the obtained 
structure of H4L4-bn two of the heterocyclic rings are parallel, while the other two rings are 
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rotated towards the outside of the macrocycle (see Figure 4.7). While in H4L4-bn crystal 
packing effects, such as -stacking between the benzene rings are thought to be responsible 
for the adopted conformation, it is assumed that the effect is of electronic nature in case of 
H4Lox and expected to be related to the preferred dihedral angle  that strongly depends on 
the heterocycle (see Section 1.3, Figure 1.5). However, NMR studies suggest that in solution 
H4Lox adopts a C4-symmetric structure and thus these effects seem to be restricted to the solid 
phase.[102] 
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4.2 Copper(II) Coordination Chemistry of H4L4 
4.2.1 Complexation Equilibria and Spectroscopy 
 
The C4-symmetric macrocycle H4L4 is a simple model system for natural cyclic pseudo octa-
peptides. It consists of four methylimidazole units connected via L-valine linkers. The com-
plexation equilibria of H4L4, shown in Figure 4.8, were previously derived from a combina-
tion of ESI-MS, UV-vis, CD, and EPR spectroscopy.[103] The UV-vis, CD and EPR spectra 
are of particular interest, as the differences between the macrocycles studied are reflected in 
their spectra. The copper(II) complexation equilibria of H4L4 are briefly described below and 
can be found in detail elsewhere.[103] In contrast to the previously reported formation of a 
µ-oxo-bridged dinuclear copper(II) complex, it is assumed that the addition of four equiva-
lents of base leads to the formation of a dihydroxo complex (see Figure 4.8). This assumption 
is based on the distance of the copper(II) ions that is predicted from the simulation of the EPR 
spectra (4.5 Å, see Table 4.3) in combination with the computed DFT structures of the 
dihydroxo- and µ-oxo complexes (see Section 4.2.3).  
 
 
Figure 4.8. Complexation equilibria of H4L4 with copper(II) and base (solvent = methanol). 
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The coordination of copper(II) to H4L4 is accompanied by a series of color changes. The 
blue mononuclear copper(II) complex [H3L4CuII]+ is converted to the turquoise dinuclear 
copper(II) complex [H2L4Cu2II]2+ upon addition of copper(II) and two equivalents of base. 
Addition of further base shifts the complexation equilibrium to the green hydroxo complex 
[H2L4Cu2II(OH)]+ (at three equivalents of base) and further to the blue dihydroxo complex 
[H2L4Cu2II(OH)2] (at four equivalents of base). The latter two complexes were found to react 
with CO2 from air to form the dark blue (bi)carbonato-bridged dinuclear complexes, 
[H2L4Cu2II(µ-HCO3)]+ and [H2L4Cu2II(µ-CO3)], respectively. One important aim of this study 
was to determine whether this reaction is catalytic or not. 
In the mono- and dinuclear copper(II) complexes the chirality of the cyclic pseudo 
peptides induces an asymmetry at the copper(II) centers that can be observed by CD spectros-
copy. Remarkably, the formation of mono- and dinuclear copper(II) complexes can even be 
observed in absence of base (see Figure 4.9 for CD and UV-vis spectra). The CD spectra 
show a negative Cotton effect at 639 nm and a positive Cotton effect at 483 nm that increase 
with the copper(II) concentration. Their separation by isosbestic points indicates an equilibri-
um involving two species. In the UV-vis spectra addition of copper(II) to a H4L4 solution 
leads to the formation of a d-d absorption band at 674 nm. Compared to solvated copper 
[CuII(MeOH)n]2+ (max = 840 nm) this band is shifted to lower wavelength as a result of the 
coordination of copper(II) to one of the binding sites of H4L4.  
All the CD and UV-vis bands of a H4L4/copper(II) 1:2 solution linearly intensify upon 
addition of up to two equivalents of base (see Figure 4.9). From the performed ESI-MS and 
EPR experiments it is known that the mononuclear copper(II) complex is formed first and 
subsequently converted to the dinuclear complex.[103] Neither the absorption bands in the UV-
vis, nor the Cotton effects in the CD spectra are shifted during the titration and this is 
consistent with an identical coordination geometry at the copper(II) centers of the mono- and 
the dinuclear copper(II) complexes of H4L4, [H3L4CuII]+ and [H2L4Cu2II]2+, respectively, 
expected from the molecular design of the macrocycle (see Chapter 4.1).  
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Figure 4.9. CD spectra (top) of the titration of 0-2 eq of CuII, in 0.1 eq steps, to a H4L4 solution 
(c = 1.25 mM, methanol), and subsequent titration of 0-2 eq of base (MeO-), in 0.1 eq steps, to a 
H4L4/copper(II) 1:2 solution. UV-vis spectra (bottom) of the titration of 0-2 eq of base (MeO-), in 
0.2 eq steps, to a H4L4/copper(II) 1:2 solution. 
 
The linear increase in intensity of the absorption bands in the UV-vis and CD spectra 
ends after the addition of two equivalents of base. The UV-vis spectra show a shift of the ab-
sorption band from 674 ( = 370 M-1cm-1) to 722 nm ( = 210 M-1cm-1) presumably a result of 
the coordination of hydroxide to one of the copper(II) centers (see Figure 4.10). The 
isosbestic points at 320 and 535 nm are consistent with an equilibrium between the two 
dinuclear species [H2L4Cu2II]2+ and [H2L4Cu2II(OH)]+. The change of the coordinated ligand 
influences the asymmetry at the copper(II) centers and consequently changes the CD spectra. 
The CD spectra now exhibit two isosbestic points, at 716 and 502 nm (see Figure 4.10) and 
change to a greater extent than the UV-vis spectra. The positive Cotton effect at 383 nm is 
slightly shifted to 388 nm and increased in intensity. The negative Cotton effect of the 
dinuclear copper(II) complex [H2L4Cu2II]2+ at 638 nm diminishes and at three equivalents of 
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base a relatively broad negative Cotton effect (550–800 nm) with a maximum at 660 nm can 
be observed. 
 
 
 
 
Figure 4.10. CD (top) and UV-vis spectra (bottom) of the titration of 2-3 eq of base (MeO-), in 0.2 eq 
steps, to a H4L4/copper(II) (1:2) solution (c(H4L4) = 1.25 mM, methanol). 
 
Addition of a fourth equivalent of base ((n-Bu4N)(OMe)) induces a further change in the 
CD and UV-vis spectra. The CD spectra are indicative of another structural rearrangement 
upon the formation of the dihydroxo complex [H2L4Cu2II(OH)2] (see Figure 4.11) as the 
Cotton effect at 388 nm is shifted to 365 nm and slightly decreased in intensity. A new nega-
tive Cotton effect at 729 nm develops while the effect at ~660 nm decreases. The absorption 
band in the UV-vis spectrum is shifted to 657 nm. This band in the UV-vis spectra is presum-
ably a superposition of the dihydroxo complex and already formed carbonato complex.  
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Figure 4.11. CD (top) and UV-vis (bottom) spectra of the titration of 3-4 eq of base (MeO-), in 0.2 eq 
steps, to a solution of H4L4/copper(II) 1:2 (c(H4L4) = 1.25 mM, methanol).  
 
The dinuclear copper(II) complexes (hydroxo and dihydroxo) that are present in solutions 
that contain four or more equivalents of base react with atmospheric CO2 and show a time-
dependent complete conversion to the carbonato complex [H2L4Cu2II(µ-CO3)] (assigned from 
ESI-MS experiments) that can be followed spectroscopically in the CD and UV-vis spectra. 
The conversion is accompanied by a shift to lower wavelength (722 to 657 nm) in the UV-vis 
spectra and a change of the CD spectra (see Figure 4.12). The positive Cotton effect at 
365 nm is increased in intensity and slightly shifted to 355 nm. At 705 nm a new negative and 
at 511 and 603 nm two new positive Cotton effects develop. The positive Cotton effects are 
assigned to the carbonato species [H2L4Cu2II(µ-CO3)], identified by ESI-MS experiments. 
When the experiments are performed under anaerobic/CO2 free conditions the formation of 
carbonato-bridged species cannot be observed (ESI-MS, EPR, UV-vis, and CD spectra). The 
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CD, UV-vis, and EPR spectra do not change within days, suggesting the formation of stable 
complexes. 
 
 
Figure 4.12. CD spectra of the time-dependent (0-24 h) conversion of the dihydroxo complex 
[H2L4Cu2II(OH)2] to the carbonato complex [H2L4Cu2II(µ-CO3)], (c(H4L4) = 1.25 mM, methanol). 
 
 
4.2.2 CO2 Fixation by the Dinuclear Copper(II) Complexes of H4L4 
 
The observed conversion of CO2 to carbonate and the formation of carbonato complexes was 
further studied by a variety of methods. Experiments with labeled water (18OH2) and carbon 
dioxide (13CO2) were performed, and the incorporation of both isotopes was followed by high 
resolution ESI mass spectrometry. The molecular formula and the experimental and 
calculated masses of representative dinuclear copper(II) complexes of H4L4 are shown in 
Table 4.2. The neutral carbonato complex [H2L4Cu2II(µ-CO3)] could be detected in the 
positive mode as the sodium and tetrabutylammonium adducts. Addition of 18O labeled water 
to a solution containing H4L4/copper(II)/base in a ratio of 1:2:2 or 1:2:3 causes a shift of the 
signal of the hydroxo complex [H2L4Cu2II(OH)]+ from m/z 913.3315 to m/z 915.3363 
([H2L4Cu2II(18OH)]+). The exchange of the coordinated hydroxide in the hydroxo complex 
[H2L4Cu2II(16/18OH)]+ with 18OH or 16OH, respectively, is fast and can be observed within 
minutes.  
When an 18OH2 containing solution is exposed to air, the ESI-MS signals of the bicar-
bonato- and carbonato-bridged species [H2L4Cu2II(µ-HCO3)]+ and [H2L4Cu2II(µ-CO3)], respec-
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tively, are shifted by two mass units indicating that the hydroxo complex is involved in the 
fixation of CO2. The exposition of a hydroxo or dihydroxo complex solution to a 13C labeled 
carbon dioxide atmosphere leads to the incorporation of 13C into the (bi)carbonato complexes 
and a shift of the signals of the bicarbonato and carbonato complexes by one mass unit to 
m/z 958.3274 and m/z 980.3072, respectively can be observed (see Table 4.2). The incor-
poration of 13C is reversible, e.g. exposure of a 13C-labeled carbonato complex 
[H2L4Cu2II(µ-13CO3)] solution to air leads to a slow (~60 min) conversion into the unlabeled 
complex [H2L4Cu2II(µ-CO3)] and vice versa.  
 
Table 4.2. Observed dinuclear high resolution ESI-MS copper(II) complexes of H4L4, their molecular 
formula and experimental and calculated exact masses.  
species molecular formula experimental calculated 
[H2L4Cu2II(OH)]+ C40H59Cu2N12O5+ 913.3315 913.3318 
[H2L4Cu2II(µ-HCO3)]+ C41H59Cu2N12O7+ 957.3214 957.3216 
[H2L4Cu2II(µ-CO3)Na]+ C41H58Cu2N12O7Na+ 979.3045 979.3036 
[H2L4Cu2II(µ-CO3)n-Bu4N]+ C57H94Cu2N13O7+ 1198.5988 1198.5986 
[H2L4Cu2II(18OH)]+ C40H59Cu2N12O418O+ 915.3363 915.3360 
[H2L4Cu2II(µ-HCO218O)]+ C41H59Cu2N12O618O+ 959.3264 959.3259 
[H2L4Cu2II(µ-CO218O)Na]+ C41H58Cu2N12O618ONa+ 981.3086 981.3078 
[H2L4Cu2II(µ-H13CO3)]+ 13CC40H59Cu2N12O7+ 958.3274 958.3250 
[H2L4Cu2II(µ-13CO3)Na]+ 
13CC40H58Cu2N12O7Na+ 980.3072 980.3069 
 
The interconversion of the labeled and non-labeled carbonato complexes in presence of 
12/13CO2 seems to be slower than the exchange of the labeled hydroxide. First indications of 
the conversion, i.e. different isotope pattern in the exact mass spectrum, were observed after 
30 minutes. A change of the isotope pattern of the coordinated hydroxide, on the other hand, 
could be observed within minutes. 
The formation of carbonato-bridged complexes was further investigated by addition of 
(NH4)2CO3 to a solution of the dinuclear copper(II) complex [H2L4Cu2II]2+. It was found that 
addition of ammonium carbonate to a solution of the dinuclear copper(II) complex 
[H2L4Cu2II]2+ or the hydroxo complex [H2L4Cu2II(OH)]+ readily leads to the formation of 
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(bi)carbonato complexes. When naturally abundant carbonate is added to a solution of a 13C 
labeled carbonato complex a slow exchange can be observed that is not completed within 24 
hours. These findings support a moderately stable carbonato complex, where carbonate can be 
exchanged.  
The findings that the carbonato complex is moderately stable and the reversibility of the 
reaction, e.g. labeled carbonate can be exchanged by unlabeled, indicate that this reaction 
might be catalytic. When an excess (> 6eq) of barium perchlorate is added to solutions of the 
carbonato complex [H2L4Cu2II(µ-CO3)], barium carbonate precipitates and the UV-vis and CD 
spectra of the solution are now identical to those of the hydroxo complex. After addition of 
one or two equivalents of base and exposure to air these solutions convert back to the 
carbonato complex. Consequently, we tested the catalytic activity of the hydroxo complex 
towards CO2 hydrolysis applying the stopped flow indicator method, first reported by 
Gibbons et al.[84, 157] It was found that the hydroxo and dihydroxo complexes of H4L4 do not 
show any significant catalytic activity. Nevertheless, the ready capture and release of CO2 
from the complexes and thus reversibility of the reaction, implies that the metabolic role of 
cyclic pseudo octapeptides might be related to CO2 capture and carbonate transport in the 
ascidian’s organism. 
 
When the reversibility of the formation of the carbonato complexes was tested, by 
passing argon through a (bi)carbonato complex solution to remove CO2 from the equilibrium, 
an unusual pink species was discovered. It was found that the formation of the pink species 
can also be followed by CD spectroscopy when a solution of the carbonato complex, i.e. 
[H2L4Cu2II(µ-CO3)], is exposed to air (see Figure 4.13). The initial CD spectrum of the carbo-
nato complex [H2L4Cu2II(µ-CO3)] exhibits two negative Cotton effects at 723 and 541 nm and 
two positive Cotton effect at 366 and 605 nm. In the course of the reaction, the negative 
Cotton effect at 723 nm is shifted to 715 nm and increases in intensity, while the negative 
effect at 541 nm vanishes and instead, a positive Cotton effect at 536 nm develops. The 
positive cotton effect at 366 nm also increases in intensity over time and is shifted to 358 nm 
and at 611 nm a new negative cotton effect develops. From the isosbestic points at 451 and 
583 nm it emerges that the carbonato complex is converted into a new complex – the 
observed pink species. The recorded CD spectra suggest that the previously assigned CD 
spectrum of the carbonato-bridged species with positive Cotton effects at 511 and 603 nm 
(see Figure 4.12) is actually a superposition of the CD spectra of the carbonato-bridged (pos. 
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Cotton effect at 605 nm and neg. Cotton effect at 541 nm) and the pink complex (pos. Cotton 
effect at 536 nm and neg. Cotton effect at 715 nm).  
 
 
Figure 4.13. Time-dependent CD spectra (0-16h) of a [H2L4Cu2II(µ-CO3)] solution (c = 1.25 mM, 
methanol) that, upon exposition to air, converts to the pink species. Time dependent increase and 
decrease of the respective Cotton effects (inlay). 
 
Given that at least 5% water is present in the methanol solution it was found that the pink 
species can also be created by addition of four or more equivalents of a strong base (MeO-) 
under aerobic conditions to the dinuclear copper(II) complex [H2L4Cu2II]2+ (see Figure 4.8). 
Solutions of the pink species do not show any signals of note in the ESI-MS spectra, 
suggestive of a neutral or manifold negatively (high base concentration) charged species. It is 
known from the CD, UV-vis, and EPR spectra that both copper(II) ions are still coordinated, 
otherwise a decrease of the Cotton effects in the CD spectra should be observable, as “free” 
copper(II) does not exhibit CD spectroscopic features. Furthermore, the EPR spectra do not 
show any signals that are attributable to “free” copper, instead solutions of the pink species 
are EPR silent at 77 K, although two equivalents of copper(II) are present in solution. This 
points to a dinuclear, strongly ferromagnetically coupled species, identified by the ability to 
record NMR spectra at room temperature. The NMR spectra display the same set of signals as 
the free cyclic pseudo peptide H4L4 (see Appendix G). An EPR at helium temperature, 
showing a set of signals attributable to a strongly coupled species, verified the pink species as 
a dinuclear copper(II) species (see Appendix G). To date the exact composition of the pink 
species could not be determined. From the interconversion of the carbonato to the pink 
species in combination with the observation that the pink species is only formed in presence 
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of water, at high base concentrations, and under aerobic conditions, it is assumed that the 
carbonato complex has to be built first and subsequently converted to the pink species. The 
strong ferromagnetic coupling indicates the presence of a bridging ligand, for example µ-oxo, 
though the presence of this ligand has yet to be confirmed.  
 
 
4.2.3 Computational and EPR Spectroscopic Investigation of the 
Copper(II) Complexes of H4L4 
 
Suitable crystals for X-ray crystallography could not be obtained from any copper(II) 
complex of H4L4. Therefore, the structural information about the complexes had to be 
obtained from computational and spectroscopic methods. From the EPR spectrum of a dipole-
dipole coupled dinuclear complex the g and A tensors of the metal centers can be extracted 
and from strongly coupled complexes the coupling constant J can be obtained. In both cases 
the relative orientation of the copper(II) centers can be extracted. As the interactions of the 
metal centers are, among others, dependent on their distance, the simulation of EPR spectra 
can be used for structure determination. Another frequently used tool for structure determina-
tion are computational methods, e.g. geometry optimization by DFT (density functional 
theory). However, the simulation of an EPR spectrum may not have one unique solution and 
one cannot be sure whether the structure derived from the DFT calculation is a local or the 
global energy minimum. Therefore, a combination of EPR spectra simulation and structure 
optimization is used to determine the structure of the investigated compounds. The putative 
complexes of the complexation equilibria depicted in Figure 4.8 were prepared in situ and 
EPR spectra of the respective solutions were measured. The simulations of the spectra in 
combination with DFT calculations were used to gain structural information about the various 
species. 
The analysis of the calculated structures of the mono- and dinuclear copper(II) complexes 
of H4L4 revealed that, upon coordination of copper(II) to the binding site, the macrocycle is 
locked into a particular conformation. The distances of copper(II) to the nitrogen atoms of the 
binding sites are nearly identical in all complexes (see Table 4.4): the copper-Nhet distances 
vary from 2.02 to 2.13 Å and the Cu-Namide distances are somewhat smaller and in the range 
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of 1.89 to 1.97 Å; the copper-copper distance in the complexes varies from 3.5 Å (µ-oxo) to 
5.4 Å (carbonato, see Table 4.4). 
The EPR spectra of the dinuclear copper(II) complexes of H4L4 were simulated with the 
program package Molecular Sophe,[123] using the spin Hamiltonian described in Eq. 3.7. In an 
automated procedure the spin Hamiltonians of the copper(II) centers were optimized and 
fitted simultaneously to the spectra of the allowed (mS = ± 1) and forbidden (mS = ± 2) 
transitions. As result of the optimization algorithm it is possible that derived g and A tensors 
of the respective copper(II) centers differ significantly (e.g. for [H2L4Cu2II]2+ gz (Cu1) = 2.376 
and gz (Cu2) = 2.163) as a result of the optimization to a local minimum. From a structural 
point of view it is unlikely that the coordination geometry of the two sites differs much and 
the obtained parameters cannot be used for a structural discussion. The distance of the 
copper(II) centers is reflected in the distance of the perpendicular peaks (~290 to 340 mT); 
these are accurately reproduced by the simulations of the spectra (see Figure 4.13) and are the 
following discussion focuses on the derived distances from DFT calculations and EPR 
simulations.  
The spectra and their preliminary simulations are depicted in Figure 4.14. The derived 
parameters from the simulations are given in Table 4.3. The simulated EPR data of the 
dinuclear copper(II) complex [H2L4Cu2II]2+ are in good agreement with the DFT calculated 
structure. From the DFT calculations, a CuII-CuII distance of 5.35 Å was derived and the 
simulation of the EPR spectrum predict a distance of 5.22 Å. In the DFT calculated structure 
both copper(II) ions have a distorted square pyramidal coordination geometry with minor 
alterations. This is reflected in the simulated A tensors of the complex that are slightly 
different to each other, yet consistent with a square pyramidal coordination environment (A┴ < 
A||, g┴ < g||) of the complex (see Table 4.3). However, one has to keep in mind, that the 
derived structural parameters from the EPR simulation are not reliable. 
From the combination of the EPR and DFT data it is assumed that in the hydroxo 
complex the hydroxide is most likely bound in a terminal fashion, although, a good agreement 
between calculated structure and EPR predicted structure could not be obtained so far. The 
EPR simulations predict a distance of 4.47 Å for the copper(II) centers. While from the DFT 
calculations of the hydroxo-bridged and terminal hydroxo complex distances of 3.97 and 
5.02 Å were derived (see Table 4.4 and Figure 4.15, left).  
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Figure 4.14. Experimental (black) and simulated (blue, dotted) EPR spectra of the dinuclear 
copper(II) complexes of H4L4 and of the carbonato-bridged complex of ascidiacyclamide (turquoise), 
methanol, T = 50 K, formally forbidden mS = ± 2 (left) and allowed mS = ± 1 transitions (right): 
a) [H2L4Cu2II]2+ ν = 9.3752 GHz;     b) [H2L4Cu2II(OH)]+ ν = 9.3748 GHz;     c) [H2L4Cu2II(OH)2] 
ν = 9.3736 GHz;     d) [H2L4Cu2II(µ-CO3)] ν = 9.3769 GHz 
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Table 4.3. Anisoptropic EPR spin Hamiltonian parameters of the dinuclear copper(II) complexes of 
H4L4 (see Appendix H for line width parameters and angles). 
Parameters  
Cu 1 /Cu 2 
[H2L4Cu2II]2+ [H2L4Cu2II(OH)]+ [H2L4Cu2II(OH)2] [H2L4Cu2II(CO3)] 
gx 2.050 2.08 2.086 2.052 2.064 2.064 2.022 2.021 
gy 2.090 2.10 2.073 2.075 2.109 2.1077 2.192 2.191 
gz 2.200 2.15 2.176 2.175 2.192 2.192 2.192 2.193 
Ax 20 30 42 29 5 68 46 9 
Ay 30 50 54 80 123 12 46 48 
Az 155 140 48 160 130 134 111 93 
J a) -20 -20 -20 -20 
d (Cu-Cu) 5.22 4.47 4.53 4.23 
Units: d [Å], A [10-4cm-1], J [cm-1]; a) H = J S1·S2. 
It was found that the geometry and the copper-copper distance in the DFT calculated 
structures strongly depends on the number of coligands (such as methanol, water) that are co-
ordinated to the copper(II) centers (see Table 4.4 for selected distances). A bridging hydrox-
ide was only obtained when no or two coligands were present at the copper(II) centers. With 
more than two water molecules as coligands or with methanol molecules as coligands, the 
structure always converted to a terminal hydroxo complex. Thus, it is assumed that in solution 
a terminal hydroxo complex is formed (see in Figure 4.15, left). In the bridged complex, the 
oxygen of the hydroxide is equidistant to both copper(II) ions (2.0 Å) and the adopted 
symmetry is high.  
 
 
  
Figure 4.15. Side views of the DFT calculated structures of the terminal hydroxo (left) and hydroxo-
bridged (right) complex of H4L4. 
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Table 4.4. Structural parameters of the dinuclear copper(II) complexes of H4L4 derived from DFT calculations and from the simulation of the EPR spectra.   
 Cu1/2-Nhet Cu1/2-Namide Cu1/2-Nhet Cu1-Cu2 
Cu1-Cu2 
(EPR) 
Nhet-Nhet 
consecutive 
Namide-Namide 
trans-disposed 
Cu1/2-O1 ס [Cu1-O1-Cu2] 
H4L4  - - - - - 5.28 7.93 - - 
[H2L4Cu2II(MeOH)4]2+ 2.02 1.90 2.05 5.35 5.22 4.11
*)/5.91 9.14*)/5.70 - - 
          
[H2L4Cu2II(µ-OH)(H2O)2]+ 2.07 1.92 2.13 3.97 
4.47 
4.1*)/4.8 7.2*)/5.5 2.0 147 
[H2L4Cu2II(µ-OH)(MeOH)2]+ 2.03 1.93 2.04 5.47 4.01
*)/5.64 9.14*)/5.65 3.82 115 
[H2L4Cu2II(OH)(H2O)3]+ 2.10 1.95 2.05 5.26 4.06
*)/5.60 9.09/5.64 1.90/3.51 164 
[H2L4Cu2II(OH)(MeOH)3]+ 2.07 1.95 2.04 5.02 4.1
*)/5.6 9.08*)/5.5 1.93 163 
          
[H2L4Cu2II(µ-O)(H2O)2] 2.05 1.97 2.12 3.53 
4.53 
4.1*)/4.6 7.03*)/5.27 1.87 140 
[H2L4Cu2II(OH)2(MeOH)2] 2.06 1.93 2.14/2.23 5.31 4.0
*)/5.9 9.02*)/5.8 1.92 - 
[H2L4Cu2II(OH)2(MeOH)2]a) 2.13 1.96 2.16 5.43 4.2
*)/5.7 8.83*)/5.9 1.92 - 
          
[H2L4Cu2II (-CO3H)(H2O)2]+ 2.03 1.89 2.07/2.24 5.40 - 4.20*)/5.87 9.13*)/5.87 - - 
[H2L4Cu2II (-CO3)(H2O)2]  2.05 1.94 2.22/2.84 5.11 4.23 4.27*)/5.88 8.88*)/6.24 - - 
Units: d [Å], ס [°]; a) alternative conformation, both OH groups on top side (see Appendix I for visualization); *) at copper(II) bound site. 
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Similar considerations led to the assumption that rather a dihydroxo than a µ-oxo 
complex is formed in solutions with four equivalents of base.[103] The predicted copper-copper 
distance from the EPR simulation is neither consistent with the calculated distance in a µ-oxo 
nor with that in a dihydroxo complex (see Table 4.4). Both distances are approximately one 
angstrom apart from the distance predicted by the EPR spectra simulation.  
 
 
Figure 4.16. DFT calculated structures of the dihydroxo (left) and the µ-oxo complex (right) of H4L4. 
 
Two conformations of the dihydroxo complex were derived from the calculations. In the 
first conformation (see Figure 4.16 left) one hydroxide is on the up side and the other 
hydroxide faces the down side of the macrocycle. In the second conformation both hydroxide 
molecules are on the up side (see Appendix I). With respect to the conformation of the macro-
cycle and the copper(II) copper(II) distance the structures are alike (see Table 4.4). There is a 
small variation in the copper-copper distance of 0.12 Å (5.31 Å (up/down) vs. 5.43 Å (both 
up)) and thus in the distance of the Namide atoms of the binding site. When these structures are 
compared to the structure of the µ-oxo complex it can be seen that the conformation adopted 
by the macrocycle is substantially different. This is reflected in the distance of the coordina-
ting Namide atoms. In the dihydroxo complex they are 9.08 Å apart while their distance in the 
µ-oxo complex is only 7.03 Å. From the experiments it is known that the complex at four 
equivalents of base is readily formed. Considering the steric strain that it put on the system by 
the formation of a µ-oxo complex it emerges that a dihydroxo complex has to be present in 
the solutions. Whether an up/down or a up/up configuration of the hydroxides in the 
dihydroxo complex is adopted cannot be distinguished. 
A large deviation between calculated and EPR derived structure was also found for the 
carbonato-bridged complex [H2L4Cu2II(µ-CO3)]. The overall shape of the EPR spectra of the 
carbonato-bridged complex of H4L4 and the carbonato-bridged complex of ascidiacyclamide 
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is alike, indicating a similar coordination geometry.[71] However, the g and A tensors of the 
copper(II) centers are quite different (see Table 4.5) and this suggests that the adopted struc-
tures and potentially also the coordination mode of carbonate is different, but might also arise 
from different electronics caused by the oxazoline and thiazole heterocycles. The different 
conformations of the macrocycles can be seen by comparing the DFT calculated structure of 
the carbonato complex of H4L4 to the X-ray structure of the carbonato complex of ascidia-
cyclamide (see Figure 4.17).  
 
Table 4.5. Anisoptropic EPR spin Hamiltonian parameters of the carbonato-bridged complexes of 
H4L4 and ascidiacyclamide.[71] 
 g┴ g||  A┴ a)  A|| a) Cu1-Cu2)
[H2L4Cu2II(µ-CO3)]  2.02/2.19 2.19 45/28 111/93 4.23 
[H2LascCu2II(µ-CO3)] *)  2.10 2.31 70 111 3.9 
Units: A [10-4 cm-1]; distance in Å; *) two equivalent copper(II) atoms.[71] 
 
One has to keep in mind that the calculated carbonato complex might not be the global 
minimum. While ascidiacyclamide adopts a conformation where trans-disposed amino acid 
residues face towards one another, the distance between the trans-disposed isopropyl residues 
in H4L4 is large. In addition, the orientation of the heterocycles with respect to each other is 
strikingly different in the two complexes. While the imidazole rings in H4L4 adopt the known 
cone like structure where all Nhet face the up side and all Nimi face the down side the folding 
of ascidiacyclamide causes the Nhet atoms to be oriented in the plane of the binding site or 
slightly towards the downside. The oxygen and sulfur atoms that correspond to the Nimi atoms 
of H4L4 face different directions and are either located in the plane of the binding site or on 
the up side.  
The combination of the DFT calculations and EPR simulations did not yet provide a 
satisfying answer about the geometry of the complexes. As DFT calculations of dicopper(II) 
complexes of cyclic pseudo peptides are quite time consuming and an investigation of dif-
ferent conformations is only possible at high computational cost, molecular mechanics (MM) 
calculations were used for a further insight into the conformations that might be adopted by a 
cyclic pseudo peptides. 
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Figure 4.17. Top (left) and side view (right)of the DFT calculated (G03, B3LYP/6-31g*) structure of 
the carbonato-bridged complex of H4L4 [H2L4Cu2II(µ-CO3)] (top) and of the X-ray structure of the 
carbonato-bridged copper(II) complex of ascidiacyclamide [H2LascCu2II(µ-CO3)] (bottom).  
 
 
4.2.4 Molecular Mechanics Investigation of [H2L4Cu2II(H2O)4]2+ and 
[H2L4Cu2II(µ-CO3)]  
 
DFT calculations, where different coordination modes of the bridging carbonate were chosen 
as starting points all converged to the structure shown above (see Figure 4.17). Thus, the DFT 
calculations suggest that a coordination mode of carbonate that shortens the copper(II)-
copper(II) distance can be excluded. The possible conformations that can be adopted from the 
dinuclear copper(II) complex of H4L4 [H2L4Cu2II(H2O)4]2+ were investigated by means of MM 
and DFT calculations.  
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Table 4.6. Structural parameters of the conformations of [H2L4Cu2II(H2O)4]2+ calculated with molecular mechanics and DFT-methods, respectively.   
 U-shape V-shape 3up-1down  2up-2down 
[H2L4Cu2(H2O)3]2+ 
V-shape 
 
MM vs DFT* (2 H2O 
dissociated) 
MM vs DFT* (1 H2O 
dissociated) 
MM vs DFT* 
MM vs DFT* (2 H2O 
dissociated) 
DFT* 
Cu1-Cu2  3.63 5.64 5.56 5.83 5.59 5.63 5.60 5.30 5.4Å 
d (NamideNamide) 
coordinated 
4.09 8.17 8.95 9.03 9.22 7.51 8.82 8.95 7,9Å 
d (NamideNamide) non 
coordinated 
4.99 5.43 5.74 5.86 5.79 6.70 6.38 6.73 6.3Å 
ס [Nhet-Calpha Nhet]  58/59 98/98 99/107 105/102 113/114 113/114a) 101/102 105/108 92°/100° 
ס [Nhet Calpha Nim(cu)]  68 71/71 67/67  67/73 67/76 72/72 67 72 70/76 
angle between binding 
sites 
9 - 126  2 124 3 85  
Units: d [Å], ס [°]; a) at flipped C *) Jaguar 6.5[158] B3LYP/LACVP[159].  
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The calculations were performed using the program package Maestro[160] and a modified 
Amber force field.[161-162] No electrostatic interactions or partial charges were considered. For 
the conformational search, a 100 ps molecular dynamics (MD) simulation was performed at a 
range of different temperatures (300 K to 800 K). The MD simulation of the dinuclear 
copper(II) complex [H2L4Cu2II(H2O)4]2+, followed by a multiple minimization of the obtained 
structures revealed four different conformers: u-shape, v-shape, 3up-1down, and 2up-2down 
(see Figure 4.18).  
 
 
Figure 4.18. Conformations of [H2L4Cu2II(H2O)4]2+. U-shape (top left), v-shape (top right), 3up-1down 
(bottom left) and 2up-2down (bottom right). 
 
The nomenclature of the conformers of [H2L4Cu2II(H2O)4]2+ refers to the shape of the 
macrocyclic backbone (u-shape and v-shape) and to the orientation of the valine residues on 
different sides of the macrocyle (3up-1down and 2up-2down), respectively. In the u- and the 
v-shaped structures (top left and top right structures in Figure 4.18) the orientation of the 
valine residues is equivalent to that of the X-ray structure of H4L4 (see Figure 4.4).  
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The considerable difference in folding of the predicted conformations is caused by a 
variation of the dihedral angle of the Cazole-C-Namide-Camide bonds in the valine linkers that 
are not part of the binding sites. The angle  changes from 90° and 92° in the u-shape form to 
42° and 172° in the v-shaped conformation. The 3up-1down and 2up-2down conformations 
even show a further modification along these bonds and as a consequence of the rotation of 
the C-Namide and the amide bond, the valine residues are flipped from the up to the down side 
of the ring. However, it is worth noting that this flip does not alter the stereochemistry at C. 
Nevertheless, the orientation of the valine residues in the 2up-2down conformation is very 
similar to the orientation of the amino acid residues in ascidiacyclamide and H4Lrs, although 
the stereochemistry at C in these macrocycles is different. The different conformations seem 
to solely be a result of the flexibility of the non-coordinated linkers.  
The conformations of the dinuclear copper(II) complex [H2L4Cu2II(H2O)4]2+, obtained 
from the MD simulations were further investigated in order to determine how much energy is 
needed to change the folding of the cyclic peptides, and whether these conformations are also 
accessible in the metal free cyclic pseudo octapeptide. Therefore, the metal free conforma-
tions v-shape, u-shape, 3up1down, and 2up2down were DFT-optimized and a frequency 
analysis was performed on the macrocyclic conformation thus obtained (see Figure 4.19). 
Interestingly, the u-shape conformation, although closer to the conformation of the natural 
cyclic pseudo peptide ascidiacyclamide, could not be optimized to a minimum, but instead 
relaxed back to the v-shape conformation, which was also present in the X-ray structure of 
H4L4. This emphasizes the influence of the configuration at C on the adopted conformation 
of the macrocycle. The v-shaped structure is lowest in energy and the 3up-1down and 2up-
2down conformations are 56 and 116 kJ/mol, respectively, higher in energy indicating an 
energy increase of ~60 kJ/mol per flipped isopropyl residue. 
 
 
 
Figure 4.19. Structures of the DFT optimized metal free conformations of H4L4. From left to right: 
v-shape, 3up-1down and 2up-2down conformation. 
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It is known that the electronic interactions between the (Cazole-Nhet)-orbital of the 
heterocycles and the */ orbital of the linker substantially influence the adopted conforma-
tion of the macrocycles (see Chapter 1.3). In the structures, obtained from the MD simulations 
the dihedral angles  in the linkers are not always at their global minimum (see Chapter 1.3, 
Figure 1.5). Hence, the structures obtained from the MM calculations were reoptimized by 
DFT methods. Upon DFT optimization of the conformations, the amide bonds are rotated in a 
way, that the oxygen atoms face towards the outside and are now at their energetical 
minimum. Futhermore, it was found that the MM calculations predict the imidazole rings of 
the binding site to be too planar, e.g. they are nearly coplanar with the plane of the binding 
site itself, whereas the DFT calculations show that in general at least one heterocyclic ring is 
twisted. A summary of selected distances and angles of the molecular mechanics and the DFT 
calculations is given in Table 4.6.  
The observed reorganization of the metal free u-shape structure to the v-shape conformer 
was also observed in case of the dinuclear copper(II) complex [H2L4Cu2II(H2O)4]2+. This 
reorganization is not unexpected as the conformation of the linker derived from the MD 
simulations puts substantial strain on the system. From the structural investigation of 
patellamides it is known that the inclusion of a solvent sphere can be crucial to stabilize 
different conformations.[75] Nevertheless DFT calculations applying a solvation model 
(Gaussian 09,[163] PCM[164]) provided identical structures and distances to those derived from 
the gas phase calculations suggesting that the u-shape conformation is not important for the 
coordination chemistry of H4L4 in solution. 
 
 
 
Figure 4.20. Coordination modes of the bridging carbonate ion considered in the MD simulations. 
 
However, as the u-shaped conformation was found to have the closest copper-copper 
distance (3.6 Å) to the one derived from the simulation of the EPR spectrum of the carbonato 
complex [H2L4Cu2II(µ-CO3)] so far, this structure was chosen as a starting point for the further 
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investigation of the carbonato complexes, given that it might provide insight into a conforma-
tion with the desired copper-copper distance of ~ 4.2 Å. 
To test the influence of the bridging carbonate ion on the possible conformations, the 
derived conformations from the molecular dynamics simulations of the dinuclear copper 
complex [H2L4Cu2II]2+ were manually bridged by a carbonate ion and subsequently a 
conformational search was performed. Three different coordination modes of the carbonate 
ion were considered (A, B, and C, see Figure 4.20). For the bridging modes A and B, two 
different orientations of the water coligands were investigated (A’ and B’).  
 
Table 4.7. Coordination modes and respective copper-copper distances for the different conformations 
of H4L4, optimized with DFT methods (Jaguar 6.5, B3LYP/LACVP) 
 A A’ B B’ C 
U-shape No stable conformation found 
V-shape 5.20 - 4.95 -  
Not converged 3up-1down - - 5.30 5.30 
2up-2down 5.18 5.18 5.22 4.91 
 
According to the MD simulations, the different conformations of the cyclic pseudo 
peptides prefer different carbonate coordination modes. A summary of the observed 
conformations for the different binding modes is given in Table 4.7. The u-shape 
conformation did not converge to a minimum with any of the considered bridging modes, but 
it was found to reorganize to the v-shape conformer. This behavior has also been observed for 
the dinuclear copper(II) complex where the u-shape conformation could not be converged to a 
minimum (see Table 4.6). It seems that the u-shape conformer is not important for the co-
ordination chemistry of H4L4 and probably just an artifact of the parameterization of the force 
field. 
Coordination mode C, where the carbonate is not located in the plane of the copper(II) 
centers, could not be converged to a minimum with any of the conformations. Therefore, it is 
assumed that the bridging mode of carbonate is either A or B. The question, why the derived 
distances from the EPR experiment and the DFT calculations are so different remains. 
Although various conformations were tested it was not possible to obtain a structure where 
the copper(II) centers are as close as predicted from the EPR experiment. So far the smallest 
 4.2 Copper(II) Coordination Chemistry of H4L
4  
87 
 
copper-copper distance (4.91 Å) is obtained for the 2up-2down conformation with a B’ 
bridging mode. Within the computational accuracy this distance can be considered as equal to 
the distance of 4.95 Å obtained from the v-shape configuration with a B bridging mode. 
Considering the high rotation barrier for a flip of the isopropyl residues (see Chapter 4.2.4) it 
is likely that the v-shape conformation is the only conformation present in solution.  
 
 
The presented results show that, although highly simplified, H4L4 is a useful model 
system for the natural occurring cyclic pseudo octapeptides. It is, as its natural analoga, highly 
preorganized, shows a cooperative effect and reacts with atmospheric CO2 to the respective 
carbonato-bridged species. However, it is not expected that the conformation adopted by the 
copper(II) complexes of H4L4 is identical to that of the natural peptides, as these are more 
flexible as a result of an alternating stereochemistry in the linkers and the incorporation of 
oxazoline rings. Furthermore, the formation of a pink species was observed, which could not 
yet be fully characterized. The pink species is known to be strongly ferromagnetically 
coupled. Such a species has not been reported for the natural cyclic peptides, but it is possible 
that it has not been observed. One advantage of H4L4 is its, compared to the natural peptides, 
easy synthesis and availability. 
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4.3 Copper(II) Coordination Chemistry of H4Lrs 
4.3.1 ESI-MS Experiments 
 
The alternating configuration of the C carbon atoms in H4Lrs is identical to the configuration 
in the patellamides and ascidiacyclamide and should enable the investigation of the influence 
of the linkers’ stereochemistry. In contrast to the C4-symmetrical macrocycle H4L4, H4Lrs has 
two enantiomeric binding sites. Copper(II) can either be coordinated to a Nhet-NS-amide-Nhet or a 
Nhet-NR-amide-Nhet binding site (see Figure 4.21 and Section 4.1.1 for a structural discussion). 
The experimental findings, especially the absence of Cotton effects in the CD spectra (see 
Section 4.3.2) suggest that neither of the binding sites is favored. This is verified by a racemic 
crystal of the hydroxo-bridged cation [H2LrsCu2II(µ-OH)(H2O)2]+ (see Section 4.3.4). The 
DFT calculations of the two conformers of the monomeric copper(II) complex 
[H3LrsCuII(H2O)2]2+, where copper(II) is bound to the different binding modes, suggest that 
the coordination of copper(II) in the Nhet-NS-amide-Nhet motif is favored by 6 kJ/mol, i.e. within 
in the accuracy of the DFT method the structures can be considered as degenerate.  
 
Figure 4.21. Chemical structure of H4Lrs. 
 
The performed ESI-MS experiments revealed that the copper(II) coordination chemistry 
of H4Lrs differs from the one of H4L4. The ESI-MS spectra of the C4-symmetric pseudo 
octapeptide H4L4 (see Section 4.2) with varying equivalents of copper(II) and base have 
concise peaks, that are consistent with the successive interconversion of the initial 
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mononuclear complex [H3L4CuII]+ to the dinuclear and then to bridged dinuclear copper(II) 
complexes. Addition of four equivalents of base to a H4L4/copper(II) (1:2) solution leads to 
the formation of the neutral dihydroxo complex [H2L4Cu2II(OH)2] (not detectible in ESI-MS 
experiments) and solutions of H4L4 with a macrocycle/copper(II)/base ratio of 1:2:3 or higher 
show a time-dependent conversion of the (di)hydroxo species to the carbonato-bridged 
species [H2L4Cu2II(µ-CO3)] (see complexation equilibria of H4L4 in Figure 4.8). The 
copper(II) coordination chemistry of H4Lrs is different. A summary of representative species, 
present in methanolic solutions of different ratios of H4Lrs/copper(II)/base is given in 
Table 4.8.  
 
Table 4.8. Observed high resolution ESI-MS signals of the mono- and dinuclear copper(II) complexes 
of H4Lrs, their molecular formula, experimental and calculated exact masses.  
species molecular formula experimental calculated 
[H5Lrs]+ C40H61N12O4+ 773.4936 773.4932 
[H4LrsNa]+ C40H60N12O4Na+ 795.4757 795.4752 
[H3LrsCuII]+ C40H59CuN12O4+ 834.4081 834.4073 
[H3LrsCuII(H2O)]+ C40H61CuN12O5+ 852.4189 852.4178 
[H2LrsCuII(H2O)Na]+ C40H60CuN12O5Na+ 874.4010 874.3997 
[H2LrsCu2II(OH)]+ C40H59Cu2N12O5
+
 913.3315 913.3318 
 
The analysis of the ESI-MS signals from the copper(II) complexes of H4Lrs indicates that 
this macrocycle has a higher preference or preorganization for the formation of a dinuclear 
hydroxo complex [H2LrsCu2II(OH)]+ than H4L4: 
Signals assigned to the dinuclear hydroxo complex [H2LrsCu2II(OH)]+ at m/z 913.3318 
could even be observed in the absence of base at a macrocycle/copper(II) ratio of 1:1. In the 
absence of base, when the copper(II) concentration is increased above one equivalent, a 
decrease of the signal intensity of the hydroxo complex [H2LrsCu2II(OH)]+ can be observed 
while that intensity of the mononuclear complex [H3LrsCuII]+ at m/z 834.4081 increases. At a 
first glance this seems to contradict the idea that the dinuclear copper(II) complexes of H4Lrs 
are preferred over the mononuclear. Nevertheless, one has to keep in mind that for each 
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coordinated copper(II) in the Nhet-Namide-Nhet binding site one amide nitrogen is deprotonated 
and accordingly a proton released. This proton is subsequently able to protonate a free H4Lrs 
molecule or a copper(II) complex, changing the equilibrium and withdrawing the protonated 
macrocycle’s ability to coordinate copper(II). The fact that addition of base immediately 
increases the amount of dinuclear hydroxo complex [H2LrsCu2II(OH)]+ present in solution 
reflects the preference of H4Lrs for the formation of dinuclear copper(II) complexes. At a 
H4Lrs/copper(II)/base ratio of 1:2:3 the dominant signal was assigned to the hydroxo complex 
[H2LrsCu2II(OH)]+ (m/z 913.3318) and the spectra were unaffected by addition of further base.  
The disappearance of signals, due to the formation of a neutral species as well as a time-
dependent conversion of the hydroxo complex [H2LrsCu2II(OH)]+ to a carbonato-bridged com-
plex, could not be observed for H4Lrs. A further difference to the coordination chemistry of 
H4L4 is that the addition of carbonate to the copper(II) complex solutions of H4Lrs does not 
lead to the formation of carbonato-bridged complexes. Instead, the added carbonate acts as a 
base and the obtained spectra are comparable to those measured at higher base concentrations. 
From these experiments the following complexation equilibrium is assumed (see Figure 4.22). 
 
 
Figure 4.22. Assumed copper(II) complexation equilibria of H4Lrs (solvent = methanol). 
 
Addition of copper(II) to a solution of H4Lrs leads to the formation of the mononuclear 
copper(II) complex [H3LrsCuII]+ that immediately is converted to the dinuclear copper(II) 
complex [H2LrsCu2II]2+. However, the formation of the complexes releases protons that acidify 
the solution and thus, in absence of base an equilibrium between the mono- and the dinuclear 
complex is observed. A complete conversion to the dinuclear complex can only be observed 
when the released protons are absorbed by added base. Addition of three equivalents of base 
shifts the equilibrium to the hydroxo complex [H2LrsCu2II(OH)]+. A reaction of the the di-
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nuclear complexes with atmospheric CO2 or the formation of a carbonato complex upon 
addition of carbonate to the solutions could not be observed.  
 
 
4.3.2 Spectroscopic Investigation of H4Lrs 
 
In contrast to the copper(II) complexes of H4L4, the analogous copper(II) complexes of H4Lrs 
do not exhibit any CD-spectroscopic features of note as the Cotton effects of enantiomeric 
compounds  have reverse signs and thus are cancelled when the two forms of the complex are 
formed with similar probability (see Figure 4.29 for the DFT calculated structures of the two 
enantiomers of the mononuclear complex). UV-vis spectroscopy, however, is insensitive to 
chirality and provides further insight into the copper(II) coordination chemistry of H4Lrs.  
In a first titration series, up to two equivalents of copper(II) were added to a solution of 
H4Lrs in steps of 0.4 eq (see Figure 4.23 top). A broad d-d-absorption band arises at ~700 nm 
that linearly increases in intensity with the copper(II) concentration and exhibits a minor shift 
throughout the titration from 690 nm in the first spectrum to 712 nm in the last spectrum. The 
small shift of the band is presumably the result of the different ratios of [H2LrsCu2II]2+ to sol-
vated copper [CuII(MeOH)n]2+ in solution. The observed band consequently can be assigned 
to a combination of the absorption band of the dinuclear copper(II) complex [H2LrsCu2II]2+ 
(λmax = 685 nm, comparable to λmax = 674 nm of [H2L4Cu2II]2+ (see Figure 4.9)) and solvated 
copper(II) [CuII(MeOH)n]+ with an absorption maximum at 840 nm. From the analysis of the 
ESI-MS spectra (see Table 4.8), it is known that at low concentrations of copper(II) a nearly 
complete formation of the dinuclear complex can be observed. On the other hand, an increase 
of the copper(II) concentration leads to an enhanced formation of the mononuclear complex 
[H3LrsCuII]+ and solvated copper(II) in solution, which consequently shifts the absorption 
band to a higher wavelength. The UV-vis experiments emphasize the high stability of the 
dinuclear complexes of H4Lrs. 
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Figure 4.23. UV-vis spectra in methanol (c(H4Lrs) = 1.25mM, base: (n-Bu4N)(OMe)): titration of 
0-2 eq of CuII, in 0.2 eq steps, to a solution of H4Lrs (top), titration of 0–2 eq of base, in 0.2 eq steps, to 
a H4Lrs/copper(II) 1:2 solution (middle), and titration of 2-5 eq of base, in 0.2 eq steps, to a 
H4Lrs/copper(II) 1:2 solution (bottom). 
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Subsequent to the addition of copper(II) to a H4Lrs solution, base (n-Bu4)(OMe) was 
added stepwise to the H4Lrs/copper(II) 1:2 solution. Addition of up to two equivalents of base 
(Figure 4.23, middle) induces a shift from 714 ( = 27 M-1cm-1) to 685 nm ( = 109 M-1cm-1) 
and an increase of the absorption band, consistent with the formation of the dinuclear 
copper(II) complex [H2LrsCu2II]2+. Upon addition of 2–3 equivalents of base a shoulder at 
550 nm emerges ( = 81 M-1cm-1). In agreement with the analysis of the ESI-MS data the 
spectra are invariant upon addition of more than three equivalents of base.  
The intensities of the absorption bands at 685 and 550 nm have an inflection point at the 
addition of two equivalents of base. While the absorption band at 685 nm strongly increases 
upon the addition of up to two equivalents of base and only slightly upon addition of the third 
equivalent of base, the effect on the absorption band at 550 nm is inverse (Figure 4.23, 
bottom). This suggests that the dinuclear copper(II) complex [H2LrsCu2II]2+ with an absorption 
maximum at 685 nm is formed first and subsequently converted into the hydroxo species 
[H2LrsCu2II(OH)]+. The ongoing increase of the d-d-absorption at 685 nm from 2-3 equivalents 
of base is caused by its overlap with the absorption band at 550 nm.  
The intensity of the whole spectrum marginally decreases during the addition of 4-5 equi-
valents of base, caused by a bluish precipitate, most likely copper(II) methoxide or hydroxide, 
that is formed at base concentrations above four equivalents and removes copper(II) from the 
solution. The addition of carbonate to H4Lrs/copper(II) 1:2 solutions shifts the UV-vis 
spectrum to a spectrum identical to that recorded at higher base concentrations. It might be 
that H4Lrs is not flexible enough to form carbonato-bridged complexes.  
 
 
4.3.3 EPR Experiments 
 
EPR measurements of solutions with varying ratios of H4Lrs/copper(II)/base were performed 
and it emerged that the copper(II) complexation equilibrium of H4Lrs depicted in Figure 4.22 
is more complex than anticipated. The EPR spectra of the mono- and especially the dinuclear 
copper(II) complexes of H4Lrs were found to have interesting features.  
In comparison to the spectrum of solvated copper (Figure 4.24 a), a new set of signals 
between 260 and 340 mT arises in the EPR spectra at a H4Lrs/copper(II)/base ratio of 1:2:1 
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(Figure 4.24 b). When a second equivalent of base is added the signals of solvated copper(II) 
disappear and the spectrum exclusively consists of the set of signals that was previously 
observed at lower base concentrations in addition to the signals of solvated copper(II) 
(Figure 4.24 b) and usually would be assigned to a mononuclear copper(II) complex of H4Lrs.  
 
    
Figure 4.24. Experimental X-Band EPR spectra in methanol, c(H4Lrs) = 1.25mM: a) solvated CuII 
[CuII(MeOH)n]2+, T = 145 K,  = 9.427799 GHz;       b) H4Lrs/copper(II)/MeO- 1:2:1, T = 10 K, 
ν = 9.377228 GHz;      c) H4Lrs/copper(II)/MeO- 1:2:2, T = 4.5 K, ν = 9.375067 GHz;      
d) H4Lrs/copper(II)/MeO- 1:2:3, T = 50 K, ν = 9.377548 GHz;         e) pure “monomer” species pre-
sent in d) derived from spectra subtraction of the spectrum with three equivalents of base from the 
spectrum with four equivalents of base (see Figure 4.26 for 1:2:4 spectrum)         f) dimeric species 
present in d), derived from spectra subtraction. 
 
Considering that two equivalents of copper(II) are present in solution and that the spin 
Hamiltonian parameters of coordinated and solvated copper(II) are significantly different (see 
Table 4.9, e.g. g|| = 2.42 (solvated) vs 2.25 (complexed)) these signals have to be due to a 
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dinuclear copper(II) complex of H4Lrs. In combination with the ESI-MS and UV-vis spectra 
this spectrum can be assigned to the dinuclear copper(II) complex [H2LrsCu2II(H2O)]2+. In 
general the EPR spectrum of a randomly oriented mononuclear copper(II) complex consist of 
a set of four peaks in the parallel region of the spectrum and one in the perpendicular region, 
caused by the interaction of the nuclear spin of copper(II) (I = 3 2ൗ ) with the spin of the un-
paired electron (S = 1 2ൗ ). The interaction of the copper(II) centers in dinuclear complexes on 
the other hand gives rise to a set of seven signals, which often overlap, resulting in compli-
cated spectra. The expected seven signals were not observed in the EPR spectra of the di-
nuclear copper(II) complexes of H4Lrs, [H2LrsCu2II(H2O)]2+ and [H2LrsCu2II(OH)]+, respec-
tively, (see Figure 4.24 c and e), where only four signals were seen. The spectra were 
recorded at a H4Lrs/copper(II)/MeO- ratio of 1:2:2 and 1:2:3.  
On behalf of their EPR spectrum the mono- and the dinuclear copper(II) complexes of 
H4Lrs are not distinguishable: the signals that arise at a H4Lrs/copper(II)/base concentration 
of 1:2:1 are a mixture of mono- and dinuclear complexes are identical to those at a 1:2:2 ratio 
and it emerges that the coordination environment of copper(II) in the mono- and in the 
dinuclear complexes is identical. In order for the detection of a pseudo mononuclear spectrum 
the dipole-dipole interaction of the copper(II) centers in the dinuclear water and hydroxo 
complex has to be cancelled. From the EPR spectrum it arises that copper(II) has a square 
pyramidal coordination environment in the mono- and in the dinuclear copper(II) complexes 
and this could be reproduced by the DFT calculated structures of the mononuclear and 
bridged dinuclear complexes (see Section 4.3.4). The observation of a dinuclear complex 
exhibiting essentially mononuclear EPR features is known in literature.[75] The dipole-dipole 
interaction between the two copper(II) centers is cancelled, when the orientation of their g 
and A tensors is twisted with respect to each other by Euler angles of α = 54.7° and β = 37.5°. 
They are said to be set up in a magic angle. 
In accordance with the initially proposed complexation equilibrium derived from ESI-MS 
and UV-vis data(see Figure 4.22), the EPR spectra change upon addition of a third equivalent 
of base (see Figure 4.24 d). The recorded spectrum now consists of a mixture of a dinuclear 
copper(II) complex and a new “mononuclear” complex. Again the “mononuclear” features 
can be assigned to a dinuclear copper(II) complex of H4Lrs, i.e. [H2LrsCu2II(OH)]+. As in case 
of the water complex, this complex is also expected to have a square pyramidal coordination 
environment at the copper(II) centers (see Figure 4.31). The formally forbidden ΔmS = ± 2 
transitions at half field, usually a good indicator for the presence of dinuclear complexes 
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could not be recorded for the dinuclear complexes [H2LrsCu2II(H2O)]2+ and [H2LrsCu2II(OH)]+. 
They are expected to be too low in intensity. Being formally forbidden, the transition proba-
bility of the ΔmS = ± 2 transitions is already one order of magnitude lower than that of the 
allowed ΔmS = ± 1 transitions. The magic angle set up of the dinuclear complexes 
[H2LrsCu2II(H2O)]2+ and [H2LrsCu2II(µ-OH)]+ reduces the already low signal intensity by a 
further order of magnitude.  
 
Figure 4.25. Assumed copper(II) complexation equilibria of H4Lrs (solvent = methanol). 
 
Considering these and the findings from the ESI-MS and UV-vis experiments, as well as 
those of the DFT calculations (see Section 4.3.4) the complexation equilibria depicted in 
Figure 4.25 are proposed. The dinuclear copper(II) complex that is formed at low base con-
centrations is bridged by a water molecule [H2LrsCu2II(H2O)]2+ and as a result of the bridge, 
the copper(II) centers are oriented in a magic angle, which leads to a  pseudo mononuclear 
copper(II) EPR spectrum. When a third equivalent of base is added, two isomeric hydroxo 
complexes [H2LrsCu2II(µ-OH)]+ and [H2LrsCu2II(OH)]+, respectively, are formed that give rise 
to the set of signals depicted in Figure 4.24 d. While the copper(II) centers in the hydroxo-
bridged isomer are still oriented at a magic angle, thus resulting in a pseudo mononuclear 
EPR spectrum, the change from a bridging to a terminal hydroxide causes a conformational 
reorientation in the pseudo octapeptide which now exhibits a dinuclear EPR spectrum (see 
Figure 4.24 f). The respective spectra of the isomeric hydroxo complexes [H2LrsCu2II(µ-OH)]+ 
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and [H2LrsCu2II(OH)]+ (see Figure 4.24 e and f), could be obtained by spectral subtraction of 
the EPR spectra measured at four and at three equivalents of base. The DFT geometry 
optimizations of the hydroxo-bridged and water bridged complexes revealed a square 
pyramidal coordination sphere of the copper(II) centers in both complexes, with a small 
difference among the complexes that gives rise to the different g and A tensors of the 
complexes (see Table 4.9).  
 
Table 4.9. Anisotropic spin Hamiltonian parameters of solvated copper(II) [CuII(MeOH)n]2+ [165] and of 
the dinuclear bridged copper(II) complexes of H4Lrs: [H2LrsCu2II(µ-H2O)]2+ and [H2LrsCu2II(µ-OH)]+.  
 [CuII(MeOH)n]2+  [H2LrsCu2II(H2O)]2+ [H2LrsCu2II(µ-OH)]+ 
gx 2.084 2.0719 2.0503 
gy 2.084 2.0456 2.0539 
gz 2.428 2.258 2.2600 
Ax (63Cu) 15 4.019 12.6896 
Ay (63Cu) 15 4.423 9.2275 
Az (63Cu) 108 166.878 161.641 
Ax (14N) – Nhet*) - 8.0751 6.9792 
Ay (14N) – Nhet *) - 11.629 9.0013 
Az (14N) – Nhet*) - 10.500 10.000 
Ax (14N) – Namide - 15.455 13.369 
Ay (14N) – Namide - 13.078 12.849 
Az (14N) – Namide  - 13.500 12.000 
*) simulated spectra of H4Lrs included two magnetically identical heterocyclic nitrogen nuclei.  
 
Addition of four and up to nine equivalents of base results in minor modifications of the 
EPR spectra, caused by a slightly different ratio of the hydroxo complex isomers (see 
Figure 4.26 a-c for the spectra with three, four, and five equivalents of base, respectively). As 
expected and observed in the previous experiments carbonate ions that are added to 
H4Lrs/copper(II) 1:2 solutions, do not appear to interact with the complex, nor lead to the 
formation of carbonato-bridged complexes. Thus, considering the so far performed 
experiments, it is possible to exclude the existence of a stable carbonato complex of H4Lrs, 
i.e. [H2LrsCu2II(µ-CO3)]. 
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Figure 4.26. Experimental (black) and simulated (blue) X-Band EPR spectra in methanol, 
c(H4Lrs) = 1.25 mM:      a) H4Lrs/copper(II)/MeO- 1:2:3, T = 50 K, ν = 9.377548 GHz; 
b) H4Lrs/copper(II)/MeO- 1:2:4, T = 5 K, ν = 9.376811 GHz;          c) H4Lrs/copper(II)/MeO- 1:2:5, 
T = 5 K, ν = 9.376811 GHz;      d) [H2LrsCu2II(µ-H2O)]2+, H4Lrs/copper(II)/MeO- 1:2:2; T = 4.5 K, 
ν = 9.375067 GHz        e) second derivative of the spectrum of [H2LrsCu2II(µ-H2O)]2+. 
 
The experimental first derivative EPR spectrum of the water bridged dinuclear complex 
[H2LrsCu2II(µ-H2O)]2+ and its simulation are shown in Figure 4.26 d. After differentiation, 
Fourier- and Savitzky-Golay filtering, the second derivative of the EPR spectra could be ob-
tained, where the superhyperfine coupling A (14,15N) of the coordinated nitrogen atoms is re-
solved. The second derivative spectrum and its simulation are shown in Figure 4.26 e. The 
spectra were simulated with the program package X-Sophe-Sophe-XeprView, based on the 
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Spin-Hamilton Operator shown in Eq. 3.7.[122] Two magnetically equivalent heterocyclic 
nitrogen nuclei and one amide nitrogen nucleus were assumed in the simulation in order to 
correctly reproduce the observed hyperfine coupling. The EPR spectrum is suggestive of a 
square pyramidal coordination sphere of both copper centers. 
 
 
Figure 4.27. Experimental (black) and simulated (blue) first (left) and second derivative (right) 
X-Band EPR spectra in methanol of the bridged hydroxo complex [H2LrsCu2II(µ-OH)]+, derived from 
spectra subtraction; T = 50 K, c(H4Lrs) = 1.25 mM, ν = 9.375402 GHz. 
 
The experimental first and second derivative EPR spectra of the bridged hydroxo com-
plex [H2LrsCu2II(µ-OH)]+, that was derived from spectra subtraction (see Figure 4.24 e) to-
gether with their simulated spectra are shown in Figure 4.27. The simulation confirmed the 
slightly different coordination sphere of the copper(II) centers in the dinuclear bridged com-
plexes [H2LrsCu2II(µ-H2O)]2+ and [H2LrsCu2II(µ-OH)]+. The spin Hamiltonian parameters are 
listed in Table 4.9. The parameters were fitted with the least mean square method to the 
experimental spectrum and show excellent agreement with the experimental spectra with a 
RMS of 0.04. The gx and Az tensors of the hydroxo complex [H2LrsCu2II(µ-OH)]+ are slightly 
smaller than those of the dinuclear complex [H2LrsCu2II(µ-H2O)]2+. Yet, in a structural sense it 
is not expected that there are large differences between the complexes, as the copper(II) 
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centers still have to be set up in an magic angle and the differences are thought to be caused 
by the deprotonation of the bridging water and hence formation of a hydroxide bridged 
complex.  
The simulated spin Hamiltonian parameters of the bridged complexes are suggestive of a 
distorted square pyramidal coordination sphere. They are in a similar range as the spin 
Hamiltonian parameters reported for the mononuclear copper(II) complexes of H3L1-3 (see 
Table 3.3) and H4L4 (g┴ = 2.09, 2.05; g|| = 2.26; A┴ = 14, 15; A|| = 169).[103] The distorted 
square pyramidal coordination sphere of copper(II) ions in µ-OHn (n = 1,2) bridged dinuclear 
copper(II) complexes of H4Lrs can also be observed in the X-ray structure of the dinuclear 
copper(II) complex [H2LrsCu2II(µ-OH)(H2O)2]+ and in the DFT calculated structures (see 
Section 4.3.4). 
A satisfactory simulation of the non-bridged hydroxo complex [H2LrsCu2II(OH)]+ has yet 
to be obtained. The simulations to date suggest a copper(II)-copper(II) distance in the range of 
4.6 Å, this distance is longer than the distance in the bridged complexes.  
 
 
4.3.4 DFT Calculations and X-Ray Crystallography 
 
In order to rationalize the experimental observations, the structures of H4Lrs and its mono- 
and dinuclear copper(II) complexes were geometry optimized using DFT methods. The 
calculations were performed in gas phase and solution, using the program packages Gaussian 
03,[119] Gaussian 09,[163] and Turbomole.[166] Geometry optimizations were performed using 
the B3LYP functional and the 6-31g* (C, H, N, O) and TZVP (Cu) basis sets.[130, 135-136, 139] 
Subsequent to the geometry optimization a frequency analysis was performed in order to 
confirm the structures as a minimum on the potential surface. 
Bearing in mind the similarity of H4Lrs and H4L4 it is surprising that in none of the ex-
periments with H4Lrs the formation of carbonato complexes could be observed. It is likely 
that this is a result of the different folding of the macrocycles that strongly influences the 
orientation of the amino acid residues. An alternating up and down conformation, as adopted 
in H4Lrs, might inhibit the formation of a carbonato complex for steric reasons. This might 
explain why in the natural cyclic pseudo octapeptides oxazoline rings are incorporated as they 
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enlarge the flexibility that might be needed to form carbonato-bridged complexes. The DFT 
calculation of two possible conformations of the metal free macrocycle of H4Lrs revealed that 
the conformation that is equivalent to the one adopted by H4L4 is 62 kJ/mol higher in energy 
than the one adopted in the X-ray of H4Lrs, emphasizing the preferred adoption of one 
conformer (see Figure 4.28). The high energy difference of flipped conformers has also been 
observed and calculated for the conformations of H4L4 (see Figure 4.19, page 84). In addition 
to the already quite high energy difference it is likely that the flip of the isopropyl residue is 
accompanied by a high rotation barrier and therefore it appears that a conformation similar to 
that of H4L4 cannot be adopted by H4Lrs.  
 
 
 
Figure 4.28. DFT calculated conformations of H4Lrs: conformation equivalent to the one adopted by 
H4L4 in the X-ray structure (left) and conformation of the X-ray structure of H4Lrs (right). 
 
The influence of a solvation model (PCM,[164] methanol) on the optimized geometry of 
the copper(II) complexes of H4Lrs was tested with the mononuclear copper(II) complex 
[H3LrsCuII(H2O)2]+ and found to be insignificant (see Appendix I). As mentioned in the 
introduction of this Chapter, H4Lrs has two different binding sites. Copper(II) can either bind 
to the Nhet-NR-amide-Nhet [H3LrsCurII(H2O)2]+ or the Nhet-NS-amide-Nhet [H3LrsCusII(H2O)2]+ bin-
ding site. The inexistence of Cotton bands was a strong indication that in the solutions are 
racemic, suggesting that the two complexes are energetically identical. In the calculated 
mononuclear copper(II) complexes, the coordination sphere of copper(II) was completed by 
two water molecules and, as assumed from the EPR spectra they were found to have a 
distorted square pyramidal coordination sphere. The equatorial positions are occupied by two 
imidazole nitrogens Nhet, one amide nitrogen Namide, and one oxygen of a coordinated water 
molecule. The water molecule that occupies the apical position has a longer Cu1-O2 distance 
N4 N10 N4 N10
N16 N16
 4.3 Copper(II) Coordination Chemistry of H4L
rs 
103 
(2.29 Å) than the water coordinated in the equatorial plane (Cu1-O1 = 2.04 Å). This water 
molecule hardly changes its position upon formation of the dinuclear complex, suggesting that 
the water molecule is used as an anchor to form the dinuclear complexes. This might also 
explain the observed preference for the formation of dinuclear complexes. 
 
  
Figure 4.29. Top views of the enantiomers [H3LrsCurII(H2O)2]+ (left) and [H3LrsCusII(H2O)2]+ (right). 
 
When the structures of the two possible monomeric complexes are compared, their 
enantiomeric character emerges (see Figure 4.29, Table 4.10). The intramolecular distances 
and angles in the two enantiomeric complexes are nearly identical, e.g. the largest deviation 
between the complexes is found to be the distance of the trans-disposed Nhet atoms (0.3 Å). 
The small variations in the adopted conformations might be the reason for the calculated 
small energy difference of 6 kJ/mol.  
CuSCuR
N4
N4
R*S
*
S* R*
O1
O1
O2
O2
N1
N1
S*
R*R*
S*
  
Table 4.10. Selected angles and distances (e.s.d.’s are given in parentheses) of the DFT a) optimized structures of the copper(II) complexes of H4Lrs, of the X-
ray structure of the hydroxo-bridged complex of H4Lrs [H2LrsCu2II(µ-OH)(H2O)2]+, and for comparison the DFT calculated structure of the hydroxo-bridged 
complex of H4L4 [H2L4Cu2II(µ-OH)]+. 
 [H3L
rsCuII(H2O)2]+ a) H4L4 H4Lrs X-ray 
 
at S*-configured 
Namide 
at R*-configured 
Namide 
[H2LrsCu2II(µ-OH)]+ 
a) 
[H2L4Cu2II(µ-OH)]+ a)
[H2LrsCu2II (µ-
H2O)]+ a) 
[H2LrsCu2II (µ-
H2O)]2+ 
[H2LrsCu2II (µ-
OH)(H2O)2]+ 
[N4-N10-N16-N22] c) 22 31 -27 28 28 28 -40 

c 11/11 -15/13 0/-14 10/6 111/37 111/37 96/22 
ס (Cu1-O1-Cu2) - - 137 148 133 145 140 
angle between binding sites) 61 61 71 86 77  77 
Namide-Namide consecutive 
5.19/5.33/ 
5.00/5.26 
5.22/5.18/ 
5.44/4.89 
5.15/5.19/ 5.19/5.12 5.05/5.19/ 5.06/5.19 
5.15/5.18/ 
5.15/5.18 
5.15/5.18/ 
5.15/5.18 
5.087(1)/5.1549(1) 
Namide-Namide trans-disposed 6.43/5.88 5.94/6.25 6.88/5.56 6.99/5.61 7.26/5.04 7.26/5.04 5.547(1)/6.753(1)*) 
Nhet-Nhet consecutive 
4.13/4.67/ 
4.50/4.76 
4.68/4.14/ 
4.43/4.48 
4.13/5.01/ 4.05/4.90 4.15/4.67/4.15/4.67 
3.90/4.97/ 
3.90/4.97 
3.90/4.97/ 
3.90/4.97 
4.6238(8)/3.999(1)*) 
Nhet-Nhet trans-disposed 6.04/6.47 5.89/6.13 6.34/6.19 5.88/6.25 5.85/6.30 5.85/6.30 6.076(2)/5.458(1) 
Cu1-Cu2 - - 3.76 3.97 4.89 4.00 3.6290 (7) 
Cu1-O1/Cu2-O1 2.04 2.11 2.00/2.03 2.06/2.06 2.01 2.09/2.09 1.93/1.93 
Cu1-O2/Cu2-O2 2.29 2.28 2.4/- 2.35/- - - 2.51/- 
Cu1-O3/Cu2-O3 - - -/2.35 -/2.35 - - -/- 
CuII coordination sphere dis. sq pyr dis. sq pyr dis. sq pyr dis. sq planar dis. sq pyr dis. sq pyr dis. sq pyr 
Units: d [Å] ס [°] a) G09, B3LYP/6-31g* (C,H,N,O)/TZVP (Cu); b) see Figure 4.3 for used abbreviations; c) see Figure 4.4 for atom numbers; *) at R*-configured C at 
copper bound site
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The coordination of the first copper(II) ion lowers the macrocycle’s high symmetry and 
induces a bending that can be nicely visualized by an examination of the angle between the 
planes of the binding sites (see Section 4.1.1 for definition of and Figure 4.6 for a 
visualization). In the metal-free cyclic pseudo octapeptide the binding sites include an angle 
of 77° that decreases to 61° upon coordination of copper(II) in one of the binding sites. In the 
dinuclear copper(II) complexes, both copper(II) ions are either bound in an Nhet-NR-amide-Nhet 
or in an Nhet-NS-amide-Nhet binding site. This coordination mode leads to the formation of 
racemic complexes, which was confirmed by the absence of Cotton effects in the CD spectra. 
It is known from the experiments, and from the calculations of the monomeric complexes, 
that none of the binding sites is favored and therefore it was chosen to solely study the 
dinuclear copper(II) complexes, with copper(II) bound in the Nhet-NS-amide-Nhet binding sites. 
The coordination of a second copper(II) ion increases the angle  between the binding 
sites back to 76°, nearly the same angle as found in the free cyclic pseudo peptide. In the 
bridged complexes, both copper(II) ions have a square pyramidal coordination sphere, where 
the equatorial planes are spanned by the nitrogen atoms of the binding site (Nhet-Namide-Nhet) 
and one additional oxygen atom. In the hydroxo complex [H2LrsCu2II(µ-OH)]+ shown on the 
right hand side in Figure 4.30, the equatorial plane of both copper(II) ions is completed by the 
oxygen atom of the bridging hydroxide anion, emphasizing the similarity of the two binding 
sites that is visible in the EPR spectra of the bridged complexes. The overlay plots of the 
X-ray structure of H4Lrs with the calculated mono- and dinuclear copper(II) complexes 
reveal, that although the planes of the binding sites are nearly identical in the dinuclear 
copper(II) complex and the X-ray structure, there is a substantial difference in the overall 
structure. When electronic effects are considered, e.g. by calculating the energetic change that 
is needed in the macrocycle’s backbone to adopt the conformation of the mono- or the 
dinuclear complex, it emerges that the dinuclear copper(II) complexes are energetically 
favored. The conformation adopted by the dinuclear complexes is 25 kJ/mol lower in energy 
than the conformation calculated for the mononuclear copper(II) complexes (Table 4.11).  
 
Table 4.11. Relative single point energies [kJ/mol] of the macrocyclic ligand backbone of the mono- 
and dinuclear copper(II) complexes of H4Lrs, compared to the energy of the metal-free cyclic pseudo 
peptide, calculated at the B3LYP/6-31g* level). 
 H4Lrs X-ray (opt) [H3LrsCuII]+ [H2LrsCu2II(µ-OH)(H2O)2]+ 
Energy [kJ/mol] 0 60 35 
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Figure 4.30. Top (top) and side views (bottom) of overlay plots of the X-ray structure of H4Lrs with 
its computed (G09, B3LYP/6-31g*/TZVP) mono- (left) and dinuclear copper(II) complexes (right). 
[H3LrsCusII]+ (turquoise, right), H4Lrs (black) and [H2LrsCu2II(µ-OH)]+ (turquoise, right). 
 
From the EPR experiments the existence of both a hydroxo-bridged and terminal 
hydroxo complex was concluded. In the so far performed DFT calculations a terminal 
hydroxo complex could not be obtained, but instead always converted to the bridging 
hydroxide. Probably the used functional and basis set prohibit the formation of a terminal 
hydroxo complex or the dinuclear complex that is seen in the EPR spectra at three equivalents 
of base arises from a species that could not be characterized yet. 
Suitable crystals for single crystal X-ray structure determination were obtained for the 
dinuclear copper(II) cation [H2LrsCu2II(µ-OH)(H2O)2]+. It is a racemic crystal that contains 
two dinuclear copper(II) complexes in the unit cell, a further proof of the equality of both 
binding sites. An ORTEP plot of the X-ray structure of [H2LrsCu2II(µ-OH)(H2O)2]+ is shown 
in Figure 4.31. The structure is nearly identical to that derived from the DFT calculations (see 
Table 4.10). Of particular interest is the short copper(II)-copper(II) distance of 3.63 Å, that 
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might be a reason for the inability to prepare carbonato complexes. However, the copper(II)-
copper(II) distance in the X-ray structure of the carbonato-bridged complex of ascidia-
cyclamide is also very short (3.9Å). Thus, the short distance of the copper(II) ions cannot be 
the only reason for the inexistence of carbonato-bridged species and other effects have to be 
considered. 
 
 
 
Figure 4.31. ORTEP plot of the S* enantiomer of the X-ray structure of the of hydroxo-bridged cation 
[H2LrsCu2II(µ-OH)(H2O)2]+ top (left) and side view (right). Ellipsoids are drawn at 50% probability, 
hydrogen atoms and solvent molecules are omitted for clarity; C = grey, N = blue, O = red, 
Cu = yellow. 
 
In the X-ray structure of [H2LrsCu2II(µ-OH)(H2O)2]+ both copper(II) centers have a square 
pyramidal coordination polyhedron. The three nitrogen atoms of the binding site and the 
oxygen atom of the bridging hydroxide form the equatorial plane. The apical positions of both 
copper(II) ions are occupied by a water molecule at a distance of 2.51 Å. The twist of the 
copper(II) planes with respect to each other is visualized in Figure 4.32. 
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Figure 4.32. Orientation of the binding sites in H4Lrs, with respect to the copper(II) copper(II) vector. 
 
It is expected that upon coordination of carbonate, the distance of the copper(II) centers 
enlarges. This would reduce the distance of trans-disposed isopropyl residues, thereby 
inducing steric strain in the macrocyclic backbone and thereby hampering the formation of a 
carbonato-bridged complex. This indicates that an alternating R* and S* configuration at C is 
inhibiting the formation of carbonato-bridged species. Yet, as mentioned above, ascidia-
cyclamide, that also exhibit an alternating configuration at C is found to readily react with 
atmospheric CO2 to the carbonato-bridged complex. However, the incorporation of the less 
flexible imidazole rings in H4Lrs seem to hamper the formation of carbonato bridged 
complexes. 
 
 
Surprisingly H4Lrs has a substantially different copper(II) coordination chemistry than 
H4L4. It was expected that its chemistry is similar to that of H4L4 and potentially closer to that 
of the natural cyclic peptides as a result of the alternating stereochemistry at C. Yet, it was 
found that H4Lrs in incapable to react with CO2 or carbonate and thus no formation of 
carbonato-bridged complexes could be observed. The reason seems to be the combination of 
imidazole heterocycles with an alternating R* and S* configuration. The imidazole rings 
induce a rigidity in the system and the alternating configuration induces steric strain that 
seems to hamper the reaction with CO2. The dinuclear bridged complexes of H4Lrs were 
found to be very interesting as due to their conformation, probably induced by the rigidity of 
the system, their copper(II) centers are set up in an magic angle and thus exhibit EPR 
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spectroscopic features of a mononuclear complex. This magic angle set up was found to be 
partly offset by the addition of more than three equivalents of base to the solutions. It was 
then possible to obtain the spectrum of a dinuclear coupled species that is thought to be a 
terminal hydroxo complex. H4Lrs is an interesting cyclic pseudo peptide, however, it cannot 
be used as a model system for the natural cyclic peptides as the reaction of CO2 seems to be 
important feature of these molecules. In future experiments the nature of the dinuclear 
coupled species shall be revealed and it might also be of interest to further investigate the 
seemingly high rigidity of the system. 
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4.4 Copper(II) Coordination Chemistry of H4Lox 
4.4.1 ESI-MS Experiments 
 
The ESI-MS experiments performed with the tetraoxazole cyclic pseudo peptide H4Lox (see 
Figure 4.33), provided spectra that contained a large number of doubly charged species and 
ions assigned to complexes with two pseudo peptide molecules per copper(II) present in the 
solutions, i.e. [(H4Lox)2CuII]2+. These observations suggest that the coordination chemistry of 
H4Lox is similar to that of the cyclic pseudo hexapeptide H3L2 (see Chapter 3). Table 4.12 
lists the species present in solutions of H4Lox found at varying ratios of H4Lox/copper(II)/base.  
 
 
Figure 4.33. Chemical structure of H4Lox. 
 
The ESI-MS experiments revealed a mixture of different species in solution, indicative of 
a complicated complexation equilibrium. The H4Lox/copper(II) 1:2 solutions with more than 
two equivalents of base give spectra that exhibit signals attributable to the dinuclear hydroxo 
complex [H2LoxCu2II(OH)]+ m/z 861.2263 and a time-dependent conversion of this signal to 
the bicarbonato [H2LoxCu2II(µ-HCO3)]+ m/z 905.2298 and carbonato-bridged complexes 
[H2LoxCu2II(µ-CO3)] could be observed. Addition of carbonate to H4Lox/copper(II) 1:2 
solutions also leads to the formation of bicarbonato and carbonato-bridged copper(II) com-
plexes, comparable to the observed coordination behavior of H4L4. 
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Table 4.12. Molecular formula, experimental and calculated masses of the observed mono- and 
dinuclear copper(II) complexes of H4Lox. 
species molecular formula experimental calculated 
[H5Lox]+ C36H49N8O8+ 721.3676 721.3667 
[H4LoxNa]+ C36H49N8NaO8+ 743.3518 743.3487 
[H5LoxK]+ C36H49N8KO8+ 759.3328 759.3227 
[(H4Lox)2CuII]2+ C72H96CuN16O162+ 751.8307 1503.6475 
[H4LoxCuII]2+  C36H48CuN8O82+ 391.6450 783.2880 
[H3LoxCuII]+ C36H47CuN8O8+ 782.3082 782.2807 
[H2LoxCu2II(OH)]+ C36H47Cu2N8O9
+ 861.2263 861.2052 
[H2LoxCu2II(HCO3)]+ C37H47Cu2N8O11+ 905.2298 905.1951 
[H2LoxCu2II(CO3)Na]+ C37H46Cu2N8NaO11+ 927.2243 927.1770 
[H2LoxCu2II(CO3)K]+ C37H46Cu2KN8O11+ 943.1859 943.1510 
 
 
4.4.2 CD, UV-vis, and NMR Spectroscopy 
 
The copper(II) complexes of H4Lox have a distinct circular dichroism in the visible region of 
the electromagnetic spectrum and the copper(II) coordination chemistry of H4Lox can thus 
nicely be followed using CD and UV-vis spectroscopy.  
UV-vis spectra of the solutions obtained by titration of up to two equivalents of 
copper(II) to a H4Lox solution have an absorption maximum at 840 nm. This absorption band 
was assigned to solvated copper(II), or copper(II) coordinated by a set of oxygen donor 
atoms. The fact that the absorption linearly increases with the copper(II) concentration and is 
not shifted throughout the titration strongly suggests that there is no interaction of copper(II) 
with the macrocycle. The CD-spectra of this titration, however, exhibit a clear change in the 
range of 250 to 300 nm. This region of the spectrum is correlated to the chirality of the 
macrocycle and can therefore provide information about its conformation (see Figure 4.34). 
The change of the CD spectra supports the assumption that there is an interaction of H4Lox 
with copper(II) and it is likely that copper(II) is coordinated from the “outside” of the 
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macrocycle, i.e. by the oxygen atoms of the peptide bonds, analogous to H3L2 (see 
Section 3.2.3). 
 
  
Figure 4.34. UV-vis and spectra of the titration of 0-2 eq of copper(II), in 0.2 eq steps, to a H4Lox 
solution, (c(H4Lox) = 1.25 mM, methanol). 
 
Even at high copper(II) concentrations, H4Lox solutions do not exhibit any CD spectros-
copic features at wavelength higher than 300 nm, and thus an asymmetric copper(II) center 
can be excluded. The absence of asymmetry at the copper(II) centers is a further indicator that 
no coordination in the Nhet-Namide-Nhet binding motif occurs, as this would introduce 
asymmetry and thus provide a CD signal. These findings further support the assumption that 
copper(II) is bound in an “outside coordination” mode. 
The binding mode of copper(II) to H4Lox in absence of base was further investigated by 
means of 13C-NMR spectroscopy. This method has provided useful insight into the copper(II) 
coordination chemistry of H3L2 (see Chapter 3, page 38). As observed for the smaller tris-
oxazole pseudo hexapeptide H3L2, the addition of copper(II) gradually broadens the peak of 
the amide carbon Camide at 164 ppm. At a H4Lox/copper(II) ratio of 1:0.6 the signal of the 
Camide resonance nearly vanished, which is highly suggestive of the unusual copper(II) coordi-
nation of H4Lox via the carbonyl oxygens (see Figure 4.35). This binding mode was further 
proved by EPR spectroscopy in acetonitrile (see Figure 4.40). 
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Figure 4.35. Section of interest of the 13C-NMR spectra (MeOH-d4, 50 MHz, 10 mM) of a titration of 
CuII to a H4Lox solution. 0 eq CuII (green, back); 0.3 eq CuII (black, middle); 0.6 eq CuII (blue, front). 
δ = 155.31 (CimCH3); 163.99 (Camide); 164.24 (NimCim) ppm. 
 
Coordination of copper(II) in the Nhet-Namide-Nhet binding motif is enabled upon addition 
of a strong base (methoxide) and can be followed spectroscopically. When base is added to a 
H4Lox/copper(II) 1:2 solution, new bands in the visible region develop and increase in 
intensity up to a base concentration that corresponds to three equivalents. The absorption 
maximum is thereby shifted from 840 nm (solvated CuII) to 706 nm (see Figure 4.36, top). 
These findings can be interpreted by the formation of a dinuclear copper(II) complex. This is 
also reflected in the fact that the shift of the absorption band can be observed up to two 
equivalents of base and thereafter only an increase of the absorption band at 706 nm can be 
observed. In combination with the recorded ESI-MS data these findings are suggestive of the 
formation of a hydroxo-bridged complex, already at low base concentration. Considering the 
findings of the EPR experiments (see Section 4.4.3) it is likely that the absorption of the 
hydroxo complex is at lower wavelength and that the absorption band observed at three 
equivalents of base is a combination of the hydroxo complex and outside coordinated 
copper(II). This could also explain why the absorption maximum of the hydroxo complex of 
H4Lox has a higher wavelength than the hydroxo complexes of H4L4 (λmax = 674 nm) and 
H4Lrs (λmax = 685 nm). When more than three equivalents of base are added, the maximum of 
the absorption band is strongly shifted to lower wavelength (605 nm) and a shoulder at 
525 nm emerges. The shift is completed after the addition of four equivalents of base, and 
thereafter, the observed bands slightly intensify. It is assumed that the change in the spectra is 
caused by the formation of the carbonato-bridged complex [H2LoxCu2II(µ-CO3)]. The shoulder 
155.0160.0
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at 525 nm could not be assigned to a distinctive species yet. The formation of a dihydroxo 
species, as observed with H4L4 (see Section 4.2) cannot be excluded. 
 
 
  
Figure 4.36. UV-vis spectra (c(H4Lox) = 1.25mM, methanol). Titration of 0-2 eq of base (MeO-), in 
0.2 eq steps, to a H4Lox/copper(II) 1:2 solution (top) and titration of 3-5 eq of base, in 0.2 eq steps, to a 
solution of H4Lox/copper(II) 1:2 (bottom). 
 
The observation of a CD signal is a clear indication of the development of asymmetry 
and, in case of the titration of copper(II) to a cyclic pseudo peptide, Cotton effects at 
wavelengths ≥ 400 nm are indicative of a coordination of copper(II) in the Nhet-Namide-Nhet 
binding site. The CD spectra obtained by the titration of base (n-Bu4N)(OMe) to a 
H4Lox/copper(II) 1:2 solution show two positive Cotton effects at 372 and 647 nm and three 
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negative Cotton effects at 322, 548, and 790 nm that are separated by four isosbestic points at 
341, 475, 583, and 692 nm (see Figure 4.37). The Cotton effects at wavelength ≤ 400 nm 
originate from the conformational change of the cyclic peptide that was induced by the 
binding of copper(II).  
The accumulated CD spectra of a base titration to a H4Lox/copper(II) 1:2 solution are 
expected to exclusively show the asymmetry of the copper(II) centers in the dinuclear 
complex. Compared to the recorded CD spectra of the dinuclear copper(II) complexes of 
H4L4 the Cotton effects are different (see Section 4.2.1). The dinuclear copper complex of 
H4L4 has an intense negative Cotton effect at 639 nm, while the dinuclear copper(II) 
complexes of H4L4 have a positive Cotton effect at 647 nm and an intense negative Cotton 
effect at 790 nm. This suggests a somewhat different coordination sphere in the complexes of 
the pseudo octapeptides.  
Several observations were made that are suggestive of the coordination environment of 
the copper(II) ion not being affected by the addition of three equivalents of base. Firstly, the 
d-d band in the recorded UV-vis data does not shift but only intensifies, and this is mirrored in 
the CD spectra. However, the isosbestic point at 341 nm that was present in the spectra from 
the addition of the first two equivalents of base disappears and this indicates a modification of 
the macrocyclic peptide backbone.  
 
  
Figure 4.37. CD spectra of the titration of 0-3 eq of base (MeO-), in 0.1 eq (0-1 eq) and 0.2 eq (1-3 eq) 
steps, to a H4Lox/copper(II) 1:2 solution (c(H4Lox) = 1.25 mM, methanol). 
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A substantial change can be observed in the CD spectra after the addition of a fourth 
equivalent of base (see Figure 4.38). The negative Cotton effect at 792 nm is shifted to a 
lower wavelength (752 nm) and the positive Cotton effects at 647 and 372 nm are shifted to 
618 and 352 nm, respectively.  
The spectrum now reminds of a combination of the carbonato complex of H4L4 
[H2L4Cu2II(µ-CO3)] (pos. Cotton effect at 605 nm and neg. Cotton effects at 541 and 723 nm) 
and the pink species of H4L4 (pos. Cotton effect at 536 nm and neg. Cotton effect at 715 nm, 
see Figure 4.13). The similarity of the spectra indicates similar coordination environments at 
the copper(II) centers. Thus, presumably the coordination environment in the carbonato-
bridged complexes of H4L4 and H4Lox is alike and possibly H4Lox also forms a species that is 
similar to the pink species of H4L4. However, the formation of a pink species has not been 
observed for H4Lox and the positive Cotton effect at 618 nm could also result from traces of 
the hydroxo-bridged complex that are left in solution and hence give rise to the observed 
spectra. 
 
 
Figure 4.38. Titration of 3-4 eq of base (MeO-), in 0.2 eq steps, to a H4Lox/copper(II) 1:2 solution 
(c(H4Lox) = 1.25 mM, methanol). 
 
When more than four equivalents of base are added, no further change in the UV-vis or 
the CD spectra can be observed. The intensity of the CD spectra does intensify, but this is 
most likely due to the formation of carbonato-bridged complexes [H2LoxCu2II(µ-CO3)], as the 
experiments have not been performed anaerobically. 
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Figure 4.39. Assumed copper(II) complexation equilibria of H4Lox. 
 
From the performed experimental results the following equilibrium is concluded (see 
Figure 4.39): in a first complexation step, copper(II) is bound to the cyclic pseudo peptide 
from the outside, coordinated by the carbonyl oxygen atoms (see also coordination of H3L2, 
Chapter 3). Addition of base then deprotonates the amide nitrogens and enables the 
coordination of copper(II) in the “normal” Nhet-Namide-Nhet binding site of the cyclic pseudo 
peptide. The fact that the mononuclear complex [H3LoxCuII]+ could only be detected in traces, 
indicates preorganizational preference for dinuclear complexes and a cooperative effect. In 
presence of CO2, a bridged carbonato complex [H2LoxCu2II(µ-CO3)] was formed, similar to the 
one observed for H4L4 [H2L4Cu2II(µ-CO3)]. 
 
 
4.4.3 EPR Experiments 
 
To probe the putative complexation equilibria, the EPR spectra of representative solutions 
were measured. In contrast to H4Lrs, H4L4, and the smaller cyclic pseudo hexapeptides H3L1-3 
and H3Lwa the amount of mononuclear copper(II) complex formed was small. In the ESI-MS 
experiments traces of a mononuclear copper(II) complex [H3LoxCuII]+ could be detected. 
Careful subtraction of different dinuclear compounds provided a very weak signal attributable 
to a mononuclear copper(II) complex [H3LoxCuII]+ (see Figure 4.40 left). However, conside-
ring the low signal intensity both in the ESI-MS spectra and in the EPR spectra, it is assumed 
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that the mononuclear complex is not important in the copper(II) coordination chemistry of 
H4Lox.  
The signal of the mononuclear copper(II) complex [H3LoxCuII]+ that could be obtained 
from spectra subtraction and its simulation are shown in Figure 4.40. The spectrum was 
simulated with the program package X-Sophe-Sophe-XeprView[122] (version 1.1.4), using the 
spin Hamiltonian described in Eq. 3.7. Unfortunately, the spectrum has a very low resolution 
and it was not possible to extract the superhyperfine coupling constants to the remote nitrogen 
atoms. The spin Hamiltonian parameters are in the expected range (gx,y,z = 2.085, 2.065, 
2.256; Ax,y,z = 20, 20, 163 · 10-4 cm-1) of a distorted square pyramidal copper(II) center 
coordinated in the Nhet-Namide-Nhet binding motif of a cyclic pseudo peptide and are 
comparable to those of the mononuclear copper(II) complexes of H4L4 (gx,y,z = 2.090, 2.050, 
2.261; Ax,y,z = 14, 15, 169 · 10-4 cm-1) and of the dinuclear bridged complexes of H4Lrs that 
have a “mononuclear” EPR spectrum as result of their magic angle set up (see Table 4.9). A 
summary of all measured and simulated mononuclear EPR spectra is given in Table 4.15, 
page 134. 
      
Figure 4.40. Experimental X-Band EPR spectra (g-space), acetonitrile, 50K of “free” copper(II) 
(black), ν = 9.445932 GHz and copper(II) coordinated to H4Lox from the “outside” (blue, dotted line), 
ν = 9.421455 GHz (left) and experimental (black) and simulated (blue) X-Band EPR spectrum of the 
mononuclear copper(II) complex [H3LoxCuII]+, derived from spectra subtraction (right). 
 
In absence of base, the measured EPR spectra in methanol are identical to those of “free” 
copper(II), [CuII(MeOH)n]2+ (see Figure 4.41 a). As discussed in Section 3.2.4, it is not 
possible to distinguish between methanol solvated copper(II) and copper(II) that is bound in 
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an external fashion to the cyclic peptides in an EPR experiment. However, copper(II) that is 
dissolved in acetonitrile [CuII(CH3CN)n]2+ has different g and A tensors than copper(II) that is 
coordinated to H4Lox in an outside fashion, as it is not coordinated by oxygen atoms. Indeed 
when the spectra of “free” copper(II) in acetonitrile are compared to those of a copper(II) 
solution that contains H4Lox a clear shift of the g factors can be observed. For a better 
comparability, the spectra were converted to the g space (see Figure 4.40). The low resolution 
of the acetonitrile spectrum that contains H4Lox was presumably caused by a bad glass. 
Furthermore it is likely that in solution there is an equilibrium between copper(II) coordinated 
by acetonitrile and copper(II) coordinated to H4Lox in an outside fashion and the overlapping 
spectra are expected to further decrease the resolution.  
Addition of base, to methanolic H4Lox solutions, causes the coordination of copper(II) to 
the binding site of H4Lox and changes the EPR spectrum. However, in contrast to the other 
cyclic pseudo peptides, at two equivalents of base there is still a considerable amount of 
outside coordinated copper(II) present in solution (see Figure 4.41 b). This observation is 
suggestive of a high stability of the outside coordinated complex [(H4Lox)2CuII]2+ at moderate 
base concentrations, possibly in the range of the mononuclear complex [H3LoxCuII]+ or even 
higher. In absence of base it seems that the outside coordinated copper(II) complex has a 
higher stability than the mononuclear complex, as no coordination in the macrocycle could be 
seen, neither in the ESI-MS, nor in the UV-vis, CD or EPR spectra. The electronic influence 
of the incorporated heterocycles have been discussed in Section 1.3 and it is likely that this 
also influences the basicity of the amide protons what would subsequently influence the metal 
assisted deprotonation of the binding site. At higher base concentrations, the spectra seem to 
be a combination of outside coordinated copper(II) and dinuclear complex, indicating a strong 
complementary effect of the macrocycle and a decrease in stability of the outside coordinated 
complex. More likely than the decreased stability of the outside coordinated complex, 
however, is an increase of the stabilities of the Nhet-Namide-Nhet binding site coordinated 
copper(II) complexes, as these are expected to strongly depend on the degree of deprotonation 
of the Namide atom. As a result of the strong complementary effect the formation of the 
monomer complex could not be observed directly but only by spectra subtraction (see also 
Figure 4.40). Supportive of a high stability of the outside coordinated complex is the fact, that 
even at three equivalents of base, still minor amounts of outside coordinated copper(II) are 
observable in the spectra (see Figure 4.41 d). When four equivalents of base are present in 
solution a coordination via the outside cannot be observed anymore and the observed EPR 
spectra correspond to dinuclear copper(II) species (see Figure 4.41 e). Whether these spectra 
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show the hydroxo-bridged or possibly a dihydroxo species could not be determined yet. The 
addition of more than four equivalents of base does not lead to a further change in the spectra. 
They are equivalent to those recorded at a H4Lox/copper/base ratio of 1:2:4 (see Figure 4.41 e 
and f).  
 
    
Figure 4.41. Experimental X-Band EPR spectra, methanol c(H4Lox) = 1.25mM, T = 10 K, free CuII 
(blue, ν = 9.429674). a) H4Lox/copper(II)/base 1:2:0, ν = 9.375956 GHz; b) H4Lox/copper(II)/base 
1:2:2, ν = 9.375771 GHz; c) H4Lox/copper(II)/base 1:2:3, ν = 9.374496 GHz; d) [H2LoxCu2II(OH)]+ 
obtained from spectra subtraction of free copper and c); e) H4Lox/copper(II)/base 1:2:4, 
ν = 9.380499 GHz; f) H4Lox/copper(II)/base 1:2:5, ν = 9.379982 GHz g) H4Lox/copper(II)/base 1:2:2, 
carbonate added, presumably the carbonato-bridged complex [H2LoxCu2II(µ-CO3)], ν = 9.426234 GHz  
 
The EPR spectra of solutions with a H4Lox/copper(II)/base ratio of 1:2:3 or higher show a 
time-dependent conversion to the spectrum of the carbonato-bridged complex (see 
Figure 4.41 g). This spectrum can also be obtained when carbonate is added to a solution of 
H4Lox/copper(II)/base in a ratio of 1:2:2. These spectra are very similar to the one of the 
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carbonato-bridged complex of H4L4 [H2L4Cu2II(µ-CO3)] (see Figure 4.14 d). Considering the 
structural likeness of the cyclic pseudo peptides it is feasible, that the carbonate complexes 
have a similar coordination sphere, an assumption that is supported by the performed DFT 
calculations (see Section 4.4.4) 
A satisfactory simulation of the dinuclear copper(II) complexes of H4Lox could not be 
obtained so far. The EPR spectra are suggestive of a stable outside coordinated complex 
[(H4Lox)2CuII]2+ that is present in solutions that contain up to three equivalents of base. 
Furthermore, H4Lox shows a high cooperativity and the stability of the formed dinuclear 
complexes seems to strongly depend on the degree of deprotonation of the macrocycle. The 
mononuclear copper(II) complex [H3LoxCuII]+ could only be detected after spectra subtraction 
and this emphasizes the strong cooperative effect. The dinuclear copper(II) complexes show a 
fast conversion to the carbonato-bridged complex [H2LoxCu2II(µ-CO3)]. 
 
 
4.4.4 DFT Calculations 
 
The DFT calculations of cyclic pseudo octapeptides are quite time consuming. Therefore, not 
all geometry optimizations were finished by the time this thesis was written. Structures of the 
outside coordinated complexes have not been calculated due to their immense computational 
costs. 
The experimental results, especially the fact that the mononuclear copper(II) complex of 
H4Lox, i.e. [H3LoxCuII]+ could only be detected in traces are suggestive of a complementary 
effect of H4Lox. Complementarity could also be observed for the cyclic pseudo hexapeptide 
H3L2 (see Section 3.2.2), the pseudo octapeptide H4L4 and was reported previously for some 
of the natural cyclic pseudo peptides.[103, 167] These findings were reproduced by the perform-
ed DFT calculations of the copper(II) complexes of H4Lox (G09, B3LYP/6-31g* (C,H,N,O)/ 
TZVP (Cu)). When the structures of the mono-, and the dinuclear copper(II) complexes of 
H4Lox, [H3LoxCuII(H2O)2]+ and [H2LoxCu2II(H2O)3]2+, are compared, it emerges that the co-
ordination of the first copper(II) ion leads to a substantial reorganization of the macrocycle, 
while the coordination of the second copper hardly leads to any change. An overlay plot of the 
 4.4 Copper(II) Coordination Chemistry of H4L
ox 
123 
mono- and the dinuclear complex is depicted in Figure 4.42, the structural parameters are 
given in Table 4.13. 
In the mononuclear complex, the coordination sphere of copper(II) was completed by two 
water molecules and a square pyramidal coordination polyhedron of copper(II) is adopted in 
the optimized structure, consistent with the recorded and simulated EPR spectrum. 
Interestingly, the adopted conformation of the macrocycle in the mononuclear complex is 
nearly identical to that of H4L4 and this is reflected in the nearly identical EPR spin 
Hamiltonian parameters of the two complexes (see page 119). The high stability of the outside 
coordinated copper(II) complexes of H4Lox suggests that possibly another conformation of the 
macrocycle might be important, as an outside coordination could not be observed for other 
C4-symmetric pseudo peptides. Potentially, it is similar to the one adopted in the solid state of 
H4Lox, where two oxazole rings are oriented in a parallel fashion (see Figure 4.7). The NMR 
spectra strongly indicate a C4-symmetric conformation in solution and this contradicts the 
idea that a different folding of the macrocycle is important for the formation of an outside 
coordinated complex. Thus, it is assumed that the outside coordination might be correlated to 
electronic effects as the electronics in imidazole and oxazole rings are known to be different 
and thus influence the macrocycle in a different way (see Section 1.3). The fact the an outside 
coordination could neither be observed with one of the imidazole containing pseudo peptides 
nor with the thiazole and oxazoline containing H4LascA (see Section 4.5) emphasizes the im-
portance of oxazole rings for the outside coordination. 
 
 
 
Figure 4.42. Top view of the DFT calculated structure of [H3LoxCuII]+ (left) and of the overlay plot of 
the DFT calculated structures of the mono- and dinuclear copper(II) complex of H4Lox [H3LoxCuII]+ 
and [H2LoxCu2II]2+, respectively. Hydrogen atoms and solvent molecules are omitted for clarity. 
 
 
N10
Cu1
N4
O26
N16
O35
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Cu1
N4
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Cu2
  
Table 4.13. Selected angles and distances of the DFT a) optimized structures of the copper(II) complexes of H4Lox.  
 
[H3LoxCuII(H2O)2]+ [H2LoxCu2II(H2O)3]2+ [H2LoxCu2II(OH)]+ [H2LoxCu2II(OH)2] [H2LoxCu2II(µ-CO3)]  
[N4-N10-N16-N22] b) 25 17 14 18 10 

b 0/3 0/5 3/3 5/0 11/4 
ס (Cu1-O1-Cu2) - 164 122 157/107 - 
      
N1-N13/N7-N19 8.83/5.76 8.90/5.84 9.10/5.95 8.72/6.31 8.89/6.41 
N22-N4/N4-N10/N10-
N16/N16-N22 
4.13/ 5.45/4.13/5.47 4.06/5.56/4.02/5.53 4.05/5.63/4.18/5.83 4.29/5.73/4.37/5.50 4.30/5.88/4.71/5.77 
N4-N16/N10-N22 6.73/6.89 6.66/6.86 7.09/6.88 7.21/6.83 6.91/7.73 
Cu1-Cu2 - 5.25 5.41 5.14 5.18 
Cu1-O1/Cu2-O1  2.03 2.05/3.24 1.91/4.14 1.84/3.38 - 
Cu1-O2/Cu2-O2 2.37 4.06/2.36 5.79/2.32 4.23/1.86 - 
Cu1-O3/Cu2-O3 - 4.31/3.36 3.45/2.07 - - 
Cu1-Nhet/Namide/Nhet 2.08/1.95/2.07 2.05/1.94/2.04 2.10/1.93/2.10 2.17/1.90/2.17 2.17/1.93/2.19 
Cu2-Nhet/Namide/Nhet - 2.06/1.93/2.05 2.10/1.93/2.13 2.18/1.95/2.30 2.19/1.96/2.69 
CuII coordination sphere 
distorted square  
pyramidal 
distorted square planar/ 
distorted tetragonal 
distorted square  
pyramidal 
distorted square planar/ 
distorted tetragonal 
distorted square planer/ 
distorted tetragonal 
Units: d [Å] ס [°] a) G09, B3LYP/6-31g* (C,H,N,O)/TZVP (Cu); b) see Figure 4.4 for atom numbers.           
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For the dinuclear copper(II) complexes, the dihydroxo complex was calculated. This 
complex could not be seen in the ESI-MS spectra, the UV-vis spectra and especially the CD 
spectra at four equivalents of base are very similar to those of H4L4 (see Section 4.2.1). This 
indicates that possibly H4Lox also forms a dihydroxo species. The calculated dinuclear 
complexes of H4Lox were found to have a nearly identical conformation of the macrocycle as 
the respective complexes of H4L4 (see Appendix I for overlay plots). It is hard to compare the 
EPR spectra as the resolution in the recorded spectra of H4Lox unfortunately is quite low and 
the presence of the outside coordinated copper(II) complex complicates the interpretation. 
The copper-copper distances in the calculated dinuclear complexes range from 5.14 Å in the 
dihydroxo complex to 5.41 Å in the terminal hydroxo complex. Interestingly, in the 
dihydroxo and in the carbonato-bridged complex one of the Cu2-Nhet bonds is elongated. This 
effect is larger in the carbonato-bridged complex and has also been observed for the 
carbonato-bridged complex of H4L4.  
 
The DFT calculations suggest that in presence of base, the copper(II) coordination 
chemistry and the formed complexes of H4Lox are nearly identical to those of H4L4. 
 
 
The cyclic pseudo octapeptide H4Lox was expected to have a similar coordination 
chemistry as H4L4. However, it was found that at low base concentrations H4Lox preferably 
coordinates copper(II) from the outside of the macrocycle, thereby forming unusual 
complexes with a H4Lox/copper(II) 2:1 ratio. Yet, at high base concentrations the coordination 
chemistry was found to be very similar to that of H4L4 and the natural cyclic pseudo peptides. 
H4Lox is preorganized for the coordination of copper(II), shows a cooperative effect and 
readily reacts with CO2 to the corresponding stable carbonato-bridged complexes. Indications 
for the existence of the equivalent of the pink species of H4L4 were found, but could not be 
definitely identified. H4Lox seems to be a potential model system for natural cyclic peptides, 
however only at high base concentrations. It is worth testing if the reaction of H4Lox with CO2 
is catalytic in contrast to the reaction of the dinuclear copper(II) complexes of H4L4 with CO2. 
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4.5 Copper(II) Coordination Chemistry of H4LascA 
4.5.1 ESI-MS Experiments 
 
H4LascA is nearly identical to the natural cyclic pseudo octapeptide ascidiacyclamide. The 
only difference is the L-amino acid, that links the thiazole and the oxazoline unit. In the 
natural cyclic peptide, the linking L-amino acid is isoleucine while in the synthetic cyclic 
peptide H4LascA the heterocycles are linked by L-valine (see Figure 4.43). Both cyclic pseudo 
octapeptides have two different Nhet-Namide-Nhet binding sites (TAO, see Figure 4.43), that 
differ in the configuration at C and in case of ascidiacyclamide additionally in the amino acid 
residue. Two different binding sites were also present in H4Lrs. However, unlike H4Lrs the 
binding sites of H4LascA and ascidiacyclamide are not enantiomeric. This is a result of the 
additional stereogenic centers that are induced by the oxazoline rings. From previous studies 
it is known that ascidiacyclamide has a high cooperativity and this is also expected for 
H4LascA.[167] 
 
 
 
Figure 4.43. Chemical structure and binding sites of H4LascA (left) and ascidiacyclamide (right). 
A = amide-, T = thiazole-, O = oxazoline nitrogen atom. 
 
The ESI-MS experiments with various ratios of H4LascA/copper(II)/base revealed that the 
copper(II) coordination chemistry of H4LascA is similar to that of H4L4. An outside co-
ordination, as it was found for the oxazole containing macrocycles H4Lox and H3L2, could not 
be observed (see Section 4.4 and Section 3.2.3, respectively). The representative species 
present in methanolic solutions of H4LascA are listed in Table 4.14. A high amount of 
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methoxide bridged dinuclear complex was detected, i.e. [H2LascACu2II(µ-OMe)]+. The 
methoxide is sterically more demanding than hydroxide and this indicates that the 
macrocyclic backbone of H4LascA is more flexible than the one of the far studied macrocycles. 
The higher flexibility is caused by the incorporation of oxazoline rings that, in contrast to the 
imidazole and oxazole rings of the other studied macrocycles include a single bond that 
enlarges the flexibility of the macrocycle. Solutions that contain the hydroxo complex 
[H2LascACu2II(OH)]+ show a time-dependent conversion of the hydroxo complex to the 
(bi)carbonato-bridged complexes [H2LascACu2II(µ-HCO3)]+ and [H2LascACu2II(µ-CO3)]. Addi-
tion of carbonate to dinuclear complex solutions also leads to the formation of carbonato-
bridged complexes. Indications for the formation of a non-charged species, such as the 
dihydroxo complex seen with H4L4 (see Section 4.2.1 and Section 4.3.1) have not been 
observed but cannot be excluded. 
 
Table 4.14: Molecular formula, experimental and calculated masses of the observed mono- and 
dinuclear copper(II) complexes of H4LascA. 
species molecular formula experimental calculated 
[H5LascA]+ C36H53N8O6S2+ 757.35423 757.3524 
[H4LascANa]+ C36H52N8O6S2Na+ 779.33460 779.33434 
[H3LascACuII]+ C36H51CuN8O6S2+ 818.26756 818.26635 
[H3LascACuII(OH2)]+  C36H53CuN8O7S2+ 836.26228 836.267291 
[H2LascACu2II(OH)]+ C36H51Cu2N8O7S2
+ 897.18972 897.19087 
[H2LascACu2II(µ-OMe)]+ C37H53Cu2N8O7S2+ 911.20586 911.20652 
[H2LascACu2II(µ-HCO3)]+ C37H51Cu2N8O9S2+ 941.18131 941.18070 
[H2LascACu2II(CO3)Na]+ C37H50Cu2N8NaO9S2+ 963.16386 963.16264 
 
From the ESI-MS experiments the copper(II) complexation equilibria depicted in 
Figure 4.44 are assumed. Addition of copper(II) to a solution of H4LascA leads to the forma-
tion of mono- and dinuclear complexes. The fact that dinuclear complexes can be observed in 
absence of base highlights the high cooperativity of H4LascA. Again the addition of base is 
mandatory to obtain a complete complexation of copper(II) to the cyclic pseudo peptide. 
When three equivalents of base are added the dominating signals are those of the hydroxo 
complex, [H2LascACu2II(OH)]+, and the methoxide bridged complex [H2LascACu2II(µ-OMe)]+. 
The hydroxo complex is presumably able to react with atmospheric CO2 to the carbonato-
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bridged complex, indicating that the role of the cyclic pseudo octapeptides in the ascidian’s 
metabolism might indeed be correlated to the capture of CO2. A reaction of the methoxide 
bridged complex with CO2 could not be observed. 
 
 
Figure 4.44. Assumed copper(II) complexation equilibria of H4LascA (solvent = methanol). 
 
 
4.5.2 CD and UV-vis Spectroscopy 
 
The copper(II) coordination to H4LascA can nicely be followed by CD- and UV-vis 
spectroscopy. The UV-vis spectra of a titration of up to two equivalents of copper(II) to a 
H4LascA solution show an absorption band at 686 nm that shifts to 666 nm during the titration 
(see Figure 4.45). This is a clear indication for the coordination of copper(II) to the binding 
motif of H4LascA. The observed absorption maximum is similar to those of the dinuclear 
copper(II) complexes of H4L4 (λmax = 674 nm) and H4Lrs (λmax = 685 nm). A deviation is 
expected as H4LascA is the only ligand that also forms methoxide bridged complexes. In the 
CD spectra the formation of Cotton effects in the range ≥ 400 nm further supports a 
coordination of copper(II) in the binding site. The negative Cotton effect at 314 nm and the 
positive Cotton effect at 380 nm reflect the conformational change in the macrocycle 
backbone that occurs upon coordination of copper(II) to the binding site.  
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Figure 4.45. UV-vis (top) and CD titration (bottom) of 0-2 eq of copper(II), in 0.2 eq steps, to a 
solution of H4LascA. 
 
Addition of base leads to an increase of the observed absorptions in the CD and UV-vis 
spectra. Up to one equivalent of base, the bands in the UV-vis spectrum linearly increase. 
Thereafter, the absorption maximum is shifted to a higher wavelength (703 nm, see 
Figure 4.46 top). Possibly this is the effect of an increased amount of the methoxide bridged 
complex. The negative Cotton effect at ~650 nm increases in intensity up to one equivalent of 
copper and stays constant after that. The fact that it is not shifted during the titration, indicates 
a similar or identical coordination sphere in the mono- and dinuclear copper(II) complexes. 
The positive Cotton effect at 379 nm increases in intensity up to one equivalent of base and 
decreases in intensity from one to two equivalents of base. This suggests an ongoing change 
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in the macrocyclic backbone during the formation of the complexes. However, this does not 
seem to effect the coordination environment of copper(II) (constant neg. effect at 679 nm). 
The exact reasons for the observed non linear behavior are not clear yet. They might be 
correlated to the enhanced asymmetry and flexibility of the cyclic pseudo peptide. 
 
 
 
Figure 4.46. UV-vis (top) and CD (bottom) spectra of the titration of 0-2 eq of base (MeO-), in 0.1 eq 
steps, to a H4LascA/copper(II) 1:2 solution (c(H4LascA) = 1.25 mM, methanol). 
 
When a third equivalent of base is added the formation of a dinuclear hydroxo complex 
and a methoxide bridged complex can be observed in the ESI-MS spectra and accordingly the 
absorption band in the UV-vis spectra is shifted to higher wavelength (722 nm), while the 
Cotton effects in the CD spectra are intensified (see Figure 4.47). The consistency of the CD 
spectra indicates that there is no change in the coordination sphere at the copper(II), again a 
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slightly rearrangement of the macrocyclic backbone, as the Cotton effect at 379 nm is 
intensified.  
 
 
 
Figure 4.47. UV-vis (top) and CD (bottom) spectra of the titration of 2-3 eq of base (MeO-), in 0.2 eq 
steps, to a H4LascA/copper(II) 1:2 solution (c = 1.25 mM, methanol). 
 
Addition of more than three equivalents of base does not lead to a change in the CD or 
UV-vis spectra, indicating that no dihydroxo species, as observed for H4L4 (see Section 4.2.1) 
and H4Lox (see Section 4.4.4) is formed with H4LascA. This observation also strongly suggests 
that there is no formation of a pink species (see Section 4.2.2, page 73). When the solutions 
are exposed to air a time-dependent shift to lower wavelength (690 nm) can be observed in 
the UV-vis spectra and this shift can be correlated to the formation of the carbonato-bridged 
species that can also be observed in the ESI-MS and in the EPR spectra (see Figure 4.49 f).  
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4.5.3 EPR Experiments 
 
EPR spectra were recorded for solutions with various H4LascA/copper(II)/base ratios in order 
to further prove and investigate the putative equilibria. The recorded spectra are consistent 
with the assumed equilibria (see Figure 4.44) and suggest that the reaction of the dinuclear 
copper(II) complexes with atmospheric CO2 is fast. The high cooperativity of H4LascA is 
reflected in the recorded EPR spectra, as traces of a dinuclear complex could even be detected 
in absence of base (see Figure 4.49 a, arrow). Satisfactory simulations of the dinuclear spectra 
could not be obtained so far.  
The experimental first and second derivative spectrum of the mononuclear copper(II) 
complex [H3LascACuII]+ together with their simulations are depicted in Figure 4.48. The 
spectra were simulated with the program package X-Sophe-Sophe-XeprView,[122] using the 
spin Hamiltonian described in Eq. 3.7.  
 
 
 
Figure 4.48. Experimental (black) and simulated (blue) first (left) and second derivative (right) 
X-Band EPR spectra, methanol, T = 110 K, c(H4LascA) = 1.25 mM, ν = 9.420872 GHz, of the 
mononuclear copper(II) complex [H3LascACuII]+. 
 
The derived spin Hamiltonian parameters are suggestive of a distorted square pyramidal 
or six fold coordinated copper(II) center and are listed together with those of the other 
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investigated macrocycles in Table 4.15. The influence of the different macrocycles emerges 
when the Az(Cu) tensors are compared. The Az tensors of the imidazole and oxazole containing 
macrocycles are in the range of ~160 · 10-4 cm-1 while the one of H4LascA is substantially 
lower (139 · 10-4 cm-1). This difference reflects the disparities between the studied systems. 
The Az(Cu) tensors of the natural cyclic pseudo peptides are in the range of 140 · 10-4 cm-1, 
thus similar to H4LascA. The similarities of the complexes indicate that the synthesized cyclic 
pseudo peptides are potential model systems for the natural metabolites. 
 
Table 4.15. Anisotropic spin Hamiltonian parameters of mononuclear copper(II) complexes of H4L4, 
H4Lox, H4LascA, and of the dinuclear bridged complexes of H4Lrs, [H2LrsCu2II(H2O)]2+ and 
[H2LrsCu2II(µ-OH)]+, respectively. 
 [H3L4CuII]+ 
H4Lrs water 
bridged 
H4Lrs hydroxo-
bridged 
[H3LoxCuII]+ [H3LascACuII]+ 
gx 2.090 2.072 2.050 2.085 2.046 
gy 2.050 2.046 2.054 2.065 2.077 
gz 2.260 2.258 2.260 2.256 2.269 
Ax (63Cu) 14.2 4.02 12.69 20.0 11.31 
Ay (63Cu) 15.1 4.42 9.23 20.0 11.72 
Az (63Cu) 169 166.9 161.6 163.0 139.77 
Ax (14N) – Nhet*) 14.3 8.08 6.98 - 9.65 
Ay (14N) – Nhet *) 12.5 11.63 9.00 - 12.69 
Az (14N) – Nhet*) 13.1 10.50 10.00 - 15.20 
Ax (14N) – Namide 12.1 15.46 13.37 - 11.59 
Ay (14N) – Namide 15.6 13.08 12.85 - 7.90 
Az (14N) – Namide 10.2 13.50 12.00 - 13.00 
a) the resolution of the spectra was too low to extract the superhyperfine coupling constants *) simulated spectra 
included two magnetically identical heterocyclic nitrogen nuclei.  
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Figure 4.49. Experimental X-Band EPR spectra, methanol, T = 110 K, “free” CuII [CuII(MeOH)n]2+ 
(blue). a) H4LascA/copper(II)/base 1:1:0, ν = 9.447809 GHz;         b) H4LascA/copper(II)/base 1:1:1 
ν = 9.420872 GHz; c) H4LascA/copper(II)/base 1:2:1 ν = 9.452139 GHz;      d) H4LascA/copper(II)/base 
1:2:2 ν = 9.444581 GHz; e) H4LascA/copper(II)/base 1:2:3 ν = 9.452139 GHz; 
f) H4LascA/copper(II)/base 1:2:3 after 1h exposure to air (black), ν = 9.421352 GHz and carbonato 
complex of ascidiacyclamide (turquoise) ν = 9.4721 GHz 
 
When more than two equivalents of base are present in the solution, signals of the mono-
nuclear complex can no longer be observed and the spectra are consistent with dinuclear 
coupled copper(II) complexes. The spectra that are recorded with three equivalents of base 
(see Figure 4.49 e) are slightly different to those that were recorded with two equivalents of 
base (see Figure 4.49 d). This could indicate a structural rearrangement of the complex, e.g. 
upon formation of a hydroxo complex. However, when the spectra are compared to the one of 
the carbonato-bridged species depicted in Figure 4.49 f it seems likely that the spectrum is 
actually caused by the superposition of the dinuclear spectrum in Figure 4.49 d and the 
carbonato-bridged complex (Figure 4.49 f). The measured solutions were not completely CO2 
free and the observed spectra indicate that the dinuclear copper(II) complexes of H4LascA react 
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fast with CO2. This assumption is supported by the fact that exposure of a solution that 
contains three equivalents of base within one hour leads to a complete conversion to the 
carbonato-bridged species (Figure 4.49 f). The similarities of the EPR spectra of the 
carbonato-bridged complex of H4LascA and the carbonato-bridged complex of 
ascidiacyclamide (Figure 4.49 f, turquoise) indicate that their adopted conformation is alike 
and this highlights the potential of the synthetic pseudo peptide as a model system for the 
natural cyclic pseudo peptides. When the EPR spectra of the copper(II) complexes of H4LascA 
are compared to those of the other studied cyclic pseudo octapeptides (H4L4, see Figure 4.14; 
H4Lrs, see Figure 4.24; and H4Lox, see Figure 4.41) it emerges that the spectra of H4LascA 
cover a wider range of the magnetic field. This is thought to arise from the structural 
difference, as H4LascA (and also the natural cyclic pseudo peptides) is substantially more 
flexible. 
 
 
The here performed experiments provided an initial insight into the copper(II) 
coordination chemistry of H4LascA. It is so far the structurally closest macrocycle in 
comparison to the natural cyclic pseudo peptides. No indications were found for an outside 
coordination of copper(II) and this highly suggest that this coordination mode is only present 
in oxazole containing pseudo peptides such as H4Lox and H3L2. H4LascA was found to be 
highly preorganized, to have a high cooperativity and to readily react with atmospheric CO2. 
The alikeness of its EPR spectra to those of ascidiacyclamide indicates that it is a very good 
model system. However, its synthesis is expensive. Evidence for a pink species has not been 
found and it might be that this is a feature of C4-symmetric macrocycles.  
In further experiments it will be of interest to simulate the obtained dinuclear EPR spectra 
to gain a detailed structural knowledge of the adopted structures that then shall be verified by 
computational methods. It is also of interest whether the reaction of H4LascA with CO2 is 
catalytic or not, as the structural differences of H4LascA and H4L4 might lead to the inhibition 
of catalysis. So far the experimental findings strengthen the idea of the involvement of the 
copper(II) complexes of natural cyclic pseudo octapeptides in CO2 fixation and probably 
transport of carbonate into the ascidian’s organism.  
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4.6 Summary and Outlook 
 
The copper(II) coordination chemistry of the investigated cyclic pseudo octapeptides was 
found to be versatile and different to that of the smaller cyclic pseudo hexapeptides (see 
Chapter 3.3). The high preference for the formation of dinuclear complexes, that had been 
observed for the smaller macrocycles H3L1-3 and H3Lwa, is even stronger pronounced as the 
macrocycles are larger and enable the coordination of two copper(II) ions in the preferred 
Nhet-Namide-Nhet binding motif. Two novel cyclic pseudo octapeptides, H4L4-bn and H4Lrs, 
have been synthesized and characterized and the copper(II) coordination chemistry of the 
cyclic pseudo octapeptides H4L4, H4Lrs,H4Lox,  and H4LascA has been investigated. The 
differences of the studied macrocycles allowed the investigation of the influence of 
incorporated heterocycle and the stereochemistry at C. The latter was found to have a 
substantial influence on the adopted conformation of the macrocycle and is observable when 
the X-ray structures of H4Lrs, H4L4 and H4L4-bn are compared (see Chapter 4.1). The 
combination of imidazole rings and an alternating R*- and S*-configuration in the macrocycle 
seems to significantly alter the copper(II) coordination chemistry of the cyclic pseudo 
octapeptides. Although quite different to the natural cyclic pseudo peptide ascidiacyclamide, 
the macrocycles H4L4 and H4Lox, with all S*-configured stereocenters were found to be a 
suitable model system for the natural pseudo peptides. Both macrocycles correctly reproduce 
many of the features found in the natural systems, e.g. cooperativity, preorganization for 
copper(II) or reaction with CO2, while for H4Lrs a different coordination chemistry was 
observed.  
Similar to the natural pseudo octapeptides, H4L4 preferably forms dinuclear complexes 
that are able to react with atmospheric CO2 to the respective carbonato-bridged complexes. 
Experiments with labeled water and CO2 revealed that this reaction is reversible. From a 
structural point of view the all S*-configuration of H4L4 leads to a different folding of the 
macrocycle, compared to the natural cyclic peptides, and this is expected to have some 
influences on the coordination chemistry. The geometry of the copper(II) complexes of H4L4 
was initially studied by a combination of EPR spectra simulations and DFT calculation. The 
derived copper-copper distances from DFT calculation and EPR simulation significantly 
deviate and therefore the possibility of different conformations of the macrocycle was studied 
by MM methods. It is unlikely that the macrocycle adopts another structure than the cone like 
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shape observed in the crystal structure and the deviation between experimental and 
computational distances is thought to be caused by the simulation of local rather than a global 
minimum. From the recorded EPR spectra it emerges that the carbonato-bridged complex of 
H4L4 adopts a slightly different conformation than the carbonato complex of the natural 
macrocycle ascidiacyclamide. The carbonato-bridged complex of H4L4 rearranges to a pink 
species upon exposure to air. This species is strongly ferromagnetically coupled and could not 
be fully characterized yet. Indications for such a species could also be observed with the 
oxazole containing macrocycle H4Lox but are missing for H4Lrs and H4LascA. It is possible 
that the pink species can only be formed with an all S*-configuration of the macrocycles. A 
species that is equivalent to the pink species of H4L4 has not been reported for the natural 
pseudo peptides. Yet, it is possible that this species is present but has not been discovered as a 
result of its complex observability. The reaction of the dinuclear copper(II) complexes of 
H4L4 with atmospheric CO2 was found to be not catalytic. 
The coordination chemistry of H4Lox is very similar to that of the natural systems, yet 
only at high base concentrations. At low base concentrations, the huge influence of the 
incorporated oxazole rings on the copper(II) coordination chemistry of a cyclic pseudo 
peptide (see also coordination chemistry H3L2, Chapter 3.2.3) can be observed with H4Lox. 
Copper(II) is not coordinated in the usual Nhet-Namide-Nhet binding motif but at the outside of 
the macrocyclic system, by the oxygen atoms of the amide bond. This unusual coordination 
mode could not be observed for any of the other investigated pseudo octapeptides and has 
been further investigated by EPR and NMR experiments. At low base concentrations the 
outside coordinated complex has a higher stability than the mono- or dinuclear complexes. At 
high base concentrations the degree of deprotonation of H4Lox increases and thus the 
coordination in the “normal” binding motif is (re)enabled. H4Lox exhibits a high cooperativity 
where the formation of mononuclear complexes can hardly be observed. The dinuclear 
copper(II) complexes react fast with atmospheric CO2 and the EPR spectra are suggestive of a 
nearly identical conformation of the carbonato complex to that of H4L4. This assumption was 
reflected in the performed DFT calculations. 
H4Lrs has the same stereochemistry as the natural pseudo octapeptides and was thus 
expected to have a copper(II) coordination chemistry that is closer to that of the natural 
systems. Surprisingly, it was found that its coordination chemistry remarkably differs from 
that of the other cyclic pseudo peptides. It does show a high cooperativity, yet the dinuclear 
copper(II) complexes have interesting EPR features. In the bridged complexes the copper(II) 
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centers are set up in a so called magic angle and this results in an EPR spectrum with 
mononuclear features. A reaction with CO2 or added carbonate could not be observed and the 
formation of carbonato-bridged species can be excluded. It emerges that the combination of 
an alternating configuration at C and imidazole heterocycles leads to a quite rigid 
macrocycle that cannot form carbonato-bridged species due to the thus induced steric strain. 
This finding might explain the presence of oxazoline rings in the natural cyclic pseudo 
peptides. Each oxazoline ring introduces an additional single bond that enlarges the flexibility 
of the macrocycle and thus might (re)enable the formation of carbonato-bridged complexes, 
what seems to be more difficult with an alternating R*- and S*- configuration. Suitable crystals 
were obtained from the free macrocycle H4Lrs and the cation [H2LrsCu2II(µ-OH)(H2O)2]+. 
These revealed a very short copper(II) copper(II) distance in the solid state. The copper(II) 
centers in the crystal were found to be oriented in an magic angle. 
The molecular setup of H4LascA is very close to the natural cyclic pseudo peptide ascidia-
cyclamide. Initial experiments suggest that its copper(II) coordination chemistry is nearly 
identical to that of ascidiacyclamide and when its chemistry is compared to that of H4L4, the 
potential of H4L4 as a model system (see above) is highlighted. From the EPR spectrum of the 
carbonato-bridged complex it emerges that the structures are nearly identical. H4LascA exhibits 
the highest cooperativity and the fastest reaction with atmospheric CO2, strengthening the 
involvement of cyclic pseudo peptides in CO2 capture and transport. Further experiments, 
simulations, and DFT calculations with the copper(II) complexes of H4LascA shall be used to 
gain further insight into the copper(II) coordination chemistry of the fascinating molecules.  
A DFT study of the carbonato complexes of H4Lrs should reveal whether the inexistence 
of carbonato-bridged species is of sterical or energetical origin. Further DFT calculations are 
also needed for the pseudo peptides H4Lox and H4LascA to gain a more detailed insight into 
their complexation equilibria. These results can then be used to simulate the measured EPR 
spectra of the dinuclear complexes. The exact metabolic purpose of patellamides is still under 
investigation, although the here presented results emphasize the correlation of the dinuclear 
copper(II) complexes of cyclic pseudo peptides to CO2. This suggests a relation to the 
hydrolysis and/or transport of CO2 in the ascidan’s metabolism.  
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Figure 4.50. Chemical structure of new cyclic pseudo octapeptides H4Lmio and H4Lox-rs. 
 
One interesting question that evolved during our studies is the effect of the oxazole rings. 
How many oxazole units are needed to enable the outside conformation? And is the outside 
coordination influenced by the stereochemistry at C? A detailed investigation of the 
copper(II) coordination chemistry of the cyclic pseudo octapeptides H4Lmio and H4Lox-rs 
should answer these questions. (see Figure 4.50).  
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5 Experimental Section 
5.1 Materials and Instruments 
 
Materials 
All solvents (absolute) and reagents (purum grade) were obtained commercially (Aldrich, 
Fluka) and were used without further purification. Labeled water was obtained commercially 
from . Labeled carbon dioxide was obtained commercially from Sigma Aldrich. The 
macrocycles H3L2, H3L3, and H4Lox were prepared in the group of Prof. Dr. G. Haberhauer 
(Institute of Organic Chemistry, University of Duisburg Essen) and used without further 
purification. The macrocycle H3Lwa was prepared by Dr. Björn Seibold and used without 
further purification. 
Chromatography 
Reactions were monitored by TLC on silica gel 60 F254 thin-layer plates (POLYGRAM® SIL 
G/UV, Macherey-Nagel). Detection was accomplished with UV-light at a wavelength of 
λ = 254 nm. Flash chromatography was performed using silica gel 60 (230–400 mesh) 
obtained from Macerey-Nagel. 
DFT and MM Calculations 
DFT calculations were performed with Gaussian 03,[119] Gaussian 09,[163] TURBOMOLE,[166] 
ORCA,[120] and MAG-ReSpect.[127] Geometry optimization were performed using the 
B3LYP[130, 135, 138] hybrid functional in combination with the basis sets 6-31g*[138] (C, H N, O, 
S) and TZVP[136] (Cu). A frequency calculation was performed subsequent to the geometry 
optimization to confirm the structures as a minimum on the potential surface. Molecular 
mechanics calculations and MD simulations were performed with the program package 
Macromodel,[160] using a modified Amber force field.[161-162] No electrostatic interactions or 
partial charges were considered in the molecular mechanics calculations. For the conformatio-
nal search, a 100 ps molecular dynamics (MD) simulation was performed at a range of 
different temperatures (300 K to 800 K). A multiple minimization was performed on the 
obtained structures of the MD simulation to give 4 structures. Calculations were run on a 
Linux cluster. 
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EPR Spectra 
Continuous-wave X-band (ca. 9 GHz) EPR spectra were recorded with a Bruker Biospin 
Elexsys E500 EPR spectrometer fitted with a super high Q cavity. The magnetic field and the 
microwave frequency were calibrated with a Bruker ER 041XK Teslameter and a Bruker 
microwave frequency counter, respectively. A flow-through cryostat in conjunction with a 
Eurotherm (B-VT-2000) variable-temperature controller provided temperatures of 127–133 K 
at the sample position in the cavity. For lower temperatures (48–52 K), an Oxford Instruments 
ESR 900 flow-through cryostat in conjunction with an ITC4 temperature controller was 
employed. Spectrometer tuning, signal averaging, and visualization were accomplished with 
BrukerTs Xepr (version 2.4b.12) software. The EPR spectra of the mono- and dinuclear 
complexes were simulated with the XSophe-Sophe-XperView[122] (version 1.1.4) and 
Molecular Sophe[123] (version 2.0.91) computer simulation software suites on a personal 
computer, running with the Mandriva Linux v2007.0 operating system. 
ITC Measurements 
ITC experiments were performed with a MicroCal VP-ITC instrument. All experiments were 
carried out in solutions containing 0.1 M (n-Bu4N)(ClO4) to keep the ionic strength constant. 
Seven micro liters of a 2 mM Cu(CF3SO3)2 MeOH solution were added in 29 steps by an 
injection syringe into the reaction vessel (V = 1.4232 mL), which contained a 0.1 mM cyclic 
pseudo hexapeptide solution. The ITC measurements were performed by Yuki Katod in the 
Laboratories of Prof. Toshiaki Taura at the University of Aichi Prefecture. 
IR Spectra 
IR spectra were measured with a Perkin Elmer 16C FTIR instrument from samples in KBr 
pellets. 
Mass Spectrometry 
High-resolution electrospray ionization mass spectrometry (ESI-MS) was performed with a 
9.4 T Bruker ApexQe Qh-ICR hybrid instrument with an Apollo II MTP ion source in the 
positive and negative-ion electrospray ionization (ESI) mode. Sample solutions in methanol at 
concentrations of 10-4–10-5M were admitted to the ESI interface by means of a syringe pump 
at 5 mLmin-1 and sprayed at 4.5 kV with a desolvation gas flow of 2.0 Lmin-1 at 25°C and a 
nebulizer gas flow of 1.0 Lmin-1. The ions were accumulated in the storage hexapole for 
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0.1-1.0 s and then transferred into the ICR cell. Trapping was achieved at a sidekick potential 
of -4.0 V and trapping potentials of roughly 1 V. The mass spectra were acquired in the 
broadband mode with 1M data points. Typically, 16 transients were accumulated for one 
magnitude spectrum. External mass calibration was performed on [argininen+H]+ cluster ions 
prior to analysis. A mass accuracy of 1 ppm was achieved. The instrument was controlled by 
Bruker ApexControl 2.0.0.beta software and data analysis was performed using Bruker 
DataAnalysis 3.4 software.  
Nominal masses were recorded on a Bruker QSTAR qQTOF instrument. An Agilent 1100 
microbore HPLC was interfaced to the electrospray ionization source for LC-MS. 
MCD Measurements 
MCD spectra were recorded on an instrument based on a high through-put / high resolution 
Jobin Yvon 750s monochromator and an Oxford Instruments SpectroMag superconducting 
magnet equipped with an SM4 Cryostat and a Blue PMT (vis) and Si APD (UV) detector, 
respectively. The MCD spectra were recorded by Dr. Marc Riley in a methanol/glycerol 1:1 
mixture at various temperatures and fields.  
Melting Points: 
Melting points were determined in capillary tubes and are uncorrected 
Microanalyses 
Elemental microanalyses were performed at the microanalytical laboratory of the University 
of Heidelberg. 
NMR Spectroscopy 
1H and 13C-NMR spectra were recorded with a Bruker 200 MHz DRX, a Bruker Avance 
400 MHz, or a Bruker 900-MHz Avance-III spectrometer. All chemical shifts () are given in 
ppm relative to TMS. The spectra were referenced to deuterated solvents, indicated in 
brackets in the analytical data. 
Spectophotometric Titrations 
Spectrophotometric titrations were performed in methanol at 25.0°C on 2 cm3 samples at a 
cyclic pseudo peptide concentration of 1.25 mM. Copper(II)triflate and base (n-Bu4N)(OMe) 
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were added stepwise in 0.1 (10µL) or 0.2 (20 µL) equivalents steps. The recorded spectra 
were corrected for the dilution factor. 
UV-vis/NIR spectra were recorded with a JASCO V-570 spectrophotometer. 
CD spectra were recorded with a JASCO J-710 spectropolarimeter. 
Stopped Flow Measurements 
Stopped flow measurements were performed with a P.D.1 photodiode-array stopped-flow 
spectrometer from Applied Photophysics. Experiments were performed in acetonitrile at 
constant ionic strength (µ = 0.2 M, NaClO4). For the blind experiments 220µL of a solution of 
inidicator (chlor phenol red, c = 0.1 mM) and buffer (3,5-lutidine, c = 0.2M) was mixed with 
220µL of a CO2-saturated solution at room temperature. After mixing, the rapid absorbance 
change at 573 nm was recorded and the absorption change correlated to the amount of 
hydrolyzed CO2.  
In the catalysis experiments a buffered (3,5-lutidine, c = 0.2M, µ = 0.2 M, NaClO4) aceto-
nitrile solution of H4L4/copper(II) 1:2 (c(H4L4) = 1.25 mM), containing 0.1mM indicator was 
prepared 30 min prior to the experiment. The formation of the hydroxo complex 
[H2L4Cu2II(OH)]+ was tested by an EPR experiment. 220µL of the macrocycle containing 
solution were mixed with 220µL of a CO2-saturated solution at room temperature and the 
rapid absorbance change at 573 nm was recorded and the absorption change correlated to the 
amount of hydrolyzed CO2. 
X-ray Crystallography 
A suitable crystal was mounted with perfluorinated polyether oil on the tip of a glass fiber and 
cooled immediately on the goniometer head to 200 K. Data collections were performed using 
a STOE IPDS diffractometer with MoKα radiation (λ=0.71073 Å). The structure was solved by 
Prof. Dr. Linti and refined using the Bruker AXS SHELXTL 5.1 program package.[168] 
Refinement was in full-matrix least-squares against F2. All non-carbon hydrogen atoms were 
taken from a difference Fourier map and refined with free isotopic U values; carbon–
hydrogen atoms were included as riding models with fixed isotropic U values in the final 
refinement. 
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5.2 Syntheses 
 
General Procedure for the Cleavage of the Methyl Ester Group:  
The protected compound (1 equiv.) was dissolved in methanol/dioxane (10:7, 0.08 M), 
followed by slow addition of 2 M NaOH solution (10 equiv.) at 0 °C. Stirring was continued 
until TLC showed the consumption of all starting material, and then brine, 1 M HCl solution 
(until a pH of 1 was reached), and DCM were added. The aqueous phase was repeatedly 
extracted with DCM; the organic layers were combined, dried with MgSO4, and concentrated 
in vacuo to give the acid compound. Remaining dioxane was removed through repetitive 
stripping with EtOAc. The acid compound was used in the next step without further 
purification. 
General Procedure for the Cleavage of the Boc Group:  
The Bocprotected compound (1 equiv.) was dissolved in ethyl acetate (0.1 M) and the 
solution was cooled to 0 °C. TFA (10 ml/mmol starting material) was added at that 
temperature. The ice bath was removed after 30 min and stirring was continued at room 
temperature for three hours. The mixture was concentrated in vacuo to provide a quantitative 
yield of the trifluoroacid salt. Remaining solvent and TFA were removed through repetitive 
stripping with EtOAc. The resulting salt was then washed with icecold DCM. 
 
5.2.1 Synthesis of the Cyclic Pseudo Peptides H3L1 and H4L4 
 
(E)-methyl 2-(hydroxyimino)-3-oxobutanoate (1): 
 
 
molecular formula: C5H7NO4 
molecular mass: 145.11 g/mol 
 
An aqueous solution of 148.5 g (2.15 mol, 2.5 eq) sodium nitrite is slowly added to an icebath 
cooled solution of 100 g methyl acetoacetate (0.86 mol, 1 eq) in 140 mL glacial acetic acid. 
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The temperature should not exceed -5 °C. The reaction mixture is stirred for three hours at -
5 °C, for 1.5 hours at room temperature and is subsequently poured on 800 g ice. The water 
phase is extracted several times with 400 mL diethyl ether. The combined organic layers are 
washed several times with saturated NaHCO3 solution until the pH a neutral pH is reached, 
dried over MgSO4 and concentrated in vacuo to yield 109.1 g (89 %) of 1 as yellowish oil that 
slowly crystallizes to a yellowish solid. 
 
C5H7NO4: calcd. (%): C 41.38, H 4.86, N 9.65; found (%): C 41.15, H 5.02, N 9.54 (20507). - 
1H-NMR (200 MHz, CDCl3):  = 2.41 (s, 3H, COCH3); 3.90 (s, 3H, CO2CH3) ppm. - 
13C-NMR (50 MHz, CDCl3):  = 25.4 (CH3CO); 52.9 (CO2CH3); 150.9 (CNOH); 162.1 
(CO2CH3); 193.9 (COCH3) ppm. - EI-HR MS: m/z calcd. for C5H7NO4+ 145.0375, found 
145.0364 – M.P.: 28°C 
 
1-methoxy-1,3-dioxobutan-2-aminium chloride   (2): 
 
 
molecular formula: C5H10ClNO3 
molecular mass: 167.59 g/mol 
 
10.0 g Palladium on charcoal (10 %) are suspended in a solution of 20 g of 1 (0.14 mol, 1eq) 
in 300 mL ethanol. 330 mL (0.42 mol, 3 equiv.) 1.25 M HCl in methanol are added dropwise. 
The reaction mixture is stirred under a H2-atmosphere for 48 h. After removal of the H2-
atmosphere, the reaction mixture is filtered over celite and the solvent evaporated at ambient 
temperature. The crude product is covered with ethyl acetate and recrystallizes at -18 °C. 
Washing with cold dichloromethane yields 18.2 g (78 %) 2 as a colorless solid.  
 
C5H10ClNO3: calcd. (%): C 35.83, H 6.01, N 8.36, Cl 21.15; found (%): C 35.79, H 5.99, 
N 8.24, Cl 20.96 (22360). - 1H-NMR (200 MHz, DMSO-d6):  = 2.38 (s, 3H, COCH3); 3.80 
(s, 3H, CO2CH3), 5.29 (s, 1H, CHNH3), 9.01 (s, 3H, NH3) ppm. - 13C-NMR (50 MHz, 
DMSO-d6)  = 28.2 (CH3CO); 53.6 (CH3CO); 61.2 (CNH3); 164.2 (CO2CH3); 196.7 
(COCH3) ppm. - FAB-HR MS: m/z calcd. for C5H10NO3+ 132.0655, found 132.0676. - Mp.: 
decomposition at T > 45°C. 
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Methyl 2-((S)-2-(tert-butoxycarbonylamino)-3-methylbutanamido)-3-oxobutanoate (3): 
 
 
molecular formula: C15H26N2O6 
molecular mass: 330.38 g/mol 
 
The synthesis was performed according to literature procedures.[48, 67] (S)-Boc-Val-OH 
(10.4 g, 47.8 mmol, 1eq) is dissolved in 400 mL THF, NMM (3.4 g, 47.8 mmol, 1eq) is added 
and the solution is cooled to -25°C. Subsequently isobutyl chloroformate (6.8 g, 47.8 mmol, 1 
eq) is added, during which the reaction mixture is maintained at -25°C. After 35 min, the 
ammonium chloride salt 2 (9.82 g, 95.6 mmol, 2 eq), followed by a second equivalent of 
NMM (3.4 g, 47.8 mmol, 1eq) are added at -25°C and stirring is continued for 20 h as the 
mixture is allowed to warm to room temperature. The solvent is evaporated, the residue 
dissolved in ethyl acetate, and then washed with water and brine. The combined organic 
layers are dried over MgSO4 and concentrated in vacuo. After recrystallization from ethyl 
acetate 14.64 g of 3 are obtained as colorless crystals (92 %). 
 
C15H26N2O6: calcd. (%): C 54.53, H 7.93, N 8.48; found (%): C 54.37, H 7.96, N 8.56 
(22263). - 1H-NMR (200 MHz, CDCl3):  = 0.90 (d, 3J = 6.9 Hz, 3H, CHCH3); 0.91 (d, 3J = 
6.9 Hz, 3H, CHCH3); 0.96 (d, 3J = 6.8 Hz, 6H, CHCH3); 1.42 (s, 9H, C(CH3)3); 1.43 (s, 9H, 
C(CH3)3); 2.10-2.28 (m, 2H, CH(CH3)2); 2.36 (s, 6H, COCH3); 3.79 (s, 6H, CO2CH3); 4.06 
(m, 2H, NHCHCO); 5.04 (m, 2H, NHCO2); 5.23 (d, 3J = 6.3 Hz, 2H, CHCO2); 7.12 (d, 3J = 
6.3 Hz, 1H, NH); 7.16 (d, 3J = 6.3 Hz, 1H, NH) ppm. - 13C-NMR (50 MHz, CDCl3):  = 17.2, 
17.4 (CH(CH3)2); 18.9, 19.0 (CH(CH3)2); 27.7, 27.8 (COCH3); 28.1 (C(CH3)3); 30.7, 30.9 
(CH(CH3)2); 53.0, 53.1 (CO2CH3); 59.0, 59.2 (NHCHCO); 62.6, 62.7 (NHCHCO2); 79.6, 
79.7 (C(CH3)3); 155.6 (NHCOC(CH3)3); 166.2, 166.3 (CO2CH3); 171.5, 175.5 (NHCO); 
198.1, 198.2 (COCH3) ppm. - FAB-HR MS: m/z calcd. For C15H27N2O6+ 331.1689, found 
331.1670. – M.P.: 109-112°C. 
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(S)- methyl 2-(1-(tert-butoxycarbonylamino)-2-methylpropyl)-1,5-dimethyl-imidazole-4-
carboxylate   (4):[48, 67] 
 
 
molecular formula: C16H27N3O4 
molecular mass: 325.40 g/mol 
 
The synthesis was performed according to literature procedures.[48, 67] Both glacial acedic acid 
(19.8 mL, 346 mmol) and NH2Me in MeOH (8 M, 15.2 mL, 123.2 mmol) were added to a 
solution of 3 (10.0 g, 30.2 mmol) in xylenes (400 mL) at room temperature. The solution was 
stirred at 155°C with azeotropic removal of water for 8 h and then cooled to room 
temperature. The solvent was concentrated, and the residue was dissolved in AcOEt, and then 
washed with saturated NaHCO3 solution and brine. The organic layer was dried over Na2SO4 
and concentrated in vacuo. Purification was achieved by performing chromatography with 
silica gel (petroleum ether/ethyl acetate 1:3) to provide 5.5 g of 6 (16.9 mmol, 54%) as a 
white solid. 
 
C16H27N3O4: calcd. (%): C 59.06, H 8.36, N 12.91; found (%): C 58.94, H 8.40, N 13.15 
(22237). - 1H-NMR (200 MHz, CDCl3):  = 0.81 (d, 3J = 6.7 Hz, 3H, CHCH3); 1.00 (d, 3J = 
6.7 Hz, 3H, CHCH3); 1.39 (s, 9H, C(CH3)3); 2.10-2.35 (m, 1H, CH(CH3)2); 2.52 (s, 3H, 
ChetCH3); 3.55 (s, 3H, NCH3); 3.87 (s, 3H, CO2CH3); 4.52 (dd, 3J = 9.26 Hz, 1H, CH); 5.45 
(d, 3J = 9.5 Hz, 1H, NHCO2) ppm. - 13C-NMR (50 MHz, CDCl3):  = 10.2 (ChetCH3); 18.5, 
19.5 (CH(CH3)2); 28.2 (C(CH3)3); 30.2 (CH(CH3)2); 33.1 (NCH3); 51.3 (CO2CH3); 52.1 (C); 
79.3 (C(CH3)3); 127.5 (ChetCO2); 136.0 (ChetNCH3), 148.5 (Cazole); 155.6 (CO2NH); 164.3 
(CO2CH3) ppm. - FAB-HR MS: m/z calcd. for C16H28N3O4+ 326.2074, found 326.2061. – 
M.P.: 122 °C. 
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(S)-2-(1-(tert-butoxycarbonylamino)-2-methylpropyl)-1,5-dimethyl-imidazole-4-carb-
oxylic acid  (5): 
 
 
molecular formula: C15H25N3O4 
molecular mass: 311.38 g/mol 
 
Compound 4 (2.04g, 6.26 mmol) was converted into 5, using 31 mL NaOH in 80 mL of a 
dioxane/methanol mixture as described above in the general procedure for the cleavage of the 
methyl ester group. Yield: 1.9 g (97%).  
 
C15H25N3O4: calcd. (%): C 57.86, H 8.09, N 13.49; found (%): C C 57.86, H 8.09, N 13.49 
1H-NMR (200 MHz, CDCl3):  = 0.74 (d, 3J = 6.7 Hz, 3H, CHCH3); 1.11 (d, 3J = 6.6 Hz, 3 
H, CHCH3); 1.35 (s, 9H, C(CH3)3); 2.48-2.62 (m, 1H, CH(CH3)2); 2.58 (s, 3H, ChetCH3); 3.67 
(s, 3H, NCH3); 4.55 (dd, 3J = 9.33 Hz 1H, CH); 7.40 (s, 1H, NHCO2); 10.67 (s, 1H, CO2H) 
ppm. - 13C-NMR (50 MHz, CDCl3):  = 9.7 (ChetCH3); 19.4, 19.6 (CH(CH3)2); 28.2 
(C(CH3)3); 31.8 (CH(CH3)2); 32.3 (NCH3); 52.6 (C); 79.9 (C(CH3)3); 123.4 (ChetCO2); 135.1 
(ChetNCH3); 149.0 (Cazole); 156.2 (CO2NH); 161.3 (CO2H) ppm. - ESI-HR MS (CH3OH): m/z 
calcd. for C15H26N3O4+ 312.19178, found 312.19200. - M.P.: 99 -102 °C. 
 
1-(4-carboxy-1,5-dimethyl-imidazole-2-yl)-(S)-1-isopropylmethyl-ammonium tri-
fluoroacetat  (6): 
  
 
molecular formula: C12H18F3N3O4 
molecular mass: 325.13 g/mol 
 
Compound 5 (1.9 g, 6.10 mmol) was converted into 6, using 18 mL TFA in 120 mL DCM as 
described above in the general procedure for the cleavage of the Boc group. Yield: 
quantitative.  
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C12H18F3N3O4: 1H-NMR (200 MHz, DMSO-D6):  = 0.83 (d, 3J = 6.7 Hz, 3H, CHCH3); 
0.98 (d, 3J = 6.7 Hz, 3H, CHCH3); 2.15-2.32 (m, 1H, CH(CH3)2); 2.47 (s, 3H, ChetCH3); 3.57 
(s, 3H, NCH3); 4.42 (m, 1H, C); 8.49 (s, 1H, CNH3); 10.67 (s, 1H, CO2H) ppm. - 
13C-NMR (50 MHz, DMSO-D6)  = 9.9 (ChetCH3); 18.2, 18.2 (CH(CH3)2); 30.7 (CH(CH3)2); 
31.8 (NCH3); 51.0 (C); 124.4 (ChetNCH3); 136.9 (ChetCO2); 143.6 (Cazole); 164.3 (CO2H) 
ppm. - ESI-HR MS (CH3OH): m/z calcd. for C10H19N3O2+ 212.13935, found 212.13988. 
 
Cyclic pseudo hexapeptide H3L1 and cyclic pseudo octapeptide H4L4:[48, 67] 
 
 
molecular formula: C30H45N9O3 
molecular mass: 579.77 g/mol 
 
The synthesis was performed according to literature procedures.[48, 67] EDIPA (4.63 g, 
35.82 mmol) and FDPP (3.89 g, 10.15 mmol) were added at room temperature to a suspension 
of 6 (1.94 g, 5.97 mmol) in acetonitrile (130 mL) and the mixture was stirred at room 
temperature for 3 days. The solvent was evaporated and the residue was dissolved in EtOAc, 
then extracted with water and brine, dried with MgSO4, and concentrated in vacuo. Flash 
chromatography on silica gel (DCM/EtOAc/MeOH, 75:25:6) gave H3L1 (235 mg, 35%) as a 
white solid, followed by H4L4 (173 mg, 15%) as a white solid  
 
C30H45N9O3·(H2O): calcd. (%): C 60.28, H 7.93, N 21.09; found (%): C 60.10, H 8.00, N 
20.29 (25434). - 1H-NMR (400 MHz, CDCl3):  = 1.08 (m, 6H, CHCH3); 2.07-2.17 (m, 1H, 
CH(CH3)2); 2.56 (s, 3H, CHetCH3); 3.52 (s, 3H, NCH3); 5.14 (dd, 3J = 9.2, 6.14 Hz, 1H, C); 
8.43 (d, 3J = 9.2 Hz, 1H, NHCO2) ppm. - 13C-NMR (100 MHz, CDCl3):  = 9.6 (ChetCH3); 
18.0, 19.5 (CH(CH3)2); 30.2 (CH(CH3)2); 34.8 (NCH3); 49.6 (CH); 129.5 (ChetCONH); 132.0 
(ChetNCH3); 146.9 (Cazole); 163.4 (CONH) ppm. - IR (KBr):   = 3378, 2962, 2873, 1656, 
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1593, 1519 cm-1. - FAB-HR MS: m/z calcd. for C30H46N9O3+ 580.3718, found 580.3723. - 
M.P.: > 250°C. 
 
molecular formula: C40H60N12O4 
molecular mass: 772.98 g/mol 
 
C40H60N12O4·(H2O)3 (772.98): calcd. (%): C 58.02, H 7.91, N 20.30; found (%): C 57.56, 
H 7.91, N 19.80 (28822). - 1H-NMR (500 MHz, CDCl3):  = 0.85 (d, 3J = 6.6 Hz, 3H, 
CHCH3); 1.10 (d, 3J = 6.7 Hz, 3H, CHCH3); 2.39-2.51 (m, 1H, CH(CH3)2); 2.47 (s, 3H, 
ChetCH3); 3.61 (s, 3H, NCH3); 4.89 (dd, 3J = 9.5, 9.5 Hz, 1H, CH); 7.52 (d, 3J = 9.4 Hz, 1H, 
NHCO2). - 13C-NMR (125 MHz, CDCl3):  = 9.8 (ChetCH3); 19.2, 19.8 (CH(CH3)2); 30.1 
(CH(CH3)2); 32.6 (NCH3); 49.7 (CHCHet); 129.3 (ChetCONH); 131.9(ChetNCH3); 147.1 
(Cazole); 163.7 (CONH). - FAB-HR MS: m/z calcd. for C40H61N12O4+ 773.4939, found 
773.4880. – M.P.: 150-152°C.  
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5.2.2 Synthesis of the Cyclic Pseudo Octapeptide H4L4-bn  
 
(S)-1-(4-(methoxycarbonyl)-1,5-dimethyl-imidazol-2-yl)-2-methylpropan-1-aminium tri-
fluoro acetate  (7): 
 
 
molecular formula: C13H20F3N3O4 
molecular mass: 339.31 g/mol 
 
Compound 4 (5 g, 15.4 mmol) was converted into 7, using 46.1 mL TFA in 460 mL DCM as 
described above in the general procedure for the cleavage of the Boc group. Yield: 
quantitative.  
 
C13H20F3N3O4 (339.31):  1H-NMR (200 MHz, DMSO-d6):  = 0.83 (d, 3J = 6.8 Hz, 3H, 
CHCH3); 0.96 (d, 3J = 6.7 Hz, 3H, CHCH3); 2.09-2.33 (m, 1H, CH(CH3)2); 2.48 (s, 3H, 
ChetCH3); 3.57 (s, 3H, NCH3); 3.75 (s, 3H, CO2CH3); 4.42 (m, 1H, CH); 8.44 (m, 1H, 
CNH3). - 13C-NMR (50 MHz, DMSO-d6)  = 9.9 (CHetCH3); 18.1, 18.2 (CH(CH3)2); 30.7 
(CH(CH3)2); 31.8 (NCH3); 51.0 (CO2CH3); 127.5 (ChetCONH); 136.7 (ChetNCH3); 143.6 
(Cazole); 164.3 (CO2CH3). - ESI-HR MS: m/z calcd. for C11H21N3O2+ 226.15500, found 
226.15514. 
 
Methyl 2-((S)-2-(benzyloxycarbonylamino)-3-methylbutanamido)-3-oxobutanoate  (8): 
[48, 67] 
 
 
molecular formula: C18H24N3O6 
molecular mass: 364.3926 g/mol 
 
The synthesis was performed according to literature procedures.[48, 67] (S)-Cbz-Val-OH 
(16.49 g, 65.64 mmol, 1eq) were dissolved in 400 mL THF, NMM (6.6 g, 65.6 mmol, 1eq) is 
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added and the solution is cooled to -25°C. Subsequently isobutyl chloroformate (8.97 g, 
65.64 mmol, 1 eq)was added, during which the reaction mixture was maintained at -25°C. 
After 35 min, the ammonium chloride salt 2 (11.0 g, 65.64 mmol, 1 eq), followed by a second 
equivalent of NMM (6.6 g, 65.6 mmol, 1eq) were added at -25°C and stirring was continued 
for 20 h as the reaction mixture was allowed to warm to room temperature. The solvent was 
evaporated, the residue dissolved in ethyl acetate, and then washed with water and brine. The 
combined organic layers were dried over MgSO4 and concentrated in vacuo. After 
recrystallization from ethyl acetate 19.8 g of 8 were obtained as colorless crystals (82 %). 
 
C18H24N2O6 (364.391) calcd. (%): C 59.33, H 6.64, N 7.69; found (%): C 58.89, H 6.72, N 
7.70 (22264). - 1H-NMR (200 MHz, CDCl3) δ = 0.83-0.93 (m, 6H, CH-(CH3)2); 2.04-2.17 
(m, 1H, CH-(CH3)2), 2.30 (s, 3H, COCH3), 3.73 (s, 3H, CO2CH3); 4.10 (m, 1H, CH-
CH(CH3)2); 5.04 (s, 2H, CH2-Ar); 5.21 (d, 3JH,H = 5.5 Hz, 1H, NHCHCO2); 5.32 (d, 3JH,H = 
7.8Hz, 1H, NH-CH2-Ar); 7.05 (d, 3JH,H = 6.1Hz, 1H, NH-CO); 7.27 (m, 5H CAr) ppm. - 
13C-NMR (50 MHz, CDCl3)  = 16.7, 17.6 (CH-(CH3)2); 19.0, 19.3 (CH-(CH3)2), 28.0, 28.2 
(COCH3); 31.2, 31.3 (CH-(CH3)2); 53.3, 53.5 (CO2CH3); 59.9, 62.9 (NHCHCO); 63.1, 67.3 
(CH2-Ar); 128.03, 128.2, 128.3, 128.64, 128.69, 136(Car);, 156.5(CO2NH); 166.1, 166.3 
(CO2CH3); 171(CONH); 197.7, 197.9 (COCH3) ppm. - FAB-HR MS: calcd for C18H25N2O6+ 
365.178, found 365.178 
 
(S)-methyl 2-(1-(benzyloxycarbonylamino)-2-methylpropyl)-5-methyl-1H-imidazole-4-
carboxylate (9):[65] 
 
 
molecular formula: C18H23N3O4 
molecular mass: 345.39 g/mol 
 
The synthesis was performed according to literature procedures.[65] To a slurry of dipeptide  
(9.7 g, 26.6 mmol) in 200 mL xylene, 6.07 g TFA (53 mmol, 2eq) and 7 M ammonia in 
methanol (7.6 mL, 53 mmol) were added. The mixture was heated under intensive reflux with 
a Dean–Stark trap for 8 h. After completion of the reaction, volatiles were removed in a rotary 
evaporator. The residual solid was subjected to column chromatography on silica gel (petrol 
ether/ethyl acetate 1:1) to obtain 4.4 g (49%) of 9 as a white fluffy solid. 
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C18H23N3O4 (345.1688) calcd. (%): C 62.59, H 6.71, N 12.17; found (%): C 62.44, H 6.74, N 
11.88 (22277). - 1H-NMR (200 MHz, CDCl3) δ = 0.79 (d, 3JH,H = 6.7Hz, 3H, CH(CH3)2); 
0.93 (d, 3JH,H = 6.7Hz, 3H, CH-(CH3)2); 2.03-2.17 (m, 1H, CH(CH3)2), 2.41 (s, 3H, ChetCH3), 
3.80 (s, 3H, CO2CH3); 4.44 (d, 3JH,H = 7.9Hz 1H, CH); 5.03 (d, 1JH,H = 3.4Hz 2H, CH2Ar); 
7.29 (m, 5H CArH) ppm. - 13C-NMR (50 MHz, CDCl3)  = 19.1 (CH3Chet); 19.6 ((CH3)2CH); 
33.9 (CH(CH3)2); 51.7 (CO2CH3); 56.8 (C); 67.8 (CH2CAr); 128.9 (CAr); 129.0 (Chet); 129.4 
(CAr); 138.1 (CAr); 142.2 (CAr); 150.2 (Chet); 158.3 (Chet); 164.3 (COOCH3) ppm. - FAB-HR 
MS: calcd for C18H24N2O6+ 346.176, found 346.208 
 
(S)-methyl 2-(1-(tert-butoxycarbonylamino)-2-methylpropyl)-5-methyl-1H-imidazole-4-
carboxylate (10):[65] 
 
 
molecular formula: C15H25N3O4 
molecular mass: 311.376 g/mol 
 
The synthesis was performed according to literature procedures.[65] Di-tert-butyldicarbonate 
(Boc2O) (2.75 g,11.6 mmol) and Pd(OH)2 (0.43 g) were added to a solution of  (3.62 g, 
10.5 mmol) in 200 mL THF at room temperature. The solution was stirred under an H2 
atmosphere at room temperature for 1 d, then filtered, and the solvent was removed in vacuo. 
Flash chromatography with silica gel (petroleum ether/ethyl acetate: 2:3) gave 2.96 g of 10 
(9.30 mmol, 89%) as a white solid.  
 
C15H25N3O4 (311.317) calcd. (%): C 47.86, H 8.09, N 14.4; found (%): C 57.37, H 8.11, N 
13.14 (22238). - 1H-NMR (200 MHz, CDCl3) δ = 0.81 (d, 3JH,H = 6.7 Hz, 3H, CH(CH3)2); 
0.98 (d, 3JH,H = 6.5 Hz, 3H, CH(CH3)2); 1.45 (s, 9H, C(CH3)3); 1.98-2.14 (m, 1H, CH(CH3)2), 
2.47 (s, 3H, COCH3), 3.86 (s, 3H, CO2CH3); 4.26-4.40 (m, br, 1H, C), 5.62-5.84 (m, 1H, 
BocNH) ppm. - 13C-NMR (50 MHz, CDCl3)  = 19.1 (CH3Chet); 19.6 ((CH3)2CH); 28.0 
(CH(CH3)3); 52.7 (CO2CH3); 81.38 (C); 86.8 (C(CH3)3); 128.2 (Chet); 148.8 (Cazole); 158.1 
(CO2CH3), ppm. - FAB-HR MS: calcd. for C15H25N3O4+ 312.1923, found 312.1944. M.P.: 
161–162°C 
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(S)-methyl 1-benzyl-2-(1-(tert-butoxycarbonylamino)-2-methylpropyl)-5-methyl-imid-
azole-4-carboxylate  (11):[65] 
 
 
molecular formula: C22H31N3O4 
molecular mass: 401.499 g/mol 
 
The synthesis was performed according to literature procedures.[65] A solution of 10 (2.87 g, 
9.3 mmol) in 180 mL DMF (400 mL) was cooled down to 0°C and both NaH (0.45 g, 
11.2 mmol) and BnBr (2.07 g, 12.1 mmol) were added at this temperature. The reaction was 
kept at 0°C for two hours and stirring was continued for 18 hours as the reaction mixture was 
allowed to warm to room temperature. The reaction mixture is poured on 800g ice. The white 
solid is filtered, washed with water and dissolved in dichloromethane. The organic layer is 
washed with water and brine and dried over MgSO4. The solvent was removed in vacuo. 
Flash chromatography with silica gel (petroleum ether/ethyl acetate: 3:1) gave 2.23 g of 11 
(5.6 mmol, 60%) as a white solid. 
 
C22H31N3O4 (401.499) calcd. (%): C 65.81, H 7.78, N 10.47; found (%): C 65.63, H 7.72, N 
10.38 (22395). - 1H-NMR (200 MHz, MeOH-d4) δ = 0.84 (d, 3JH,H = 6.7 Hz, 3H, CH(CH3)2); 
0.97 (d, 3H, CH(CH3)2); 1.45 (s, 9H, C(CH3)3); 1.98-2.15 (m, 1H, CH(CH3)2), 2.48 (s, 3H, 
COCH3), 3.86 (s, 3H, CO2CH3); 4.43 (dd, 1H, CH); 5.83 (d 1JH,H = 16.1 Hz, 1H, CH2Ar); 
7.08-7.28 (m, 5H, CarH) ppm. - 13C-NMR (50 MHz, MeOH-d4)  = 10,2 (CH3-Chet); 19,1 
((CH3)2CH); 19,9 ((CH3)2CH); 28,5 (C(CH3)3); 32,7 (CH(CH3)2); 54,17 (CO2CH3); 67,9 
(CH2CAr); 80,7 ((CH3)2CH); 126.6 (CAr); 126.7 (Chet); 127.2, 129.0 (CAr); 130,0 (Chet); 136,5 
(CAr); 137,8; 149,9 (Chet); 157.4 (CO2NH); 164.5 (CO2CH3) ppm. - HR-ESI MS: calcd. for 
C22H32N3O4+ 402.239, found 402.219. M.P.: 126°C 
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(S)-1-benzyl-2-(1-(tert-butoxycarbonylamino)-2-methylpropyl)-5-methyl-imidazole-4-
carboxylic acid (12): 
 
 
molecular formula: C21H29N3O4 
molecular mass: 387.47 g/mol 
 
Compound 11 (2.24g, 5.60 mmol) was converted into 12, using 28 mL NaOH in 70 mL of a 
dioxane/methanol mixture as described above in the general procedure for the cleavage of the 
methyl ester group. Yield: quantitative.  
 
C21H29N3O4 (387.470) calcd. (%): C 65.09, H 7.54, N 10.84; found (%): C 66.22, H 7.93, N 
9.80 (22654). - 1H-NMR (200 MHz, DMSO-d6) δ = 0.19 (d, 3JH,H = 6.2 Hz, 3H, CH(CH3)2); 
0.78 (d, 3JH,H = 6.4 Hz 3H, CH(CH3)2); 1.38 (s, 9H, C(CH3)3); 1.80-1.92 (m, 1H, CH(CH3)2); 
2.36 (s, 3H, ChetCH3); 4.52 (m, 1H, CH); 5.16 (d, 1JH-H = 16.8 Hz, 1H, CH2CAr); 5.39 (d, 
1JH-H = 16.7 Hz, 1H, CH2CAr); 7.01-7.12 (m, 2H, CArH); 7.21-7.35 (m, 3H, CArH); 7.59 (d, 
3JH,H = 9.8 Hz, NH-(CH3)3) ppm. - 13C-NMR (50 MHz, DMSO-d6)  = 9.6 (CH3Chet); 19.4 
((CH3)2CH); 19.5 ((CH3)2CH); 28.1 (C(CH3)3); 28.6 (CH(CH3)2); 52.1 (CO2CH3); 66.7 (C); 
78.4 ((CH3)3C); 126.1 (Chet); 127.0, 128.8 (CAr); 134.2 (Cazole); 136.0, 147.4 (CAr); 154.0 
(Chet); 155.6 (CO2NH); 166.4 (CO2CH3) ppm. - HR-ESI MS: calcd. for C21H30N3O4+ 
388.2236, found 388.2316. M.P.: 113°C 
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Methyl 2-((S)-1-(1-benzyl-2-((S)-1-(tert-butoxycarbonylamino)-2-methylpropyl)-5-me-
thyl-imidazole-4-carboxamido)-2-methylpropyl)-1,5-dimethyl-imidazole-4-carboxylate
 (13): 
 
 
molecular formula: C32H46N6O5 
molecular mass: 594.747 g/mol 
 
EDIPA (4.87g, 37.7 mmol) and FDPP (2.10 g, 5.50 mmol) were added at room temperature to 
the benzyl imidazole building block 12 (1.90 g, 4.90 mmol) and the methyl imidazole 
building block 7 (2.10 g, 6.20 mmol) in 150 mL acetonitrile, and the mixture was stirred at 
room temperature for 4 days. The solvent was then evaporated and the residue dissolved in 
ethyl acetate. The organic layers were washed with water and brine, dried with MgSO4, and 
concentrated in vacuo. Flash chromatography on silica gel (petrol ether/ethyl acetate 1:2) gave 
building block 13 (1.25 g, 43%) as a white solid. 
 
C32H46N6O5 · ½ EtOAc (387.470) calcd. (%): C 63.98, H 7.82, N 13.17; found (%): C 63.69, 
H 7.80, N 13.50 (24297). - 1H-NMR (400 MHz, CDCl3) δ = 0.71 (d, 3JH,H = 6.6 Hz, 3H, 
CH(CH3)2 ); 0.92 (d, 3JH,H = 6.6 Hz, 3H, CH(CH3)2 ); 0.96 (d, 3JH,H = 6.6 Hz, 3H, CH(CH3)2 ); 
1.13 (d, 3JH,H = 6.6 Hz, 3H, CH(CH3)2 ); 1.38 (s, 9H, C(CH3)3); 2.06-2.24 (m, 2H, CH(CH3)2); 
2.30 (s, 3H, ChetCH3); 2.38 (s, 3H, ChetCH3); 3.56 (s, 3H, NhetCH3); 3.63 (s, 3H, NhetCH3); 
4.38 (dd, 1H, 3JH,H = 9.1 Hz, CH); 4.91 (dd, 1H, 3JH,H = 9.1 Hz, CH); 5.21 (s, 2H, CH2-Ar), 
6.21 (d, 3JH,H = 9.4 Hz, 2H, NHC(CH3)3); 6.94-7.26 (m, 5H, CarH), 7.44 (d, 1H, 3JH,H = 9.6Hz, 
NHCO) ppm. - 13C-NMR (100 MHz, CDCl3)  = 9.6, 10.2 (CH3Chet); 18.2, 19.4, 19.5, 19.90 
((CH3)2CH); 28.1 (C(CH3)3); 30.4 (NimiCH3); 32.4, 32.6 (CH(CH3)2); 46.2, 49.3 (C); 51.1 
(CO2CH3); 51.8 (CH2Ar); 79.4 ((CH3)3C); 126.0(Chet); 127.4, 128.5(CAr); 129.1, 132.3, 132.5, 
136.1, 147.3(CAr); 163.4 (CO2NH); 163.7(CO2CH3) ppm. - HR-ESI MS: calcd. for 
C32H47N5O6+ 595.3608, found 595.3610. M.P.: 83°C 
 
  
5. Experimental Section    
158 
2-((S)-1-(1-benzyl-2-((S)-1-(tert-butoxycarbonylamino)-2-methylpropyl)-5-methyl-imida-
zole-4-carboxamido)-2-methylpropyl)-1,5-dimethyl-imidazole-4-carboxylic acid  (14): 
 
 
molecular formula: C31H44N6O5 
molecular mass: 580.727 g/mol 
 
Compound 13 (1.25 g, 2.11 mmol) was converted into 14, using 11 mL NaOH in 30 mL of a 
dioxane/methanol mixture as described above in the general procedure for the cleavage of the 
methyl ester group. Yield: quantitative.  
 
C31H44N6O5 · H2O (580.727) calcd. (%): C 62.19, H 7.74, N 14.04; found (%): C 62.49, H 
7.75, N 13.56 (24423). - 1H-NMR (400 MHz, CDCl3) δ = 0.58 (d, 3JH,H = 6.3 Hz, 3H, 
CH(CH3)2 ); 0.92 (d, 3JH,H = 6.6 Hz, 3H, CH(CH3)2 ); 0.96 (d, 3JH,H = 6.6 Hz, 3H, CH(CH3)2 ); 
1.16 (d, 3JH,H = 6.6 Hz, 3H, CH(CH3)2 ); 1.33 (s, 9H, C(CH3)3); 2.19-2.42 (m, 2H, CH(CH3)2); 
2.52 (s, 3H, ChetCH3); 2.58 (s, 3H, ChetCH3), 2.67-2.84 (m, 2H, CH(CH3)2); 3.56 (s, 3H, 
NhetCH3); 4.55 (dd, 1H, 3JH,H = 9.3 Hz, CH); 5.06 (dd, 1H, 3JH,H = 9.1 Hz, CH); 5.21 (d, 1H, 
1JH,H = 16.1 Hz, CH2-Ar); 5.39 (d, 1H, 1JH,H = 16.1 Hz, CH2-Ar); 5.87 (d, 3JH,H = 8.9 Hz, 2H, 
NHC(CH3)3); 7.04-7.36 (m, 5H, CarH), 8.72 (d, 1H, 3JH,H = 8.6Hz, NHCO), 11.3 (s, br, 1H, 
COOH) ppm. - 13C-NMR (100 MHz, CDCl3)  = 9.6 (CH3Chet); 10.2 (CH3Chet); 18.2, 19.4, 
19.5, 19.90 ((CH3)2CH); 28.1 (C(CH3)3); 30.4 (NCH3); 32.4, 32.6 (CH(CH3)2); 46.2, 49.3 
(C); 51.1 (CO2CH3); 51.8 (CH2Ar); 79.4 ((CH3)3C); 126.0(Chet); 127.4, 128.5(CAr); 129.1, 
132.3, 132.5, 136.1, 147.3(CAr); 163.4 (CO2NH); 163.7(CO2H) ppm. - HR-ESI MS: calcd. 
for C31H45N5O6+ 581.3608, found 581.3600. M.P.: 112°C 
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(S)-1-(1-benzyl-4-((S)-1-(4-carboxy-1,5-dimethyl-imidazol-2-yl)-2-methyl-propyl-carb-
amoyl)-5-methyl-imidazol-2-yl)-2-methylpropan-1-aminium trifluoro acetate  (15): 
 
 
molecular formula: C26H31N6O3 · C2F3O2 
molecular mass: 577.623 g/mol 
 
Compound 14 (1.22 g, 2.10 mmol) was converted into 15, using 6.3 mL TFA in 42 mL DCM 
as described above in the general procedure for the cleavage of the Boc group. Yield: 
quantitative.  
 
C26H31N6O3 · C2F3O2 (577.623) - 1H-NMR (400 MHz, CDCl3) δ = 0.67 (m, 3H, CH(CH3)2 ); 
0.91 (d, 3JH,H = 5.3 Hz, 3H, CH(CH3)2 ); 0.99 (d, 3JH,H = 5.05 Hz, 3H, CH(CH3)2 ); 1.24 (m, 
3H, CH(CH3)2 ); 2.19-2.29 (m, 1H, CH(CH3)2); 2.45 (s, 3H, ChetCH3); 2.51-2.59 (m, 1H, 
CH(CH3)2); 2.54 (s, 3H, ChetCH3), 3.91 (s, 3H, NhetCH3); 4.45 (m, 1H, CH); 5.18-5.30 (m, 
2H, CH2-Ar); 7.04-7.36 (m, 5H, CarH), 8.72 (m, br, 1H, NHCO), 11.3 (s, br, 1H, COOH) 
14.5-15.5 (s, br, 3H, NH3) ppm. - 13C-NMR (100 MHz, CDCl3)  = 9.1, 9.6 (CH3Chet); 17.3, 
18.3, 18.9, 19.34 ((CH3)2CH); 31.4 (NimiCH3); 32.0 (CH(CH3)2); 47.2 (CH2Ar); 50.7, 52.6 
(C); 111.31, 114.21, 117.1, 119.96 (TFA); 126.0(Chet); 128.4, 128.5(CAr); 129.1, 134.3, 
135.5, 142.1, 147.3(CAr); 160.4; 163.7(CO2H) ppm. - HR-ESI MS: calcd. for C26H31N6O3+ 
481.293, found 481.3121.  
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Cyclic Pseudo Octapeptide H4L4-bn: 
 
 
molecular formula: C52H68N12O4 
molecular mass: 925.172 g/mol 
 
The synthesis was performed analogous to literature procedures.[48, 67] EDIPA (1.91 g, 
14.77 mmol) and FDPP (1.62 g, 4.22 mmol) were added at room temperature to a suspension 
of 15 (1.22 g, 2.11 mmol) in 200 mL acetonitrile and the mixture was stirred at room 
temperature for 3 days. The solvent was evaporated and the residue was dissolved in EtOAc, 
then extracted with water and brine, dried with MgSO4, and concentrated in vacuo. Flash 
chromatography on silica gel (petrol ether/ethyl acetate 1:1) gave H4L4-bn in 45 % yield 
(880 mg, 0.95 mmol).  
 
C52H68N12O4 · 2H2O (925.172) calcd. (%): C 64.98, H 7.55, N 17.49; found (%): C 64.73, H 
7.65, N 17.19 (24233). - 1H-NMR (400 MHz, CDCl3) δ 0.67 (m, 3H, CH(CH3)2 ); 0.91 (d, 
3JH,H = 5.3 Hz, 3H, CH(CH3)2 ); 0.99 (d, 3JH,H = 5.05 Hz, 3H, CH(CH3)2 ); 1.24 (m, 3H, 
CH(CH3)2 ); 2.19-2.29 (m, 1H, CH(CH3)2); 2.45 (s, 3H, ChetCH3); 2.51-2.59 (m, 1H, 
CH(CH3)2); 2.54 (s, 3H, ChetCH3), 3.91 (s, 3H, NhetCH3); 4.45 (m, 1H, CH); 5.18-5.30 (m, 
2H, CH2-Ar); 7.04-7.36 (m, 5H, CarH), 8.72 (m, br, 1H, NHCO), 11.3 (s, br, 1H, COOH) 
14.5-15.5 (s, br, 3H, NH3) ppm. - 13C-NMR (100 MHz, CDCl3)  = 9.1, 9.6 (CH3Chet); 17.3, 
18.3, 18.9, 19.34 ((CH3)2CH); 31.4 (NimiCH3); 32.0 (CH(CH3)2); 47.2 (CH2Ar); 50.7, 52.6 
(C); 111.31, 114.21, 117.1, 119.96 (TFA); 126.0(Chet); 128.4, 128.5(CAr); 129.1, 134.3, 
135.5, 142.1, 147.3(CAr); 160.4; 163.7(CO2H) ppm. - HR-ESI MS: calcd. for C52H69N12O4+ 
925.3564, found 925.5564.  
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5.2.3 Synthesis of the Cyclic Pseudo Octapeptide H4Lrs 
 
Methyl 2-((R)-2-(tert-butoxycarbonylamino)-3-methylbutanamido)-3-oxobutanoate (16): 
 
 
molecular formula: C15H26N2O6 
molecular mass: 330.38 g/mol 
 
The Synthesis was performed analogous to literature procedures.[48] (R)-Boc-Val-OH (3.5 g, 
15.6 mmol, 1eq) is dissolved in 100 mL THF, NMM (1.7 g, 16.65 mmol, 1eq) is added and 
the solution is cooled to -25°C. Subsequently isobutyl chloroformate (2.13 g, 15.6 mmol, 
1 eq) is added, during which the reaction mixture is maintained at -25°C. After 35 min, the 
ammonium chloride salt 2 (2.6 g, 15.6 mmol, 1 eq), followed by a second equivalent of NMM 
(1.7 g, 47.8 mmol, 1eq) are added at -25°C and stirring is continued for 20 h as the mixture is 
allowed to warm to room temperature. The solvent is evaporated, the residue dissolved in 
ethyl acetate, and then washed with water and brine. The combined organic layers are dried 
over MgSO4 and concentrated in vacuo. After recrystallization from ethyl acetate 4.5 g of 16 
are obtained as colorless crystals (87 %). 
 
C15H26N2O6: calcd. (%): C 54.53, H 7.93, N 8.48; found (%): C 54.66, H 7.94, N 8.62 
(28053). - 1H-NMR (200 MHz, CDCl3):  = 0.87 (d, 3JH,H = 6.9 Hz, 3H, CHCH3), 0.88 (d, 
3JH,H = 6.9 Hz, 3H, CHCH3), 0.93 (d, 3JH,H = 6.8 Hz, 6H, CHCH3); 1.39(s, 9H, C(CH3)3); 
1.40 (s, 9H, C(CH3)3); 2.10-2.26 (m, 2H, CH(CH3)2); 2.33 (s, 6H, COCH3); 3.76 (s, 6H, 
CO2CH3); 4.0 - 4.08 (m, 2H, CHCONH); 5.07 (d, 3JH,H = 8.1 Hz, 1H, NHCO2); 5.09 (d, 
3JH,H = 8.6 Hz, 1H, NHCO2); 5.21 (d, 3JH,H = 6.3 Hz, 2H, CHCO2); 7.13 (d, 3JH,H = 6.3 Hz, 
1H, NH); 7.18 (d, 3JH,H = 6.5 Hz, 1H, NH) ppm. - 13C-NMR (50 MHz, CDCl3):  = 17.3, 17.5 
(CH(CH3)2); 19.1; 19.2 (CH(CH3)2); 27.9, 28.0 (COCH3); 28.2 (C(CH3)3); 30.7, 30.9 
(CH(CH3)2); 53.2, 53.3 (CO2CH3); 59.4, 59.5 (NHCHCO); 62.8, 62.9 (NHCHCO2); 80.1 
(C(CH3)3); 155.7 (NHCOC(CH3)3); 166.3, 166.4 (CO2CH3); 171.6 (NHCO); 198.0; 198.1 
(COCH3) ppm. - FAB-HR MS: m/z calcd. for C15H27N2O6+ 331.1866, found 331.1853. - 
M.P.: 106°C. 
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(R)-methyl 2-(1-(tert-butoxycarbonylamino)-2-methylpropyl)-1,5-dimethyl-imidazole-4-
carboxylate (17): 
 
 
molecular formula: C16H27N3O4 
molecular mass: 325.40 g/mol 
 
The synthesis was performed analogous to the synthesis of 4.[67] Both glacial acedic acid 
(7.9 mL, 33.5 mmol, 1 eq) and NH2Me in MeOH (8 M, 6.45 mL, 62.96 mmol, 4eq) were 
added to a solution of 16 (5.2 g, 15.7 mmol, 1eq) in 200 mL xylenes at room temperature. The 
solution was stirred at 155°C with azeotropic removal of water for 8 h and then cooled to 
room temperature. The solvent was concentrated, and the residue was dissolved in AcOEt, 
and then washed with saturated NaHCO3 solution and brine. The organic layer was dried over 
Na2SO4 and concentrated in vacuo. Purification was achieved by performing chromatography 
with silica gel (petroleum ether/ethyl acetate 1:3) to provide 3.6 g of 17 (72%) as a white 
solid. 
 
C16H27N3O4 (325.40): calcd. (%):C 59.06, H 8.36; N 12.91; found (%): C 58.82, H 8.36, 
N 12.86 (28052). -  1H-NMR (200 MHz, CDCl3):  = 0.74 (d, 3JH,H = 6.7 Hz, 3H, CHCH3), 
0.93 (d, 3J = 6.7 Hz, 3H, CHCH3), 1.31 (s, 9H, C(CH3)3), 2.02-2.30 (m, 1H, CH(CH3)2), 2.44 
(s, 3H, ChetCH3), 3.48 (s, 1H, NCH3), 3.79 (s, 1H, CO2CH3), 4.45 (dd, 3JH,H = 9.18 Hz, 1H, 
C), 5.26 (d, JH,H = 9.58 Hz, 1H, NH) ppm. - 13C-NMR (50 MHz, CDCl3): 10.2 (ChetCH3); 
18.5, 19.6 (CH(CH3)2); 28.3 (C(CH3)3); 30.3 (NCH3); 33.2 (CH(CH3)2); 51.4 (CO2CH3); 52.1 
(C); 79.4 (C(CH3)3); 127.5 (ChetCO2); 135.9 (ChetCH3); 148.4 (ChetN); 155.6 (NHCO); 164.2 
(CO2CH3) ppm - ESI-HR MS: m/z calcd. for C16H28N3O4+ 326.2074, found 326.2075. - 
M.P.: 106°C. 
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(R)-2-(1-(tert-butoxycarbonylamino)-2-methylpropyl)-1,5-dimethyl-imidazole-4-carbo-
xylic acid (18): 
 
 
molecular formula: C15H25N3O4 
molecular mass: 311.38 g/mol 
 
Compound 17 (1.9 g, 5.8 mmol) was converted into 18, using 29 mL NaOH in 73 mL of a 
dioxane/methanol mixture as described above in the general procedure for the cleavage of the 
methyl ester group. Yield: quantitative.  
 
C15H25N3O4 (311.38): calcd. (%): C 59.06, H 8.36, N 12.91; found (%): C 58.82, H 8.36, N 
12.86 (28052). -  1H-NMR (200 MHz, CDCl3):  = 0.74 (d, 3JH,H = 6.7 Hz, 3H, CHCH3); 1.11 
(d, 3JH,H = 6.6 Hz, 3 H, CHCH3); 1.35 (s, 9H, C(CH3)3); 2.48-2.62 (m, 1H, CH(CH3)2); 2.58 
(s, 3H, ChetCH3); 3.67 (s, 3H, NCH3); 4.55 (dd, 3JH,H = 9.33 Hz 1H, C); 7.40 (s, 1H, 
NHCO2); 10.67 (s, 1H, CO2H) ppm. - 13C-NMR (50 MHz, CDCl3):  = 9.7 (ChetCH3); 19.4, 
19.6 (CH(CH3)2); 28.2 (C(CH3)3); 31.8 (CH(CH3)2); 32.3 (NCH3); 52.6 (C); 79.9 (C(CH3)3); 
123.4 (ChetCO2); 135.1 (ChetNCH3); 149.0 (Cazole); 156.2 (CO2NH); 161.3 (CO2H) ppm. - 
FAB-HR MS: m/z cald. for C15H26N3O4+ 312.2074, found 336.2088. - M.P.: 104 °C. 
 
Methyl 2-((S)-1-(2-((R)-1-(tert-butoxycarbonylamino)-2-methylpropyl)-1,5-dimethyl-imi-
dazole-4-carboxamido)-2-methylpropyl)-1,5-dimethyl-imidazole-4-carboxylate (19): 
 
molecular formula: C26H42N6O5 
molecular mass: 518.64 g/mol 
 
EDIPA (5.7 mL, 31.2 mmol) and FDPP (3.50 g, 9.12 mmol) were added at room temperature 
to a solution of 18 (1.50 g, 4.80 mmol) and 7 (2.40 g, 7.20 mmol) in 150 mL acetonitrile, and 
the mixture was stirred at room temperature for 4 days. The solvent was then evaporated and 
the residue dissolved in ethyl acetate. The organic layers were washed with water and brine, 
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dried with MgSO4, and concentrated in vacuo. Flash chromatography on silica gel (petrol 
ether/ethyl acetate 1:2) gave building block 13 (1.7 g, 68%) as a white solid. 
 
C26H42N6O5 · H2O: calcd. (%): C 58.19, H 8.26, N 15.66, found (%): C 58.53, H 8.08, 
N 14.70 (26011). - 1H-NMR (400 MHz, CDCl3):  = 0.82 (d, 3JH-H = 6.9 Hz, 3H, CHCH3); 
0.84 (d, 3JH-H = 6.7 Hz, 3H, CHCH3); 0.94 (d, 3JH-H = 6.7 Hz, 3H, CHCH3); 1.06 (d, 3JH-H = 
6.55 Hz, 3H, CHCH3); 1.44 (s, 9H, C(CH3)3); 1.99-2.13 (m, 1H, CHCH3); 2.51 (s, 6H, 
ChetCH3); 2.52-2.62 (m, 1H, CHCH3), 3.47 (s, 3H, NCH3); 3.64 (s, 3H, NCH3); 3.85 (s, 3H, 
CO2CH3); 4.51 (dd, 3JH-H = 8.57 Hz, 1H, CH); 4.96 (dd, 3JH-H = 9.85 Hz, 1H, CH); 5.36-
5.22 (m, 1H, NH); 7.68 (m, 1H, NH) ppm. - 13C-NMR (100 MHz, CDCl3): δ = 9.7, 10.2 
(ChetCH3); 18.1, 19.2, 19.6, 20.0 (CHCH3); 28.3 (CCH3); 30.0, 30.4 (CH(CH3)2); 32.3, 32.9 
(NCH3); 52.1 (CO2CH3); 79.5 (C(CH3)3); 135.9, 146.9, 148.3 (Chet); 155.7, 163.5, 163.7 (CO) 
ppm. - FAB-HR MS: m/z. calcd. for C26H43N6O5+ 519.32894 found: 519.3318– M.P.: 179 °C 
. 
 
2-((S)-1-(2-((R)-1-(tert-butoxycarbonylamino)-2-methylpropyl)-1,5-dime-thyl-imidazole-
4-carboxamido)-2-methylpropyl)-1,5-dimethyl-imidazole-4-carboxylic acid   (20): 
 
molecular formula: C25H40N6O4 
molecular mass: 504.62 g/mol 
 
Compound 19 (1.7 g, 3.26 mmol) was converted into 12, using 33 mL NaOH in 40 mL of a 
dioxane/methanol mixture as described above in the general procedure for the cleavage of the 
methyl ester group. Yield: quantitative. 
 
C25H40N6O4: 1H-NMR (400 MHz, CDCl3):  = 0.82 (d, 3J = 6.9 Hz, 3H, CHCH3); 0.84 (d, 3J 
= 6.7 Hz, 3H, CHCH3); 0.94 (d, 3J = 6.7 Hz, 3H, CHCH3); 1.06 (d, 3J = 6.55 Hz, 3H, 
CHCH3); 1.44 (s, 9H, C(CH3)3); 1.99-2.13 (m, 1H, CHCH3); 2.51 (s, 6H, ChetCH3); 2.52-2.62 
(m, 1H, CHCH3), 3.47 (s, 3H, NCH3); 3.64 (s, 3H, NCH3); 3.85 (s, 3H, CO2CH3); 4.51 (dd, 3J 
= 8.57 Hz, 1H, NHCH); 4.96 (dd, 3J = 9.85 Hz, 1H, NHCH); 5.36-5.22 (m, 1H, NH); 7.68 
(m, 1H, NH) ppm. - 13C-NMR (100 MHz, CDCl3): δ = 9.4, 9.5 (ChetCH3); 18.2, 19.7, 19.0, 
19.3 (CHCH3); 28.0 (CCH3); 30.4, 30.8 (CH(CH3)2); 31.2, 31.9 (NCH3); 78.5 (C(CH3)3); 
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128.3, 130.8, 133.9, 136.8, 146.1, 148.1 (CHet); 155.4, 160.5, 162.3 (CO) ppm. - FAB-HR 
MS: m/z calcd. found – M.P.: 217 °C . 
 
(R)-1-(4-((S)-1-(4-carboxy-1,5-dimethyl-imidazol-2-yl)-2-methylpropylcarbamoyl)-1,5-
dimethyl-imidazol-2-yl)-2-methylpropan-1-aminium trifluoro acetate (21): 
 
molecular formula: C22H32F3N6O4 
molecular mass: 501.52 g/mol 
 
Compound 20 (1.5 g, 2.90 mmol) was converted into 21, using 8.7 mL TFA in 58 mL DCM 
as described above in the general procedure for the cleavage of the Boc group. Yield: 
quantitative.  
 
C22H32F3N6O4: 1H-NMR (400 MHz, CDCl3):  = 0.82 (d, 3J = 6.9 Hz, 3H, CHCH3); 0.84 (d, 
3J = 6.7 Hz, 3H, CHCH3); 0.94 (d, 3J = 6.7 Hz, 3H, CHCH3); 1.06 (d, 3J = 6.55 Hz, 3H, 
CHCH3); 1.44 (s, 9H, C(CH3)3); 1.99-2.13 (m, 1H, CHCH3); 2.51 (s, 6H, ChetCH3); 2.52-2.62 
(m, 1H, CHCH3), 3.47 (s, 3H, NCH3); 3.64 (s, 3H, NCH3); 3.85 (s, 3H, CO2CH3); 4.51 (dd, 3J 
= 8.57 Hz, 1H, NHCH); 4.96 (dd, 3J = 9.85 Hz, 1H, NHCH); 5.36-5.22 (m, 1H, NH); 7.68 
(m, 1H, NH) ppm. - 13C-NMR (100 MHz, CDCl3): δ = 9.4, 9.5 (CHetCH3); 18.2, 19.7, 19.0, 
19.3 (CHCH3); 28.0 (CCH3); 30.4, 30.8 (CH(CH3)2); 31.2, 31.9 (NCH3); 78.5 (C(CH3)3); 
128.3, 130.8, 133.9, 136.8, 146.1, 148.1 (CHet); 155.4, 160.5, 162.3 (CO) ppm. - M.P.: > 200 
°C . 
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Cyclic Pseudo Octapeptide H4Lrs: 
 
molecular formula: C40H60N12O4 
molecular mass: 772.98 g/mol 
 
The synthesis was performed analogous to the synthesis of H4L4-bn. EDIPA (1.87 g, 
14.77 mmol) and FDPP (2.23 g, 5.8 mmol) were added at room temperature to a suspension 
of 21 (1.5 g, 2.11 mmol) in 150 mL acetonitrile and the mixture was stirred at room 
temperature for 2 days. The solvent was evaporated and the residue was dissolved in EtOAc, 
then extracted with water and brine, dried with MgSO4, and concentrated in vacuo. Flash 
chromatography on silica gel (DCM/EE/MeOH 70:30:4) gave H4Lrs in 54 % yield (302 mg, 
0.95 mmol). 
 
C40H60N12O4 • H2O • ½EtOAc: calcd. (%): C 60.45, H 7.91, N 20.14; found (%): C 60.64, 
H 8.00, N 20.47 (28059). - 1H-NMR (750 MHz, CDCl3):  = 0.87 (d, 3JH,H = 6.75 Hz, 3H, 
CH(CH3)2); 0.92 (d, 3JH,H = 6.76 Hz, 3H, CH(CH3)2); 2.19-2.29 (m, 1H, CHCH3); 2.55 (s, 
3H, ChetCH3); 3.64 (s, 3H, NCH3); 5.11-5.14 (m, 1H, CH); 8.60 (d, 3J = 9.04 Hz, 1H, NH) 
ppm. -13C-NMR (175 MHz, CDCl3): δ = 9.8 (ChetCH3); 18.7, 19.6 (CH(CH3)2); 30.7 
(CH(CH3)2); 35.6 (NCH3); 51.0 (NHCH); 130.1 (ChetCO); 134.5 (ChetNCH3); 148.2 (Cazole); 
165.4 (NHCO) ppm. - FAB-HR MS: m/z. calcd. for C40H61N12O4+ 773.4939, found 773.4944 
– M.P.: > 250 °C. 
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5.2.4 Synthesis of the Cyclic Pseudo Octapeptide H4LascA 
(2S,3R)-methyl 2-((S)-2-(benzyloxycarbonylamino)-3-methylbutanamido)-3-hydroxybu-
tanoate  (22):[100] 
 
 
molecular formula: C18H26N2O6 
molecular mass: 366.408 g/mol 
 
The synthesis was performed according to literature.[100] (S)-Cbz-Val-OH (4.73 g, 17 mmol) 
and NMM (4.52 g, 25.6 mmol) were dissolved in 50 mL DCM and cooled to -15°C, isobutyl 
chloroformate (2.51 g, 25.5 mmol) was added drop wise at this temperature. Subsequently a 
solution of threonine methylester hydrochloride (2.8 g, 17 mmol) and NEt3 (1.81 g, 17 mmol) 
in 10 mL DMF was added and stirring was continued while as the reaction mixture was 
allowed to warm to room temperature. 50 mL DCM were added and the organic layers 
washed with 1N HCl, 1 N NaOH and brine, dried over MgSO4, and concentrated in vacuo. 
After recrystallization from hexane 4.2 g of 22 were obtained as colorless crystals (68 %). 
 
C18H26N2O6 (366.41): calcd. (%): C 59.00, H 7.15, N 7.65; found (%): C 58.766, H 7.05, N 
7.52 (23872). - 1H-NMR (200 MHz, CDCl3):  = 0.95 (d, 3JH,H = 7.0 Hz, 3H, CH(CH3)2); 
0.98 (d, 3JH,H = 7.0 Hz, 3H, CH(CH3)2); 1.16 (d, 3JH,H = 6.4 Hz, 3H, C(R)HCH3); 2.02-2.18 (m, 
1H, CH(CH3)2); 3.74 (s, 3H, CO2CH3); 4.10 (dd, 3JH,H = 6.8, 8.8 Hz, 1H, COCHNH); 4.34 
(dq, 3JH,H = 6.2, 2.4 Hz, 1H, C(R)HCH3); 4.61 (dd, 1H, 3JH,H = 2.5, 9.0 Hz, CHCO2); 5.09 (s, 
2H, CArCH2), 5.62 (d, 1H, 3JH,H = 7.8 Hz, NHCbz); 7.01 (d, 1H, 3J = 8.9 Hz, NHCO); 7.28-
7.42 (m, 5H, CHAr). - 13C-NMR (50 MHz, CDCl3):  = 18.4, 19.5 (CH(CH3)2); 20.3 
(C(R)HCH3); 31.5 (CH(CH3)2); 53.0 (CO2CH3); 57.7 (CHCO2); 60.9 (COCHNH); 67.5 
(CArCH2); 68.5 (C(R)HCH3); 128.4, 128.6, 128.9, 136.6 (CAr); 156.7 (CO2NH); 171.3; 172.4 
(CHCoxa, CONH). - FAB-HR MS: m/z calcd. for C18H27N2O6+ 367.1864, found 367.1848. – 
M.P.: 135-137°C. 
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(4S,5S)-methyl 2-((S)-1-(benzyloxycarbonylamino)-2-methylpropyl)-5-methyl-4,5-di-
hydrooxazole-4-carboxylate (23):[100] 
 
 
molecular formula: C18H24N2O5 
molecular mass: 349.391 g/mol 
 
The synthesis was performed according to literature.[100] A solution 22 (2.09 g, 5.72 mmol) in 
40 mL of dry THF was treated with Burgess’ reagent (1.5 g, 2.2 mmol) and heated at 75°C 
for 2.5 h. The reaction mixture was evaporated onto silica gel and chromatographed 
(EtOAc/hexanes 1:1) to yield 23 (1.13 g, 57%) as an oil: 
 
C18H24N2O5 (348.39): calcd. (%): C 62.05, H 6.94, N 8.04; found (%): C 61.76, H 7.01, N 
8.00 (22320). - 1H-NMR (200 MHz, CDCl3):  = 0.96 (d, 3JH,H = 6.9 Hz, 3H, CH(CH3)2); 
1.01 (d, 3JH,H = 6.9 Hz, 3H, CH(CH3)2); 1.28 (d, 3JH,H = 6.3 Hz, 3H, COxaHCH3); 2.10-2.26 
(m, 1H, CH(CH3)2); 3.73 (s, 3H, CO2CH3); 4.39 (dd, 3JH,H = 9.2, 4.3 Hz, 1H, CHCOxa); 4.76 
(d, 3JH,H = 10.1 Hz, 1H, CoxaHCO2); 4.85-4.99 (m, 1H, CoxaHCH3); 5.05, 5.16 (2J = 12.2 Hz, 
2H, CArCH2);, 5.54 (d, 3J = 9.2 Hz, 1H, NHCbz); 7.27-7.36 (m, 5H, CHAr). - 13C-NMR (50 
MHz, CDCl3):  = 16.0 (CoxaHCH3); 17.0, 18.7 (CH(CH3)2); 31.3 (CH(CH3)2); 51.9 
(CO2CH3); 54.2 (CHCoxa); 66.8 (CArylCH2); 70.7 (CoxaHCO2); 78.4 (CoxaHCH3); 128.0, 128.4, 
136.3(CAr); 156.2 (CO2NH); 169.6; 170.0 (CHCoxa, CO2CH3). - FAB-HR MS: m/z calcd. for 
C18H25N2O5+ 349.1758, found 349.1745. 
 
(2S,3S)-methyl 2-((S)-2-(benzyloxycarbonylamino)-3-methylbutanamido)-3-hydroxybu-
tanoate (24):[48] 
 
 
molecular formula: C18H26N2O6 
molecular mass: 366.408 g/mol 
 
The synthesis was performed according to literature.[100] A solution of 23 (1 g, 2.87 mmol) in 
44 mL of dry THF was treated with 22 mL of 1 M HCl. The reaction mixture was stirred for 
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30 min at room temperature and then the pH was adjusted to 9.5 by the addition of solid 
K2CO3. The reaction was complete after 2 h (TLC). The organic solvent was evaporated and 
the aqueous layer extracted with EtOAc (2£30 mL). The combined organic extracts were 
washed with brine and dried over Na2SO4. Filtration followed by evaporation in vacuo 
yielded 24 (950 mg, 90%) as a colorless solid. 
 
C18H26N2O6 (366.41): calcd. (%): C 59.00, H 7.15, N 7.65; found (%): C 58.66, H 7.08, 
N 7.64 (24812). - 1H-NMR (200 MHz, CDCl3):  = 0.93 (d, 3JH,H = 6.7 Hz, 3H, CH(CH3)2); 
0.96 (d, 3JH,H = 6.7 Hz, 3H, CH(CH3)2; 1.19 (d, 3JH,H = 6.5 Hz, 3H, C(S)HCH3); 2.00-2.16 (m, 
1H, CH(CH3)2); 3.75 (s, 3H, CO2CH3); 4.10-4.18 (m, 2H, COCHNH, C(S)HCH3); 4.66 (dd, 
3JH,H = 3.2, 7.7 Hz, 1H, CHCO2); 5.12, 5.07 (2JH,H = 12.2 Hz, 2H, CArylCH2); 5.70 (d, 3JH,H = 
8.7 Hz, 1H, NHCbz); 7.25 (m, 1H, NHCO); 7.28-7.42 (m, 5H, CHAr). - 13C-NMR (50 MHz, 
CDCl3):  = 18.4 (CH(CH3)2); 19.3 (C(S)HCH3); 19.5 (CH(CH3)2); 31.6 (CH(CH3)2); 
52.9(CO2CH3); 58.5 (CHCO2); 60.8 (COCHNH); 67.5 (CArCH2); 69.0 (C(R)HCH3); 128.4, 
128.6, 128.9, 136.6 (CAr); 157.1 (CO2NH);; 170.9; 172.5 (CHCoxa, CONH). - FAB-HR MS: 
m/z calcd. for C18H27N2O6+ 367.1864, found 367.1860. – M.P.: 122-125 °C 
 
(4S,5R)-methyl 2-((S)-1-(benzyloxycarbonylamino)-2-methylpropyl)-5-methyl-4,5-dihy-
drooxazole-4-carboxylate (25):[48] 
 
 
molecular formula: C18H24N2O5 
molecular mass: 349.391 g/mol 
 
The synthesis was performed according to literature.[100] A solution 24 (940 mg, 2.59 mmol) 
in 50 mL of dry THF was treated with Burgess’ reagent (679 mg, 2.85 mmol) and heated at 
75°C for 2.5 h. The reaction mixture was evaporated onto silica gel and chromatographed 
(EtOAc/hexanes 1:1) to yield 25 (700 mg, 77%) as an oil 
 
C18H24N2O5 ·½ H2O (348.39): calcd. (%): C 60.49, H 7.05, N 7.80; found (%): C 60.38, 
H 7.02, N 8.17 (28824). - 1H-NMR (200 MHz, CDCl3):  = 0.90 (d, 3JH,H = 6.9 Hz, 3H, 
CH(CH3)2); 0.96 (d, 3JH,H = 6.8 Hz, 3H, CH(CH3)2); 1.39 (d, 3JH,H = 6.3 Hz, 3H, CoxaHCH3); 
2.05-2.21 (m, 1H, CH(CH3)2); 3.74 (s, 3H, CO2CH3); 4.25 (d, 3J = 7.0 Hz, 1H, CH); 4.40 
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(dd, 3JH,H = 9.1, 4.6 Hz, 1H, CoxaHCO2); 4.75-4.88 (m, 1H, CoxaHCH3); 5.05, 5.12 (2JH,H = 
12.3 Hz, 2H, CArCH2); 5.51 (d, 1H, 3JH,H = 9.2 Hz, NHCbz); 7.23-7.35 (m, 5H, CHAr). - 13C-
NMR (50 MHz, CDCl3):  = 17.1, 18.7 (CH(CH3)2); 20.8 (CoxaHCH3); 31.6 (CH(CH3)2); 52.5 
(CO2CH3); 54.3 (CHCoxa); 66.8 (CArCH2); 74.0 (CoxaHCO2); 79.6 (CoxaHCH3); 128.0, 128.4, 
136.3 (CAr); 156.1 (CO2NH); 168.7; 171.2 (CHCoxa, CO2CH3). - FAB-HR MS: m/z calcd. for 
C18H25N2O5+ 349.1758, found 349.1748. 
 
(4S,5R)-2-((S)-1-(benzyloxycarbonylamino)-2-methylpropyl)-5-methyl-4,5-dihydro-
oxazole-4-carboxylic acid (26): 
 
 
molecular formula: C17H22N2O5 
molecular mass: 334.361 g/mol 
 
Compound 25 (700 mg, 2 mmol) was converted into 26, using 10 mL NaOH in 26 mL of a 
dioxane/methanol mixture as described above in the general procedure for the cleavage of the 
methyl ester group. Yield: quantitative.  
 
C17H22N2O5 (334.37): calcd. (%): C: 61.07, H 6.63, N 8.38; found (%): 60.37, H 7.06, N 8.27 
(28823). - 1H-NMR (200 MHz, CDCl3):  = 0.89 (d, 3H, 3JH,H = 6.8 Hz, CH(CH3)2); 0.95 (d, 
3JH,H = 6.8 Hz, 3H, CH(CH3)); 1.34 (d, 3JH,H = 6.3 Hz, 3H, CHCH3); 2.02-2.18 (m, 1H, 
CH(CH3)2); 4.17 (d, 3JH,H = 6.9 Hz, 1H, CH); 4.46 (dd, 3JH,H = 9.5, 5.0 Hz, 1H, CHCH3); 
4.87-5.00 (m, 1H, CHCO2); 5.05, 5.14 (2JH,H = 12.6 Hz, 2H, CArCH2); 6.85 (d, 3JH,H = 10.0 
Hz, 1H, NHCbz); 7.28-7.36 (m, 5H, CHAr). - 13C-NMR (50 MHz, CDCl3):  = 17.3, 18.8 
(CH(CH3)2); 20.2 (CoxaHCH3); 31.4 (CH(CH3)2); 54.3 (CHCoxa); 66.7 (CArCH2); 72.4 
(CoxaHCO2); 80.6 (CoxaHCH3); 127.7, 128.0, 128.5, 136.5 (CAr); 156.6 (CO2NH); 171.9, 172.7 
(CHCoxa, CO2H). - FAB-HR MS: m/z calcd for C17H23N2O5+ 335.1602, found 335.1647. - 
M.P.: 162°C 
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(R)-methyl 2-(1-(tert-butoxycarbonylamino)-2-methylpropyl)-5-methylthiazole-4-carb-
oxylate (27):[48] 
 
 
molecular formula: C15H24N2O4S 
molecular mass: 328.431 g/mol 
 
The synthesis was performed according to literature procedure.[48] Lawesson’s Reagent (10.0 
g, 24.7 mmol) was added at room temperature to a solution of 16 (5.46 g, 16.53 mmol) in 
170 mL anhydrous THF. The mixture was stirred at reflux for 8 h. The solvent was removed 
and the residue dissolved in EtOAc, washed with water, 1 N HCl, saturated NaHCO3 solution 
and brine, dried with MgSO4, and concentrated in vacuo. The crude product was 
chromatographed (petroleum ether/EtOAc: 3:1) to yield 27 (3.67 g, 70%) as a solid. 
 
C15H24N2O4S (328.43):calcd. (%): C 54.86, H 7.37, N 8.53 S 9.76; found (%): C 54.84, 
H 7.35, N 9.64, S 9.64 (24793). - 1H-NMR (200 MHz, CDCl3):  = 0.85 (d, 3JH,H = 6.9 Hz, 
3H, CH(CH3)2); 0.92 (d, 3JH,H = 6.8 Hz, 3H, CH(CH3)2); 1.39 (s, 9H, C(CH3)3); 2.24-2.45 (m, 
1H, CH(CH3)2); 2.68 (s, 3H, CthiaCH3); 3.87 (s, 3H, CO2CH3); 4.75 (dd, 3JH,H = 5.6, 8.5 Hz, 
1H, CH); 5.21 (d, 3JH,H = 8.6 Hz, 1H, NHCO2). - 13C-NMR (50 MHz, CDCl3):  = 13.0 
(CthiaCH3); 17.1, 19.3 (CH(CH3)2); 28.2 (C(CH3)3); 33.0 (CH(CH3)2); 52.0 (CO2CH3); 57.7 
(C); 79.9 (C(CH3)3); 140.9, 144.3 (CthiaCH3, CthiaCO2); 155.3 (CO2NH); 162.8, 168.3 
(CHCthia, CO2CH3). - FAB-HR MS: m/z calcd. for C15H25N2O4S+ 329.1457, found 329.1514. 
– M.P.: 111°C. 
 
(R)-2-(1-(tert-butoxycarbonylamino)-2-methylpropyl)-5-methylthiazole-4-carboxylic acid
 (28): 
 
 
molecular formula: C14H22N2O4S 
molecular mass: 314.137 g/mol 
 
Compound 27 (1.2 g, 3.65 mmol) was converted into 28, using 18 mL NaOH in 40 mL of a 
dioxane/methanol mixture as described above in the general procedure for the cleavage of the 
methyl ester group. Yield: quantitative.  
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C14H22N2O4S (314.14): calcd. (%): C 53.48, H 7.05, N 8.91; found (%): C 52.99, H 7.07, 
N 8.71 (24857). - 1H-NMR (200 MHz, CDCl3):  = 0.91 (d, 3JH,H = 6.9 Hz, 3H, CHCH3); 
0.96 (d, 3JH,H = 6.9 Hz, 3H, CHCH3); 1.42 (s, 9H, C(CH3)3); 2.25-2.41 (m, 1H, CH(CH3)2); 
2.74 (s, 3H, CthiaCH3); 4.77 (dd, 3JH,H = 6.0, 7.9 Hz, 1H, CH); 5.31 (d, 3JH,H = 8.0 Hz, 1H, 
NHCO2). - 13C-NMR (50 MHz, CDCl3):  = 13.0 (CthiaCH3); 17.4, 19.3 (CH(CH3)2); 28.2 
(C(CH3)3); 33.0 (CH(CH3)2); 57.7 (C); 80.2 (C(CH3)3); 140.4, 145.3 (CthiaCH3, CthiaCO2); 
155.4 (CO2NH); 168.4 (CHCthia). - FAB-HR MS: m/z calcd. for C14H23N2O4S+ 315.1373, 
found 315.1343. - M.P.: 146°C. 
 
(R)-benzyl 2-(1-(tert-butoxycarbonylamino)-2-methylpropyl)-5-methylthiazole-4-carb-
oxylate (29): 
 
molecular formula: C21H28N2O4S 
molecular mass: 404.523 g/mol 
 
The reaction was performed analogous to literature.[48] DBU (0.48 mL, 3.26 mmol) and BnBr 
(0.50 mL, 4.23 mmol) were added at room temperature to a solution of 28 (1.02 g, 
3.256 mmol) in 50 mL acetonitrile and the mixture was stirred at that temperature for 6 days. 
The solvent was evaporated and the residue was dissolved in EtOAc, extracted with water and 
brine, dried with MgSO4, and concentrated in vacuo. Purification was accomplished by 
chromatography on silica gel (petroleum ether/ethyl acetate, 2:1) to yield 29 (1.2 g, 91%) as a 
white solid.  
 
C21H28N2O4S (404.52): calcd. (%): C 62.35, H 6.98, N 6.93 S 7.93; found (%): C 62.14, 
H 6.97, N 6.76 S 7.95 (24856). - 1H-NMR (200 MHz, CDCl3):  = 0.87 (d, 3JH,H = 6.8 Hz, 
3H, CHCH3); 0.95 (d, 3JH,H = 6.8 Hz, 3H, CHCH3); 1.41 (s, 9H, C(CH3)3); 2.28-2.44 (m, 1H, 
CH(CH3)2); 2.66 (s, 3H, CThiaCH3); 4.77 (dd, 3JH,H = 8.7, 5.4 Hz, 1H, CH); 5.22 (d, 3JH,H = 
8.5 Hz, 1H, NHCO2); 5.33, 5.40 (2JH,H = 12.6 Hz, 2H, CH2CAr); 7.25-7.46 (m, 5H, CHAr). - 
13C-NMR (50 MHz, CDCl3):  = 13.0 (CthiaCH3); 17.2, 19.4 (CH(CH3)2); 28.3 (C(CH3)3); 
33.1 (CH(CH3)2); 57.7 (CHCthia); 66.6 (CArCH2); 79.9 (C(CH3)3); 128.2, 128.3, 128.5, 136.0 
(CAr); 141.1, 144.3 (CthiaCH3, CthiaCO2); 155.4 (CO2NH); 162.2, 168.0 (CHCthia, CO2Bn). - 
FAB-HR MS: m/z calcd. for C21H29N2O4S+ 405.1843, found 405.1831. - M.P.: 74°C. 
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(R)-1-(4-(benzyloxycarbonyl)-5-methylthiazol-2-yl)-2-methylpropan-1-aminium trifluoro 
acetate (30): 
 
molecular formula: C18H21F3N2O2S 
molecular mass: 418.432 g/mol 
 
Compound 29 (1.1 g, 2.7 mmol) was converted into 30, using 8.4 mL TFA in 60 mL DCM as 
described above in the general procedure for the cleavage of the Boc group. Yield: 
quantitative.  
 
C18H21F3N2O2S (418.43). - 1H-NMR (200 MHz, CDCl3):  = 0.89 (d, 3JH,H = 6.8 Hz, 3H, 
CHCH3); 0.95 (d, 3J = 6.9 Hz, 3H, CHCH3); 1.76 (s, 2H, NH2); 2.07-2.23 (m, 1H, CH(CH3)2); 
2.68 (s, 3H, ChetCH3); 4.05 (d, 3JH,H = 5.3 Hz, 1H, C); 5.33, 5.40 (2JH,H = 12.4 Hz, 2H, 
CH2CAr); 7.24-7.46 (m, 5H, CHAr). - 13C-NMR (50 MHz, CDCl3):  = 13.2 (CthiaCH3); 16.8, 
19.3 (CH(CH3)2); 34.1 (CH(CH3)2); 59.2 (CHCthia); 66.3 (CArCH2); 128.0, 128.2, 128.3, 135.9 
(CAr); 140.4, 144.4 (CthiaCH3, CthiaCO2); 162.3, 172.8 (CHCthia, CO2Bn). - FAB-HR MS: m/z 
calcd. for C16H21N2O2S+ 305.1324, found 305.1489. 
 
Methyl 2-((1R)-1-((5R)-2-((S)-1-(benzyloxycarbonylamino)-2-methylpropyl)-5-methyl-
4,5-dihydrooxazole-4-carboxamido)-2-methylpropyl)-5-methylthiazole-4-carboxylate
 (31): 
 
molecular formula: C33H40N4O6S 
molecular mass: 620.761 g/mol 
 
EDIPA (728 mg, 5.64 mmol) and DPPA (752 mg, 2.73 mmol) were added at room 
temperature to 30 (702 g, 1.67 mmol) and 26 (510 g, 1.52 mmol) in 40 mL acetonitrile, and 
the mixture was stirred at room temperature for 20 hours. The solvent was then evaporated 
and the residue dissolved in ethyl acetate. The organic layers were washed with water and 
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brine, dried with MgSO4, and concentrated in vacuo. Flash chromatography on silica gel 
(DCM/EE/MeOH 75:25:2) gave 31 (550 mg, 58%) as a white solid 
 
C33H40N4O6S (620.76): 1H-NMR (400 MHz, CDCl3):  = 0.85 (d, 3JH,H = 6.9 Hz, 3H, 
CvalHCHCH3); 0.95 (d, 3JH,H = 6.8 Hz, 3H, CvalHCHCH3); 1.01 (d, 3JH,H = 6.8 Hz, 3H, 
CvalHCHCH3); 1.02 (d, 3JH,H = 6.8 Hz, 3H, CvalHCHCH3); 1.52 (d, 3JH,H = 6.2 Hz, 3H, 
CoxaHCH3); 2.08-2.16 (m, 1H, CH(CH3)2); 2.43-2.51 (m, 1H, CH(CH3)2); 2.69 (s, 3H, 
CthiaCH3); 4.26 (d, 3J = 7.3 Hz, 1H, CoxaHCO); 4.43 (dd, 3JH,H = 8.8, 4.8 Hz, 1H, CH); 4.78-
4.84 (m, 1H, CoxaHCH3); 5.10 (dd, 3J = 9.2, 2.8 Hz, 1H, CHCthia); 5.16-5.20 (m, 2H, CH2CAr), 
5.36-5.43 (m, 2H, CH2CAr), 5.51 (d, 3J = 8.7 Hz, 1H, NHCO2); 7.29-7.49 (m, 11H, NHCO2, 
CArH). - 13C-NMR (100 MHz, CDCl3):  = 13.2 (CthiaCH3); 17.4, 17.8, 18.8, 19.5 
(CH(CH3)2); 21.8 (CoxaHCH3); 31.3, 32.9 (CH(CH3)2); 54.8 (CHCoxa); 56.2 (CHCthia); 66.6, 
67.0 (CArCH2); 74.3 (CoxaHCO); 80.7 (CoxaHCH3); 128.1, 128.2, 128.2, 128.4, 128.5, 135.9, 
136.2 (CAr); 141.2 (CthiaCH3); 144.3 (CthiaCO); 156.1 (CO2NH); 162.1 (CHCoxa); 164.5 
(CHCthia); 169.0 (CthiaCO2); 171.2 (CoxaHCONH). - EI-HR MS: m/z calcd. for C33H40N4O6+ 
620.2669, found 620.2689. - M.P.: 56 °C. 
 
Cyclic Pseudo Octapeptide H4LascA: 
 
molecular formula: C36H52N8O6S2 
molecular mass: 756.982 g/mol 
 
Pd/C (10%, 240 mg) was added to a solution of 31 (280 mg, 0.42 mmol) in 30 mL methanol. 
The suspension was stirred for 1 h under an H2 atmosphere, subsequently filtered and the 
solvent evaporated. The crude reaction mixture was dissolved in 30 mL acetonitrile and FDPP 
(327 mg, 0.85 mmol) and EDIPA (0.35 mL, 2 mmol) were added at room temperature. The 
mixture was stirred for 3 days. The solvent was evaporated and the residue was dissolved in 
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EtOAc, extracted with water and brine, dried with MgSO4, and concentrated in vacuo. 
Purification was accomplished by chromatography on silica gel (DCM/ethyl acetate/MEOH 
75:25:2) to yield H4LascA (45 mg, 28%) as a white solid 
 
C36H52N8O6S2 (756.98): 1H-NMR (400 MHz, benzene-d6):  = 0.76 (d, 3JH,H = 6.9 Hz, 6H, 
C(S)valHCHCH3); 0.92 (d, 3JH,H = 6.7 Hz, 6H, C(R)valHCHCH3); 0.93 (d, 3JH,H = 6.8 Hz, 6H, 
C(S)valHCHCH3; 1.01 (d, 3JH,H = 6.3 Hz, 6H, CoxaHCH3); 1.04 (d, 3JH,H = 6.8 Hz, 6H, 
C(R)valHCHCH3); 1.78-1.91 (m, 4H, C(S)valHCH(CH3)2, C(R)valHCH(CH3)2); 2.57 (s, 6H, 
CthiaCH3); 4.00 (d, 3JH,H = 6.7 Hz, 2H, CoxaHCO); 4.75-4.82 (m, 2H, CoxaHCH3); 5.01 (m, 2H, 
CHCoxa); 5.56 (dd, 3JH,H = 9.9, 7.6 Hz, 2H, CHCthia); 5.51 (d, 3JH,H = 10.0 Hz, 2H, 
C(R)valHNH); 8.50 (d, 3J = 7.8 Hz, 2H, C(S)valNH). - 13C-NMR (100 MHz, benzene-d6) 
 = 12.4 (CthiaCH3); 17.8, 18.9, 19.0, 19.1 (CH(CH3)2); 21.6 (CoxaHCH3); 32.5, 34.4 
(CH(CH3)2); 52.8 (C(R)valHNH); 54.4 (C(S)valHNH); 73.9 (CoxaHCO); 81.4 (CoxaHCH3); 140.7 
(CthiaCH3); 143.7 (CthiaCO); 162.1 (CHCoxa); 163.8 (CHCthia); 169.2 (CthiaCONH); 170.3 
(CoxaHCONH). - ESI-HR MS: m/z calcd. for C36H53N8O6S2+ 757.35240, found 757.35367. 
 
5.2.5 Preparation of the Copper(II) Complexes of Cyclic Pseudo Peptides 
The copper(II) complexes of the cyclic pseudo peptides were prepared in situ by mixing of 
methanolic solutions of the respective macrocycle (c = 1.25 mM) with a copper(II)triflate 
solution (c = 25mM) and base (n-Bu4N)(OMe) (c = 25 mM). 
The mononuclear complexes were prepared by mixing the solutions in a macro-
cycle/copper(II)/base ratio of 1:1:1.  
The dinuclear copper(II) complexes were prepared by mixing the solutions in a macro-
cycle/copper(II)/base ratio of 1:2:0 or 1:2:1.  
The hydroxo (bridged) complexes were prepared by mixing the solutions in a macro-
cycle/copper(II)/base ratio of 1:2:3.  
The dinuclear carbonato bridged complexes were prepared by exposing mixed solution with a 
macrocycle/copper(II)/base ratio of 1:2:3 for 30min to two hours to air. 
 
A suitable crystal for X-ray diffraction was obtained from the dinuclear copper(II) complex of 
H4Lrs, the cation [H2LrsCu2II(µ-OH)(H2O)2]+, after a complex solution was dissolved in a 
water/methanol mixture of 1:1 and slowly evaporated at room temperature. 
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[(-OCH3)CuII2(HL1)](CF3SO3) 
 
 
 
9.7 mg (2 eq) copper(II) triflate and 43 µL (3 eq) were added at room temperature to a 
solution of 15.36 mg (1eq) H3L1. The solution was stirred for 24 h and the solvent evaporated 
to yield 25.1 mg [(-OCH3)CuII2(HL1)](CF3SO3) as a dark green solid.  
 
C32H46Cu2F3N9O7S · 3.5 H2O (947.97): calcd. (%): C 40.54, H 5.64, N 13.30; found (%): 
C 40.39, H 5.47, N 13.63 (21609). - IR (KBr):  = 3292, 2961, 2982, 2871, 1617, 1594, 1508. 
– ESI-HR MS: m/z calcd. for C31H46Cu2N9O4+ 734.22593, found 734.22459. 
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Appendices 
A Abbreviations 
µL Microliters 
Å Ångström 
Ala Alanine 
Bn Benzyl 
Boc Tertbutylcarboxycarbonyl 
Bu Butyl 
c Concentration 
Calcd. Calculated 
Cbz Carboxybenzyl 
CD Circular Dichroism 
CT Charge Transfer 
CW Continuous Wave 
d Days 
DCM Dichloromethane 
DFT Density Functional Theory 
DMF N,N’-Dimethylformamide 
DMSO Dimethyl sulfoxide 
DPPA Diphenylphosphorylazide 
e.s.d Estimated Standard Deviation 
EDIPA N,N-diisopropylethylamine 
EPR Electron Paramagnetic Resonance 
eq Equivalents 
Eq.  Equation 
ESI Electrospray Ionisation 
Et2O Diethylether 
EtOAc Ethyl Acetate 
EtOH Ethanol 
FAB Fast Atom Bombardment 
FDPP  Pentafluorophenyl diphenylphosphinate 
G03 Gaussian 03 
G09 Gaussian 09 
h Hours 
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HF Hartree Fock 
HR High resolution  
Ile Isoleucine 
IR Infrared 
M.P. Melting Point 
MCD Magnetic Circular Dichroism 
MD Molecular Dynamics 
Me Methyl 
MeOH Methanol 
mL Milliliters 
mM Millimolar 
MM  Molecular Mechanics 
MS Mass Spectrometry 
NaOH Sodium Hydroxide 
neg. Negative 
NMM N-methyl Morpholine 
NMR Nuclear Magnetic Resonance 
Otf Trifluoromethane sulfonate 
PCM Point Charge Model 
Phe Phenylalanine 
pos. Positive 
ppm Parts Per Million 
RMS Root Mean Square 
RMSD Root Mean Square Deviation 
SH Spin Hamiltonian 
SOC Spin Orbit Coupling 
THF Tetrahydrofuran 
UV-vis Ultraviolet / visible 
Val Valine 
VH Variable Field 
vs. Versus 
VT Variable Temperature 
A Absorption 
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B ITC Data 
Fit for the mono- and dinuclear copper(II) complexes of H3L1 [H2L1CuII(solvent)2]+ (left) and 
[HL1Cu2II(OMe)]+ (right). 
0,0 0,5 1,0 1,5 2,0 2,5 3,0 3,5
0
5
Data: H3L111Cuco_NDH
Model: OneSites
Chi^2/DoF = 4.181E4
N 0.962 ±0.021
K 5.85E5 ±1.7E5
H 5231 ±283
S 43.9
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Data: H3L113Cuco_NDH
Model: Sequential Binding Sites
Chi^2/DoF = 5493
K1 2.03E5 ±2.2E4
H1 2153 ±175
S1 31.5
K2 6.70E4 ±6.5E3
H2 1.013E4 ±122
S2 56.1
Molar Ratio
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Fit for the mono- and dinuclear copper(II) complexes of H3L2 [H2L2CuII(solvent)2]+ (left) and 
[HL2Cu2II(OMe)]+ (right). 
0,0 0,5 1,0 1,5 2,0 2,5 3,0
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Data: H3L211Cuco_NDH
Model: OneSites
Chi^2/DoF = 1.382E5
N 0.439 ±0.027
K 2.41E5 ±8.0E4
H -9546 ±915
S -7.37
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Data: H3L2CuComb_NDH
Model: Sequential Binding Sites
Chi^2/DoF = 2.247E5
K1 3.31E5 ±8.3E4
H1 -2.700E4 ±2.40E3
S1 -65.3
K2 4.14E5 ±9.9E4
H2 1.717E4 ±2.36E3
S2 83.3
Molar Ratio
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Fit for the mono- and dinuclear copper(II) complexes of H3L3 [H2L3CuII(solvent)2]+ (left) and 
[HL3Cu2II(OMe)]+ (right).  
 
0,0 0,5 1,0 1,5 2,0 2,5 3,0 3,5
0
5
Data: H3L311Cuco_NDH
Model: OneSites
Chi^2/DoF = 6737
N 0.725 ±0.011
K 5.60E5 ±8.1E4
H 5008 ±172
S 43.1
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Data: H3L3CuComb_NDH
Model: Sequential Binding Sites
Chi^2/DoF = 1.047E4
K1 1.97E5 ±1.9E4
H1 -1050 ±318
S1 20.7
K2 4.95E4 ±6.2E3
H2 1.220E4 ±217
S2 62.4
Molar Ratio
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C DFT Calculated Structures of the Dinuclear Copper(II) complexes of 
H3L2 and H3L3   
Topview of DFT calculated (G03, B3LYP/6-31g*) mononuclear copper(II) complexes of 
H3L2 (a), H3L3 (b), and H3Lwa (c). 
 
 
 
  
a) b) c)
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Topview of the DFT calculated structures (G03, B3LYP/6-31g*) methanol bridged dinuclear 
complexes of H3L2 (a), H3L3 (b), and H3Lwa (c). 
 
 
 
 
D Calculated g and A tensors of H3L2,3 and H3Lwa 
Calculated g and A tensors with various combinations of functionals and basis sets: tables and 
visualizations. See in text (Chapter 3) for references. Wachters[142] basis set was solely applied 
on copper. 
 
H3L2:  
 Experimental g values Experimental A tensors  
[10-4 cm-1] 
Functional / Basis set gx = 2.083 gy = 2.034 gz = 2.279 Ax = 15 Ay = 17 Az = 153 
MAG-ReSpect[127]  2.081 2.095 2.292 19 4 182 
BHLYP / TZVP[136] Wachters[142] 2.092 2.102 2.319 9 31 314 
BHLYP / IGLO-II[140] Wachters 2.081 2.101 2.305 1 17 298 
BHLYP / EPR-II[141] Wachters 2.060 2.142 2.304 21 72 305 
BHLYP / 6-311g*[139] Wachters 2.085 2.100 2.304 11 33 311 
B40LYP / IGLO-II Wachters 2.086 2.097 2.302 21 72 305 
BHLYP / IGLO-II Wachters SOC 2.061 2.143 2.305 15 66 291 
 
Cu1 Cu2
N1
N4
O1
N13
a)
Cu1
Cu2
N1
N4
O1
N13
c)
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H3L3: 
 
Experimental g values Experimental A tensors  
[10-4 cm-1] 
Functional / Basis set*) gx = 2.082 gy = 2.037 gz = 2.263 Ax = 15 Ay = 19 Az = 150 
MAG-ReSpect 2.082 2.096 2.295 35 25 166 
B38LYP / IGLO-II Wachters 2.070 2.083 2.244 9 28 289 
B38LYP / IGLO-II Bauschlicher 2.071 2.085 2.257 100 120 175 
BHLYP / 6-311g* IGLO-II 
Wachters 
2.088 2.099 2.305 11 31 311 
BHLYP / 6311g* Wachters 2.081 2.102 2.306 18 18 298 
BHLYP / EPR II Wachters  2.087 2.099 2,302 109 31 310 
BHLYP / IGLO-II Wachters  2.081 2.101 2.305 2 17 298 
BHLYP / IGLO-II grid5 2.086 2.099 2.302 10 31 310 
BHLYP / IGLO-II grid5 SCF tight 2.086 2.099 2.302 11 31 311 
BHLYP / IGLO-II Kaupp 2.089 2.100 2.309 12 31 305 
BHLYP / IGLO-II SOCFlag 
1,3,3,5 
2.086 2.099 2.302 10 31 310 
BHLYP / TZV[136] Wachters  2.086 2.109 2.322 2 15 300 
BHLYP / TZV IGLO-II Wachters 2.088 2.099 2.306 10 30 310 
BHLYP / TZVP[136] Wachters 2.086 2.109 2.322 3 15 300 
BHLYP / IGLO-II Wachters  2.086 2.099 2.302 11 31 310 
BHLYP / IGLO-II Wachters SOC 2.086 2.098 2.300 12 30 176 
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H3Lwa: 
 
 Experimental g values Experimental A tensors  
[10-4 cm-1] 
Functional / Basis set*) gx = 2.083 gy = 2.051 gz = 2.267 Ax = 14 Ay = 16 Az = 175 
BHLYP / EPR-II Wachters 2,072 2,097 2,298 0 35 303 
BHLYP / IGLO-II Wachters 2,091 2,101 2,324 8 16 302 
BHLYP / IGLO-II Partridge 2,095 2,110 2,344 0 13 296 
MAG-ReSpect BHLYP IGLO-II 2,090 2,094 2,311 not determined 
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E MCD Data: Fits of the VTVH Curves 
VTVH curves of [H1L1Cu2II(µ- OHCH(CH2OH)2)]2+ 
Fit assuming an isolated S = ½ species (e.g. monomeric impurity): 
 
 
Fit assuming an anitferromagnetically coupled species with small J: 
 
  
-0.10
-0.08
-0.06
-0.04
-0.02
0.00
A
1.21.00.80.60.40.20.0 H/2kT
  1.75
Chi^2=  0.72329592E-05; C=-0.2531
B=-0.0007, J= 0
gx1=2.0500, gy1=2.0500, gz1=2.8560
D1=   0.00,  E1=  0.00
Mxy1= 1.00, Mxz1= 0.03, Myz1= 0.03
-0.10
-0.08
-0.06
-0.04
-0.02
0.00
A
1.21.00.80.60.40.20.0 H/2kT
  1.75K
  3.00K
  6.00K
 12.00K
 25.00K
 50.00K
Chi^2=  0.51229669E-03; C=-0.3016
B= 0.0000, J= -0.40
gx1=2.0500, gy1=2.0500, gz1=3.4110
D1=   0.00,  E1=  0.00
Mxy1= 1.00, Mxz1=-0.10, Myz1=-0.10
gx2=2.0500, gy2=2.0500, gz2=3.4110
D2=   0.00,  E2=  0.00
Mxy2= 1.00, Mxz2=-0.10, Myz2=-0.10
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F Crystallographic Data 
 H4L4-bn H4Lrs  [H2LrsCu2II(µ-OH)(H2O)2]+ 
Identification code nd1 nd4a nd8b 
Empirical formula C26 H41 N6 O5 C40 H60 N12 O4 
C40 H62 Cu2 N12 O7, Cl 
O4, 2(H2 O) 
Formula weight 517.65 773.00 1085.58 
Temperature / Wavelength  200(2) K / 71.073 pm 200(2) K / 71.073 pm 200(2) K / 71.073 pm 
Crystal system Tetragonal Tetragonal Monoclinic 
Space group P 41 21 2 I -4 P 2 / c 
Unit cell dimensions 
a = 16.824(2) pm, = 90°. 
b = 16.824(2) pm, = 90°. 
c = 20.119(4) pm,  
 = 90°. 
a = 19.861(3) pm, 
= 90°. 
b = 19.861(3) pm, 
= 90°. 
c = 6.9222(14)pm.  
 = 90°. 
a = 11.876(2) pm ,  
= 90°. 
b = 11.599(2) pm,  
= 102.09 (3). 
c = 18.240(4) pm,  
 = 90°. 
Volume 5694.5(16) nm3 2730.4(8)nm3 2456.8(8) nm3 
Z 8 2 2 
Absorption coefficient 0.085 mm-1 0.063 mm-1 0.993 mm-1 
F(000) 2232 832 1138 
Crystal size 0.2 x 0.02 x 0.02 mm3 
0.3 x 0.21 x 0.11 
mm3 
0.2 x 0.06 x 0.05 mm3 
Theta range for data 
collection 
1.58 to 22.38 2.90 to 28.12 2.57 to 30.47 
Index ranges 
-17 ≤ h ≤ 17, 
-17 ≤ k ≤ 18,  
-20 ≤ l ≤ 21 
-26 ≤ h ≤ 26,  
-26≤ k ≤ 29,  
-9 ≤ l ≤ 9 
-16 ≤ h ≤ 16,  
-16≤ k ≤ 17,  
-24 ≤ l ≤ 25 
Reflections collected 29980 13373 29065 
Independent reflections 3651 [R(int) = 0.0450] 
3313 [R(int) = 
0.0450] 
3384 [R(int) = 0.0503] 
Completeness to theta = 
22.62° 
99.6% 99.6% 91.5% 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3651 / 9 / 371 3316 / 0 / 132 6841 / 0 / 324 
Goodness-of-fit on F2 0.863 1.13 0.847 
Final R indices [I>2sigma(I)] 
R1 = 0.0450, wR2 = 
0.0994 
R1 = 0.1749, wR2 = 
0.3757 
R1 = 0.1206, wR2 = 
0.1262 
R indices (all data) 
R1 = 0.0761, wR2 = 
0.1085 
R1 = 0.1288, wR2 = 
0.3577 
R1 = 0.0503, wR2 = 
0.1015 
Absolute structure parameter -1 (2) 6 (6) -1 (2) 
Largest diff. peak and hole 0.269 d -0.310 e.Å-3 1.613 d -0.534e.Å-3 0.578 and -0.612e. Å-3 
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G NMR and EPR Spectra of the Pink Species of H4L4  
 
NMR spectra (200 MHZ, MeOH-d4) of H4L4 (green) and the pink species. NMR signals: 
 = 0.85 (d, 3J = 6.6 Hz, 3H, CHCH3); 1.10 (d, 3J = 6.7 Hz, 3H, CHCH3); 2.39-2.51 (m, 1H, 
CH(CH3)2); 2.47 (s, 3H, ChetCH3); 3.61 (s, 3H, NCH3); 4.94 (dd, 3J = 9.5, 9.5 Hz, 1H, CH) 
ppm. 
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H  Anisoptropic Spin Hamiltonian Parameters of the Dinuclear 
Copper(II) Complexes of H4L4 
 
Parameters a) [H2L4Cu2]2+ b) [H2L4Cu2(OH)]+ c) [H2L4Cu2(OH)2] d) [H2L4Cu2(13CO3)] e) 
Cu 1  gx 2.05 2.0855 2.0049 2.0215 
 gy 2.09 2.0732 2.1128 2.1920 
 gz 2.20 2.1760 2.212 2.1924 
Ax 20 42.742 35.917 45 
Ay 30 54.523 26.876 45 
Az 155 48.225 169.838 111.2339 
 0 0.000 129.671 0 
 0 90.000 86.962 0 
 0 0.000 143.146 0 
X 0 0.000 2.71258 0.0 
Y 0 0.000 0.480993 0.0 
Z 0 0.000 0.262991 0.0 
Cu 2  gx 2.08 2.0520 1.9923 2.0211 
 gy 2.10 2.0748 2.1462 2.1914 
 gz 2.15 2.1753 2.1948 2.1930 
Ax 30 28.526 29.402 9.1233 
Ay 50 79.599 24.316 47.51394 
Az 140 160.366 156.481 93.34469 
 30 0.000 129.472 0 
 5 90.000 173.592 0 
 30 0.000 160.457 0 
X -5.49910 0.000 -2.53655 0.0 
Y -0.154500 0.000 -0.2352 0.0 
Z 0.217100 4.473 -0.7078 4.259 
J f) -20 -20 -20 -20 
R 5.223 4.473 4.9691 4.259 
a) Units:X,Y,Z, R [Å], A [10-4cm-1], J [cm-1], Line width parameters [Units: dA, lw, 10-4cm-1; dJ, cm-1; dr, Å]; 
b) Line width parameters for the two Cu(II) centers: LWx1,y1,z1 = 15; LWx2,y2,z2 = 15.  
c) Line width parameters for the two Cu(II) centers: dgx1=0.002, dgy1=0.002, dgz1=0.002, dAx1=1.0, dAy1=1.0, 
dAz1=1.0; dgx2=0.002, dgy2=0.002, dgz2=0.002, dAx2=1.0, dAy2=1.0, dAz2=1.0, dJ=0.00 dr-3=0.000885; lwx = 
41.514791, lwy=18.359317, lwz=11.978638.  
d, e) Line width parameters for the two Cu(II) centers: dgx1=0.000018, dgy1=0.000023, dgz1=0.000000, 
dAx1=49.670672, dAy1=86.721661, dAz1=44.414936; dgx2=0.025879, dgy2=0.000000, dgz2=0.026824, 
dAx2=59.283464, dAy2=88.877275, dAz2=13.504909, dJ=0.00 dr-3=0.00; lwx=0.001997, lwy=30.310447, 
lwz=31.107599. The unresolved hyperfine coupling arises from contributions of A, lw, dg, and dA.  
f) H = J S1.S2 
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I  DFT Calculated Structures of the Copper(II) Complexes of 
Cyclic Pseudo Octapeptides 
Dihydroxo complex of H4L4, top and side view [H2L4Cu2II(OH)2]  
 
 
 
 
Overlay Plots of the DFT Calculated Structures of the Dinuclear Copper(II) Complexes of 
H4Lox and H4L4: 
 
[H2L4Cu2II]2+ (orange) vs [H2LoxCu2II]2+ (black). Top (left) and sideview (right). 
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[H2L4Cu2II(µ-CO3)]2+ (orange) vs [H2LoxCu2II(µ-CO3)]2+ (black). Top (left) and sideview 
(right). 
 
 
 
 
Top (left) and side view (right) of the overlay plots of the DFT calculated structures of the 
mononuclear copper(II) complex [H3LrsCusII(H2O)2]+, calculated with (Gaussian 09, 
B3LYP/6-31g*/TZVP, PCM, methanol) and without a solvation model. 
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J UV-vis and CD Spectra of H4LascA  
Titration of 1-2 eq of base to an H4LascA : copper(II) 1:2 solution 
 
 
 
Titration of 2-3 equivalents of base an H4LascA : copper(II) 1:2 solution 
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